# EDGAR Filing Document

**Accession Number:** 0001803599
**File Stem:** 0001803599-26-000027
**Filing Date:** 2026-1
**Character Count:** 566094
**Document Hash:** ad323d508f1a1615d0a3e5a1ef2ca8ac
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001803599-26-000027.hdr.sgml**: 20260128

**ACCESSION NUMBER**: 0001803599-26-000027

**CONFORMED SUBMISSION TYPE**: 10-K

**PUBLIC DOCUMENT COUNT**: 116

**CONFORMED PERIOD OF REPORT**: 20251130

**FILED AS OF DATE**: 20260128

**DATE AS OF CHANGE**: 20260128

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Concentrix Corp
- **CENTRAL INDEX KEY:** 0001803599
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 271605762
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1130

**FILING VALUES:**
- **FORM TYPE:** 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39494
- **FILM NUMBER:** 26572528

**BUSINESS ADDRESS:**
- **STREET 1:** 39899 BALENTINE DRIVE
- **CITY:** NEWARK
- **STATE:** CA
- **ZIP:** 94560
- **BUSINESS PHONE:** 8007470583

**MAIL ADDRESS:**
- **STREET 1:** 39899 BALENTINE DRIVE
- **CITY:** NEWARK
- **STATE:** CA
- **ZIP:** 94560

?xml version='1.0' encoding='ASCII'? cnxc-20251130

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-K**

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

**For the fiscal year ended November 30, 2025**

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

**For the transition period from _______ to ________**

**Commission File Number: 001-39494**

![Concentrix Logo.jpg](cnxc-20251130_g1.jpg)

**CONCENTRIX CORPORATION**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **27-1605762** |
| (State or other jurisdiction of <br>incorporation or organization) | (I.R.S. Employer <br>Identification No.) |

---

---

| | |
|:---|:---|
| **39899 Balentine Drive, Suite 235, Newark, California** | **94560** |
| (Address of principal executive offices) | (Zip Code) |

---

(Registrant's telephone number, including area code): **(800) 747-0583** 

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of each exchange on which registered</u>** |
| Common Stock, par value $0.0001 per share | CNXC | The Nasdaq Stock Market LLC |

---

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer&nbsp;&nbsp;&nbsp;&nbsp;☒&nbsp;&nbsp;&nbsp;&nbsp;Accelerated filer&nbsp;&nbsp;&nbsp;&nbsp; ☐&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-accelerated filer&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Smaller reporting company&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp;☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐ No **☒**

The aggregate market value of the registrant's common stock held by non-affiliates of the registrant was $2,948,926,137, computed by reference to the closing sale price of the common stock on the Nasdaq Stock Market LLC on May 31, 2025, the last business day of the registrant's most recently completed second fiscal quarter.

As of January 16, 2026, there were 61,597,304 shares of common stock issued and outstanding.

**DOCUMENTS INCORPORATED BY REFERENCE**

Items 10, 11, 12, 13 and 14 of Part III of this Annual Report on Form 10-K incorporate by reference portions of the Registrant's definitive proxy statement relating to its 2026 Annual Meeting of Stockholders (the "2026 Proxy Statement") where indicated. The 2026 Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Table of Contents**

---

| | |
|:---|:---|
| | Page |
| **<u>[PART I](#ic6c7f84d93cf4ade8f96643eb3cd05dd_10)</u>** |  |
| <u>[Item 1. Business](#ic6c7f84d93cf4ade8f96643eb3cd05dd_13)</u> | <u>[2](#ic6c7f84d93cf4ade8f96643eb3cd05dd_13)</u> |
| <u>[Item 1A. Risk Factors](#ic6c7f84d93cf4ade8f96643eb3cd05dd_16)</u> | <u>[14](#ic6c7f84d93cf4ade8f96643eb3cd05dd_16)</u> |
| <u>[Item 1B. Unresolved Staff Comments](#ic6c7f84d93cf4ade8f96643eb3cd05dd_19)</u> | <u>[27](#ic6c7f84d93cf4ade8f96643eb3cd05dd_19)</u> |
| <u>[Item 1C. Cybersecurity](#ic6c7f84d93cf4ade8f96643eb3cd05dd_22)</u> | <u>[27](#ic6c7f84d93cf4ade8f96643eb3cd05dd_22)</u> |
| <u>[Item 2. Properties](#ic6c7f84d93cf4ade8f96643eb3cd05dd_25)</u> | <u>[29](#ic6c7f84d93cf4ade8f96643eb3cd05dd_25)</u> |
| <u>[Item 3. Legal Proceedings](#ic6c7f84d93cf4ade8f96643eb3cd05dd_28)</u> | <u>[29](#ic6c7f84d93cf4ade8f96643eb3cd05dd_28)</u> |
| <u>[Item 4. Mine Safety Disclosures](#ic6c7f84d93cf4ade8f96643eb3cd05dd_31)</u> | <u>[29](#ic6c7f84d93cf4ade8f96643eb3cd05dd_31)</u> |
| **<u>[PART II](#ic6c7f84d93cf4ade8f96643eb3cd05dd_34)</u>** |  |
| <u>[Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](#ic6c7f84d93cf4ade8f96643eb3cd05dd_37)</u> | <u>[30](#ic6c7f84d93cf4ade8f96643eb3cd05dd_37)</u> |
| <u>[Item 6. \[Reserved\]](#ic6c7f84d93cf4ade8f96643eb3cd05dd_40)</u> | <u>[33](#ic6c7f84d93cf4ade8f96643eb3cd05dd_40)</u> |
| <u>[Item 7. Management's Discussion and Analysis of Financial Condition and Result of Operations](#ic6c7f84d93cf4ade8f96643eb3cd05dd_43)</u> | <u>[33](#ic6c7f84d93cf4ade8f96643eb3cd05dd_43)</u> |
| <u>[Item 7A. Quantitative and Qualitative Disclosures About Market Risk](#ic6c7f84d93cf4ade8f96643eb3cd05dd_73)</u> | <u>[50](#ic6c7f84d93cf4ade8f96643eb3cd05dd_73)</u> |
| <u>[Item 8. Financial Statements and Supplementary Data](#ic6c7f84d93cf4ade8f96643eb3cd05dd_76)</u> | <u>[51](#ic6c7f84d93cf4ade8f96643eb3cd05dd_76)</u> |
| <u>[Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](#ic6c7f84d93cf4ade8f96643eb3cd05dd_157)</u> | <u>[98](#ic6c7f84d93cf4ade8f96643eb3cd05dd_157)</u> |
| <u>[Item 9A. Control and Procedures](#ic6c7f84d93cf4ade8f96643eb3cd05dd_160)</u> | <u>[98](#ic6c7f84d93cf4ade8f96643eb3cd05dd_160)</u> |
| <u>[Item 9B. Other Information](#ic6c7f84d93cf4ade8f96643eb3cd05dd_163)</u> | <u>[98](#ic6c7f84d93cf4ade8f96643eb3cd05dd_163)</u> |
| <u>[Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](#ic6c7f84d93cf4ade8f96643eb3cd05dd_166)</u> | <u>[98](#ic6c7f84d93cf4ade8f96643eb3cd05dd_166)</u> |
| **<u>[PART III](#ic6c7f84d93cf4ade8f96643eb3cd05dd_169)</u>** |  |
| <u>[Item 10. Directors, Executive Officers and Corporate Governance](#ic6c7f84d93cf4ade8f96643eb3cd05dd_172)</u> | <u>[99](#ic6c7f84d93cf4ade8f96643eb3cd05dd_172)</u> |
| <u>[Item 11. Executive Compensation](#ic6c7f84d93cf4ade8f96643eb3cd05dd_175)</u> | <u>[99](#ic6c7f84d93cf4ade8f96643eb3cd05dd_175)</u> |
| <u>[Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](#ic6c7f84d93cf4ade8f96643eb3cd05dd_178)</u> | <u>[99](#ic6c7f84d93cf4ade8f96643eb3cd05dd_178)</u> |
| <u>[Item 13. Certain Relationships and Related Transactions, and Director Independence](#ic6c7f84d93cf4ade8f96643eb3cd05dd_181)</u> | <u>[99](#ic6c7f84d93cf4ade8f96643eb3cd05dd_181)</u> |
| <u>[Item 14. Principal Accounting Fees and Services](#ic6c7f84d93cf4ade8f96643eb3cd05dd_184)</u> | <u>[100](#ic6c7f84d93cf4ade8f96643eb3cd05dd_184)</u> |
| **<u>[PART IV](#ic6c7f84d93cf4ade8f96643eb3cd05dd_187)</u>** |  |
| <u>[Item 15. Exhibits and Financial Statement Schedules](#ic6c7f84d93cf4ade8f96643eb3cd05dd_190)</u> | <u>[100](#ic6c7f84d93cf4ade8f96643eb3cd05dd_190)</u> |
| <u>[Item 16. Form 10-K Summary](#ic6c7f84d93cf4ade8f96643eb3cd05dd_193)</u> | <u>[104](#ic6c7f84d93cf4ade8f96643eb3cd05dd_193)</u> |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

***Note Regarding Forward-Looking Statements***

*Unless otherwise indicated or except where the context otherwise requires, the terms "Concentrix," "the Company,"* "*we,*" "*us*" *and* "*our*" *and other similar terms in this Annual Report on Form 10-K refer to Concentrix Corporation and its subsidiaries.*

*This Annual Report on Form 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the* "*Securities Act*"*), and Section 21E of the Securities Exchange Act of 1934, as amended (the* "*Exchange Act*"*). Forward-looking statements include, but are not limited to, statements regarding our expected future financial condition and growth, cash flows, results of operations, effective tax rate, leverage, liquidity, business strategy, competitive position, the future growth of, and demand and market acceptance for, our services and products, seasonality of our business, international operations, the potential benefits associated with use of the Company's technology and services, acquisition opportunities and the anticipated impact of acquisitions, capital allocation and dividends, growth opportunities, spending, capital expenditures and investments, debt repayment and obligations, competition and market forecasts, industry trends, our human capital resources and sustainability initiatives, and statements that include words such as believe, expect, may, will, provide, could, should, and other similar expressions. These forward-looking statements are inherently uncertain and involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things: risks related to general economic and geopolitical conditions and their effects on our clients' businesses and demand for our services, including consumer demand, interest rates, inflation, international tariffs and global trade policies, supply chains, and the conflicts in Ukraine and the Middle East, and tensions between India and Pakistan; cyberattacks on our or our clients*' *networks and information technology systems; uncertainty around, and disruption from, new and emerging technologies, including the adoption and utilization of artificial intelligence ("AI") including agentic AI and generative AI; the failure of our staff and contractors to adhere to our and our clients' controls and processes; the inability to protect personal and proprietary information; the effects of communicable diseases or other public health crises, natural disasters, and adverse weather conditions; geopolitical, economic and climate- or weather-related risks in regions with a significant concentration of our operations; the ability to successfully execute our strategy; competitive conditions in our industry and consolidation of our competitors; variability in demand by our clients or the early termination of our client contracts; the level of business activity of our clients and the market acceptance and performance of their products and services; the demand for end-to-end solutions and technology; damage to our reputation through the actions or inactions of third parties; changes in law, regulations or regulatory guidance, or changes in their interpretation or enforcement, including changes in law and policy that restrict travel or visas between countries in which we have operations; the operability of our communication services and information technology systems and networks; the loss of key personnel or the inability to attract and retain staff with the skills and expertise needed for our business; increases in the cost of labor; the inability to successfully identify, complete and integrate strategic acquisitions or investments or realize anticipated benefits within the expected timeframe; higher than expected tax liabilities; currency exchange rate fluctuations; investigative or legal actions; and other risks that are described under "Risk Factors" in Part I, Item 1A of our Annual Report on Form 10-K. We do not intend to update forward-looking statements, which speak only as of the date hereof, unless otherwise required by law.*

*Concentrix, Webhelp, and all Concentrix company, product, and services word and design marks and slogans are trademarks or registered trademarks of Concentrix Corporation and its subsidiaries. Other names and marks are the property of their respective owners. All rights reserved.*

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Part I**

**ITEM 1. BUSINESS**

**Our Company**

We are a global technology and services leader that powers exceptional brand experiences and digital operations for more than 2,000 clients across the globe. We design, build, and run fully integrated, end-to-end solutions — including customer experience ("CX") process optimization, technology innovation and design engineering, front- and back-office automation, analytics, and business transformation services — for clients in five primary industry verticals. Our solutions help our clients drive deep understanding, full lifecycle engagement, and differentiated customer experiences for their brands.

We strive to deliver exceptional services globally, supported by our deep industry knowledge, technology and security practices, talented people, and digital and analytics expertise. Our differentiated portfolio of solutions supports Fortune Global 500 and new economy companies across the globe in their efforts to deliver an optimized, consistent brand experience across all channels of communication, including voice, chat, email, generative AI ("GenAI") and agentic AI-powered self-service, social media, asynchronous messaging, and other custom applications.

We offer our clients integrated solutions to support the entirety of their customer lifecycles, transform their businesses, and solve business challenges:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• CX and user experience ("UX") strategy and design;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• digital operations, including business-to-business ("B2B") sales, performance marketing, customer loyalty, trust and safety, collections, and financial compliance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• data analytics, enterprise intelligence, artificial intelligence ("AI") readiness, and actionable insights; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• innovative new approaches to enhancing the customer experience through the latest technological advancements in our industry, including GenAI and agentic AI technologies.

Through our end-to-end capabilities, we believe we deliver better economic outcomes for our clients with solutions designed to meet their unique needs as they navigate a landscape characterized by discerning consumers and new market entrants.

We have strong relationships with global brands and are a partner of choice for industry leaders, including more than 160 Fortune Global 500 clients as of November 30, 2025. We believe in deepening and broadening our support of clients over the long term to build enduring relationships, and we prioritize the pursuit of clients in verticals characterized by high growth, high transaction volume, high levels of compliance and security, and steep barriers to entry. Our average client tenure for our top 30 clients is 16 years. Our strategic verticals include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• technology and consumer electronics;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• retail, travel and e-commerce;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• communications and media;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• banking, financial services and insurance; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• healthcare.

Our clients include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 8 of the top 10 global tech and consumer electronics companies

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 8 of the top 10 global fintech companies

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 2 of the top 5 global retail and e-commerce companies

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 8 of the top 10 European banks

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 7 of the top 10 U.S. banks

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 5 of the top 5 U.S. health insurance companies

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 3 of the top 5 global healthcare companies

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 10 of the top 10 global automotive companies

Through our technology-infused solutions, our clients benefit from having a single partner that can deliver integrated solutions globally at scale, enabling them to address the entirety of the customer journey, from acquisition to support to renewal. Our end-to-end capabilities and broad service offerings help our clients acquire, retain, and improve the lifetime value of their customer relationships while optimizing their back-office processes.

We combine global consistency with local expertise, enhancing the end user experience for our clients' customers through services rendered by a team of approximately 455,000 employees and staff, which we refer to as game-changers, across approximately 483 locations in 74 countries and six continents in the languages and dialects that are relevant to our clients and their customers.

***Strategic Growth***

We have a long history of growth through strategic acquisitions, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our September 2025 acquisition of SAI Digital, an end-to-end digital commerce and CX technology solutions company with a strong presence in Asia;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our September 2023 acquisition of the Webhelp business ("Webhelp"), a leading provider of CX solutions, including sales, marketing, and payment services, with significant operations and client relationships in Europe, Latin America, and Africa;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our July 2022 acquisition of ServiceSource International, Inc. ("ServiceSource"), a global outsourced go-to-market services provider that delivered business-to-business ("B2B") digital sales and customer success solutions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our December 2021 acquisition of PK, a leading CX design engineering company that created pioneering experiences to accelerate digital outcomes for their clients' customers, partners and staff; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our October 2018 acquisition of Convergys Corporation, a customer experience outsourcing company that added scale, diversified our revenue base, and expanded our service delivery capabilities.

Our strategic acquisitions have strengthened our position as a global technology and services leader by expanding our scale in the digital IT services market and creating one of the most robust, well-balanced global footprints in the industry. Our disciplined approach to growth has strengthened our value proposition for our clients by broadening our offering of AI solutions, digital capabilities, and high-value services.

We trace our roots to 2004 when SYNNEX Corporation, now known as TD SYNNEX Corporation ("TD SYNNEX"), acquired BSA Sales, Inc., a company with 20 employees focused on helping clients through outsourced sales and marketing services. In 2006, TD SYNNEX combined New York-based Concentrix with BSA Sales under the Concentrix name, with the goal of bringing technology and innovation into businesses to help clients reimagine and design the next generation of experiences. Concentrix Corporation was incorporated in Delaware in December 2009. In December 2020, Concentrix was separated from TD SYNNEX through a tax-free distribution of all of the issued and outstanding shares of our common stock to TD SYNNEX stockholders (such separation and distribution, the "spin-off"). As a result of the spin-off, we became an independent public company and our common stock commenced trading on the Nasdaq Stock Market ("Nasdaq") under the symbol "CNXC" on December 1, 2020.

**Our Solutions and Technology**

Through our strategy, talent, and technology, we are fully equipped to design, build, and run solutions that help our clients enhance their customers' experience and improve business performance. Through our integrated solutions offering, we assist our clients in acquiring, supporting and renewing customers, leveraging customer feedback and insights to constantly improve business performance, and identifying and implementing customer-facing and back-office process improvements. We help our clients by creating tools that their customers and

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

employees love to use, enabling better customer interactions through real-time sentiment analysis, and integrating multiple customer interactions and touchpoints into one-stop smart mobile applications.

***Services Portfolio.*** We deliver integrated solutions and services that address the entirety of the customer lifecycle, support business transformations, and solve business challenges. We offer our clients the means to acquire, support, and renew customers across all channels while minimizing attrition and increasing customer lifetime value.

Our broad portfolio of services include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Strategy and Design****.* We strive to help our clients reimagine what great is by using human-centered design and tech-enabled innovation to design next-generation solutions that shape experiences, strategies, and operations. Our Strategy and Design solutions include business transformation consulting, next-gen experience design, digital innovation — including GenAI and agentic AI, and lifecycle engagement. Through these services, we promote a more rapid integration of digital and enabling technologies, providing transformational business services to our clients.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Data and Analytics****.* We use technology and innovative domain-specific solutions to assist our clients in maximizing the value of their data by evaluating and using enterprise data to drive business decisions and integrating the insights gained from the analysis of enterprise data into business processes. Our Data and Analytics services include data and analytics transformation, data annotation and engineering, advanced analytics, enterprise intelligence, operational insights, and voice of the customer ("VOC") solutions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Enterprise Technology.*** Utilizing our deep knowledge of our clients' businesses, industries, and enterprise technology, we partner with our clients to evaluate, modernize, adopt, integrate, and enhance their use of technology for enhanced efficiency. Our game-changers: advise clients on their technology strategy and roadmap; develop personalized customer journey experiences; design, build, and run enterprise-wide applications, such as self-service AI bots and GenAI-powered platforms; accelerate development cycles with quality assurance and testing services; and reinforce cybersecurity through managed security services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Digital Operations.*** We combine expert knowledge, cutting-edge technologies, and distinct operating models, using the best of human and AI capabilities to assist our clients in solving business challenges. Our digital operations services include marketing, B2B sales, customer service, trust and safety, and finance and compliance services.

***Intelligent Experience Products.*** In September 2024, we launched our Intelligent Experience ("iX") suite of products, designed to solve client and customer challenges and improve efficiency and performance. Our current iX suite offerings include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***iX Hello***<sup>TM</sup> is an enterprise-grade GenAI-powered self-service application that is designed to accelerate productivity across multiple business functions by enabling users to create customizable virtual assistants that can integrate with leading large language models as well as internal data sources. iX Hello is capable of researching the latest online information, translating text in over 90 languages, analyzing files, images, and data, transcribing voice and meeting notes, and creating training materials, documentation, and reports, among other applications.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***iX Hero***<sup>TM</sup> is an agentic AI-powered application that works together with a human in the loop to accelerate customer experience delivery. iX Hero is designed to analyze advisor performance and provide data-driven real-time coaching and insights, find and surface ready-to-use answers during customer interactions, summarize and automatically transcribe conversations, and deliver essential news and updates to advisors. iX Hero includes two agentic AI features, Harmony, which fine-tunes speech patterns for clearer pronunciation, and Clarity, which suppresses background noise to deliver clearer audio.

In addition, in September 2025, we announced the launch of our Agentic Operating Framework<sup>TM</sup>, which combines advanced technologies with consulting capabilities to assist enterprises in overcoming common problems that can result in AI pilot failures. The framework utilizes agentic AI services - from readiness and strategy to brand-aligned language models, agentic engineering, data management, and monitoring - integrating our flexible approach with strategic partners and our proprietary iX suite of products.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Our Market Opportunity**

Our clients must transform and continually evolve their systems in response to increased competition and to meet the demands of consumers and employees. To meet these growing demands, our clients look to large solutions and technology providers with a broad portfolio of services, such as Concentrix, to automate their systems and provide professional support to address complexities beyond the scope of automation. We are a leader in next-generation CX technology and a trusted partner to leading global brands, driven by a focus on innovation, which we believe will increase our total addressable market as we grow across new and existing markets.

We offer a unique combination of technology and services and deliver our solutions globally at scale. Our suite of integrated solutions include: digital transformation services that design and engineer CX solutions to enable efficient customer self-service and build customer loyalty; customer engagement solutions and services that address the entirety of the customer lifecycle; AI technology that can intelligently act on customer intent to improve customer experience with non-human engagement; self-service GenAI and agentic AI assistants that can be customized to fit a myriad of use cases from data analysis to language translations to internal chatbots; VOC solutions to gather and analyze customer feedback to foster loyalty to, and growth with, clients; analytics and consulting solutions that synthesize data and provide professional insight to improve clients' customer experience strategies; specialized support to specific industry verticals, including collections, know-your-customer, and financial crime and compliance; and back-office services that support clients in non-customer facing areas.

***Industry Trends***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Technological Innovation***. Emerging technology is driving change within our industry and shaping the demands of our clients. AI and automation acceleration, as well as rapid advancements in areas such as digital services, GenAI, agentic AI, and machine learning ("ML") are further changing our markets and our clients' markets while opening new avenues for growth and opportunities for us to better serve our clients. These technologies provide clients with the opportunity to interact more effectively with their customers and employees, and improve experiences by automating processes, optimizing customer journeys to reach faster solutions, enabling personalized engagement across multiple platforms, and focusing human engagement on the most complex interactions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***• Importance of Customer Experience****.* We believe customer experience is a strategic imperative for enterprises today. Data, analytics, and digital solutions have reshaped the ways enterprises interact with their customers and internal stakeholders. As a result, enterprises are modernizing how they manage the customer experience across all channels of communication. The market has evolved from customer relationship management solutions that act as a cost cutting measure toward end-to-end management solutions that create value throughout the entire customer lifecycle at an appropriate cost.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Empowered Consumers and Users***. Modern consumers are discerning and have come to expect a high level of care and responsiveness from their service providers. Old paradigms have shifted as increasingly competitive markets, easily accessible crowd-sourced information, and self-service GenAI and agentic AI solutions have empowered consumers to unprecedented levels. As consumers demand more and have an increasing number of alternatives, companies must differentiate on how they manage their customer relationships. This shift is driving the market toward consumer-centric solutions that reduce customer churn and promote brand loyalty.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Mission Critical Nature of Cybersecurity***. Technological innovation coupled with the proliferation of smart devices and mobile connectivity is generating sensitive data at scale. At the same time, the avenues for access have become numerous, and an increasing number of malicious actors are becoming more sophisticated and active. Data security is paramount in an environment where external intrusion, improper access, or carelessness can compromise customers and businesses. Businesses require scalable, industry-leading data protection and security to avoid reputational and operational risks in an environment characterized by the threats and benefits of free-flowing information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***• Evolving Role of People***. The skill set required of customer-facing employees is shifting as enterprises continue to place increased importance on CX and automation of lower complexity contacts continues. Contacts in the voice and chat channels are increasingly complex and driving a trend of longer customer engagements, requiring individuals to have a more robust skill set. However, the transition of lower

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

complexity support to online and self-support options, driven by heavy automation and the increased use of new technologies, reduces volumes in the voice channel. Despite growth in digital channels, we expect the human element will continue to be important in our industry, as focus shifts from routine service to "last-mile" support requiring human-touch to deliver a stronger customer experience. In our view, attracting and retaining skilled talent that can adapt to the evolving focus of customer engagements requires a diverse and inclusive workplace that supports staff wellness.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Enterprise Preferences Driving Vendor Consolidation***. Enterprises have become increasingly global. As their scope of business increases, enterprises require partners that can serve their needs by rapidly deploying solutions and new technology consistently across multiple geographies and channels. Enterprises therefore prefer vendors with scale and end-to-end capabilities and a deep knowledge of their business and industry that can be a one-stop shop and are consolidating existing relationships to vendors with scale to achieve their business objectives and pursue cost savings.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Market Fragmentation Driving Industry Consolidation****.* We operate in a fragmented marketplace characterized by numerous vendors offering a variety of services across different levels of the value chain. Our competitive landscape includes global, fully integrated solutions providers, core CX solutions providers, digital IT services competitors, and other CX solutions competitors that primarily provide complementary services such as consulting and design, IT services, business process services, and data and analytics. Market share across this competitive landscape is highly dispersed with thousands of vendors participating in different portions of the market and no single provider or small number of providers holding a significant share of the total addressable market. As client preferences continue to evolve in line with enterprise preferences, we anticipate that the market will undergo further consolidation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Legacy Solutions Have Many Limitations****.* As executives look to successfully navigate digital transformation and manage their customers' experience across a wider variety of channels, unsophisticated providers and solutions often fail to meet customers' evolving needs. Currently there is a limited set of providers with end-to-end, global offerings of scale in the marketplace. The fragmentation of the market and, for many industries, high regulatory hurdles create additional complexity as most providers are small, niche, or local players. These issues are compounded by a lack of sufficient investment in cybersecurity, creating exposure to regulatory, reputational, and operational risks. These pain points, coupled with the prevalence of providers offering legacy solutions that fail to address the increasing demands of the modern consumer, create an opportunity for large-scale, global end-to-end solutions providers.

**Our Competitive Strengths**

We believe the following strengths differentiate us from our competitors and provide us with a competitive advantage:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Market Leader with a Differentiated Brand and Value Proposition***: We strive to have a compelling brand and reputation as a leading provider of solutions and technology that improve business outcomes and shape the customer experience. We have a differentiated combination of global scale, local reach, technological expertise, end-to-end solution capabilities and full lifecycle services, and we are also an industry leader in cybersecurity best practices. We are widely recognized as a leading provider of CX solutions and technology, garnering industry attention via 195 industry awards in fiscal year 2025. Third-party researchers have also taken note of our leading global practice with Everest Group Research distinguishing us in 2025 as a leader and star performer for global customer experience management, including recognition as a leader in each of the Americas, APAC, and EMEA regions for the fourth consecutive year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***• Strong Relationships with a Growing and Diversified Client Base***: We partner with more than 2,000 clients worldwide. Leading global companies, including more than 160 Fortune Global 500 brands, rely upon our solutions and technology. We serve a wide variety of clients, extending across numerous verticals. Our end-to-end capabilities and global scale have enabled us to build long-lasting relationships with our largest clients spanning 16 years on average. Our commitment to our clients is our primary focus and has generated numerous accolades to date, including 70 client awards in fiscal year 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Extensive Global Presence***: We operate globally in 74 countries across six continents with the ability to conduct business in those locations in the languages and dialects that are relevant to our clients and their

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

customers. We believe we are well-positioned to serve the largest global brands in nearly every market in which they operate. Our global footprint includes a strong presence in emerging markets such as India, Egypt, Brazil, Türkiye, China, South Africa, Vietnam, Indonesia, Mexico, Poland and Thailand, which provides an opportunity to grow with our clients in these regions. Our ability to create value for our clients across a global delivery platform has enabled us to be a partner of choice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Continued Investment in Technology***: We believe that our focus on innovation and our investment in technology enables us to maximize value for our clients and differentiates us from our competitors. We have provided technology-infused CX solutions for nearly two decades. We have been at the forefront of developing CX solutions and technology that improve the customer experience, through all stages of the engagement lifecycle, and will continue to strive for this in the future. We have been a leader in our industry in advancements such as conversational virtual assistants, multichannel and augmented CRM, predictive analytics, emotion analytics, cognitive learning, AI, GenAI, and agentic AI and believe we enjoy a first mover advantage. In September 2024, we introduced our iX suite of technology with the release of iX Hello, a GenAI-powered platform for creating virtual assistants and in fiscal year 2025, expanded our offerings with the addition of iX Hero, an agentic AI-powered application for accelerating customer experience delivery. By proactively introducing technological innovation to our clients, we deepen our relations and are often rewarded with opportunities to expand our engagements and secure additional sources of revenue.

Despite our focus on investing in technology, due to our size, scale, and the regular implementation of our technology-infused solutions, historically, our costs of developing, maintaining, and integrating new technologies were not material on a stand-alone basis. Beginning in fiscal year 2024, we increased our investment in technology to approximately 1% of revenue, including expenses related to the development of our iX suite of technology.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***• Corporate Culture Committed to Our Clients*' *Success***: Our unified team allows us to deliver consistent and exceptional results. As of November 30, 2025, our team consisted of approximately 455,000 game-changers globally. We enjoy high staff engagement because of a strong company culture that champions our people and is committed to creating game-changing brand experiences for our clients and their customers. We promote integrity and collaboration, strive for inclusion and belonging in the workplace, and emphasize the wellness and mental health of our game-changers. We believe this supportive environment reinforces the commitment of our team, empowers our game-changers to make an impact on our global community, and drives better customer experiences and improved outcomes for our clients.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Demonstrated History of Strategic Acquisitions***: We have acquired and integrated more than 20 companies since our inception. We have a demonstrated ability to complete scale acquisitions, as well as revive underutilized assets and maximize their value, which we believe allows us to explore a broader scope of opportunities than our peers. In fiscal year 2025, we acquired SAI Digital, scaling our presence in Vietnam as a strategic hub to deliver innovation and intelligent experiences for global brands and expanding our digital and AI capabilities across digital commerce and CX. In fiscal year 2023, we completed our combination with Webhelp, which significantly expanded our geographic footprint in Europe, Latin America, and Africa, and expanded the breadth and global reach of our higher-value services and digital capabilities. In fiscal year 2022, we acquired PK, which expanded our scale in the digital IT services market and supported our growth strategy of investing in digital transformation to deliver exceptional customer experiences, and ServiceSource, which complemented our B2B digital sales and customer success solutions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Experienced Management Team***: Our passionate and committed management team with a deep understanding of our clients' needs and significant experience in our industry, with our executive officers having an average of 35 years of experience. Through our acquisitions we have benefited from the addition of management talent, who have contributed valuable new perspectives and insights. Under our tenured management team, we have grown our revenue from $1.1 billion in fiscal year 2014 to $9.8 billion in fiscal year 2025, while delivering strong profitability.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Our Growth Strategy** 

The key elements to our growth strategy are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Expand and Deepen Relationships with Existing Clients***: We have a well-established track record of cross-selling and offering additional solutions and premium services to sustain and grow our relationships with our existing clients. We believe our global offerings and scale, efficiency, and technology generates incremental value for our clients with each process we manage, naturally driving our customers to spend more with us. Our focus on technological innovation, our deep understanding of our clients' businesses, and our responsiveness to our clients' needs position us for continued growth with our clients beyond traditional CX support.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Relentlessly Innovate and Develop Technology Services and Solutions***: We have developed innovative solutions for our clients, and we are focused on investing in technology. Investment in technology and digital transformation can enable more effective engagement with customers and improve the customer and user experience through increased automation, optimize customer journeys to reach faster solutions, enable personalized engagement across multiple platforms, and focus human engagement on the most complex interactions. For these reasons, we believe investments in disruptive technologies, applications, and services, including GenAI and agentic AI, will continue to be instrumental in driving better value for our clients and, over time, result in increased profitability.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***• Further Expand into Adjacent Markets***: Our marketplace continues to expand, and we see significant opportunity for growth across adjacent markets. We believe we are a unique global provider of technology and services that can power our clients' brand experiences and digital operations at scale. We expect to continue to provide our clients with a fully integrated offering that includes strategy and design, data and analytics, and enterprise technology. We have strengthened our presence in adjacent markets through recent acquisitions, and through significant investments across emerging technologies, including the launch of our iX suite of AI and GenAI products in 2024 and our Agentic Operating Framework in 2025. As our industry evolves, we will continue to invest in new technologies and faster growing markets to further sustain long-term growth.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Selectively Pursue Strategic Acquisitions***: We have made targeted acquisitions to increase our technology expertise, enter new verticals and geographies, and increase our scale, including our acquisitions of the IBM Customer Care Business, Convergys Corporation, PK, ServiceSource, Webhelp, and SAI Digital. Our market remains highly fragmented and we believe that our acquisition strategy enhances and augments our growth avenues. We intend to continue to evaluate and pursue complementary, value enhancing acquisitions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Invest in Emerging Markets***: We have invested in delivery operations in emerging, high-growth markets such as India, Egypt, Brazil, Türkiye, China, South Africa, Vietnam, Indonesia, Mexico, Poland, and Thailand. We expect to continue to strategically invest in similar markets to be well-positioned to grow with our clients in the regions and countries where they are growing and cost-effectively serve global brands in multiple time zones.

**Our Clients**

In fiscal year 2025, we served more than 2,000 clients across various verticals and geographies. Our strategic verticals include: technology and consumer electronics; retail, travel and e-commerce; communications and media; banking, financial services, and insurance; healthcare; and other. We focus on developing long-term, strategic relationships with clients in verticals with certain characteristics, such as high growth, high transaction volume, high levels of compliance and security, and steep barriers to entry.

**Sales and Marketing**

We market our services through a sales force organized by industry vertical and geography. Our efforts may begin in response to our lead generation program, a perceived opportunity, a reference by an existing client, a request for proposal or otherwise. The length of our sales cycle varies depending on the type of services work as well as whether there is an existing relationship with the client.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

We have designated client partners or global relationship managers for each of our strategic relationships. The relationship manager is supported by process improvement, quality, transition, finance, human resources, information technology, and industry or subject matter expert teams to ensure we are offering our best possible solution to clients.

We strive to foster relationships between our senior leadership team and our clients' senior management. These "C-level" relationships ensure that both parties are focused on establishing priorities, aligning objectives, and driving client value from the top down. High-level executive relationships have been particularly constructive as a means of increasing business from our existing clients. It also provides us with a forum for addressing client concerns. We constantly measure our client satisfaction levels to ensure that we maintain high service levels for each client.

**Our Operations**

We have global delivery capabilities that allow us to scale our operations with people, technology, and other resources from around the world, including language fluency, proximity to clients, and time-zone advantages. A critical component of this capability is our approximately 483 locations in 74 countries across six continents. Our service delivery centers improve the efficiency of our engagement teams through the reuse of processes, solution designs, and infrastructure by leveraging the experience of delivery center professionals. Services are provided from these global locations to customers worldwide in multiple languages. These services are supported by proprietary and third-party technologies to enable efficient and secure contacts through various channels including voice, chat, web, email, social media and other digital platforms, including automated bots, RPA, AI, GenAI, and agentic AI.

Our delivery and data centers are subject to annual certifications and attestation audits that include Payment Card Industry Data Security Standard (PCI DSS) version 4.0.1, ISO 27001:2022, ISO 22301:2019, and SOC 2 Type II. Our risk-based independent assurance requirements, as well as client requirements, help define the scope of these certification and attestation audits. Twenty-eight of our delivery centers around the world are certified to the COPC (Customer Operation Performance Center) Outsource Service Provider standard. For our healthcare clients, we have achieved HITRUST Common Security Framework (CSF) 11.2.0 certification. We also maintain a Level 3 CMMI version 1.3 certification for services and development for our major technology development centers globally. For IT service management (ITIL standard), we have more than 100 delivery centers that are ISO/IEC 20000-1:2018 certified. We are one of the few companies globally recognized for our AI governance, privacy and security standards by receiving the ISO/IIEC 42001:2023 Artificial Intelligence Management System certification for our iX suite of products, together with meeting the ISO 31700:2023 Privacy by Design and HITRUST AI requirements.

We operate a globally distributed data processing environment that can seamlessly connect and integrate our service delivery centers with our data centers and points of presence with multiple resilient circuits. Our technologically advanced and secured data centers provide availability 24 hours a day, 365 days a year, with redundant equipment, power and communication feeds and emergency power back-up, and are designed to withstand most natural disasters. We maintain a 24x7 security monitoring and alert function to guard against and respond to the threat of malicious actors.

We also have the capability to provide services for our clients through our utilization of remote staff. We support secure remote work environments through digital tools and technology that authenticate the remote advisor, restrict unauthorized personnel and devices, and alert of attempts to circumvent control. Approximately 20% of our global team currently works remotely.

The capacity of our data center and service delivery center operations, our nimble approach to remote staff, and the scalability of our customer management solutions enable us to meet the dynamic and challenging needs of large-scale and rapidly growing companies. By leveraging our scale and efficiencies across our common system platforms, we can provide rapid client-specific enhancements and modifications at competitive costs, which positions us as a value-added provider of technology and services.

**International Operations**

In fiscal year 2025, approximately 89% of our revenue was generated by our non-U.S. operations. A key element in our business strategy has been to locate our service delivery centers in markets that are strategic to our

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

client requirements and cost beneficial. We have operations in 74 countries across six continents, with a significant presence in the Philippines and India.

Sales and cost concentrations in international jurisdictions subject us to various risks, including the impact of changes in the value of foreign currencies relative to the U.S. dollar, which in turn can impact reported revenue and cost of revenue.

See "Risk Factors" in this Annual Report on 10-K for a discussion of these risks and others that we face and see Note 9 to the consolidated financial statements included elsewhere in this Annual Report on Form 10-K for additional financial information related to our international and domestic operations.

**Seasonality**

Our revenue and margins fluctuate with the underlying trends in our clients' businesses. As a result, our revenue and margins are typically the highest in our fourth fiscal quarter. However, our results in a particular year may vary based on client transaction volume and macroeconomic factors.

**Information Technology**

We invest in information technology systems, infrastructure, automation and security to enhance workforce management and enhance productivity. Our delivery centers employ a broad range of technology, including advanced network and computing platforms, digital switching, intelligent call routing and tracking, proprietary workforce management systems, case management tools, computer telephony integration, interactive voice response and advanced speech recognition, with multiple layers of embedded security. Our innovative use of technology, including automation, GenAI, agentic AI, and AI, enables us to improve our voice, chat, web and e-mail handling and personnel scheduling, thereby increasing our efficiency and enhancing the quality of the services we deliver to our clients and their customers. We are able to dynamically scale to respond to changes in our clients' business volumes. Additionally, we use technology to analyze information and trends from our clients' customer interactions to support quality of service and improve the customer journey and experience. See Item 1C. Cybersecurity in this Annual Report on Form 10-K for a discussion of our cybersecurity program.

**Competition**

We face competition from various technology service providers, including global, fully integrated service providers, core CX solutions providers, digital IT services competitors, and other CX solutions competitors that primarily provide complementary services such as consulting and design, IT services, business process services, and data and analytics. Our major competitors include Accenture plc, Capgemini SE, Cognizant Technology Solutions Corporation, Endava UK Ltd., EPAM Systems, Inc., ExlService Holdings, Inc., Foundever Group, Genpact Limited, Globant S.A., HCL Technologies Limited, Infosys Limited, TaskUs Inc., Tata Consultancy Services, Teleperformance S.A., TELUS Digital, Thoughtworks Holding, Inc., and TTEC Holdings, Inc.

In the future, we may face greater competition due to the consolidation of solutions providers. Consolidation activity may result in competitors with greater scale, a broader footprint, or more attractive pricing than ours. In addition, a client or potential client may choose not to outsource its business, by setting up captive outsourcing operations or performing formerly outsourced services for themselves, or may switch CX solutions providers.

**Human Capital Resources**

We are committed to fostering a workplace rich in talent and that represents the diversity of thought, experiences, and perspectives of the communities in which we operate. Through ongoing staff development, comprehensive compensation and benefits, and a focus on health, safety, and staff wellbeing, we strive to help our team in all aspects of their lives so they can do their best work.

As of November 30, 2025, we had approximately 455,000 full-time game-changers, of which approximately 85,000 were based in the Americas, approximately 240,000 were based in Asia-Pacific, and approximately 130,000 were based in EMEA. Except for a small portion of our team in certain countries, generally required by local regulations or brought in through acquisitions, our staff are not represented by labor unions, nor are they covered by collective bargaining agreements.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

***Inclusion and Belonging***

We have a long history of intentionally building teams that are rich in talent and represent the diversity of thought, experiences, and perspectives of the communities in which we operate. We believe that the best workplaces embrace varied identities, perspectives, beliefs, lifestyles, backgrounds, and socioeconomics, and we remain committed to finding, promoting, and retaining a diverse workforce. We strive to create an inclusive workplace where people can bring their authentic selves to work. Our game-changers are encouraged to leverage their personal strengths and experiences to continually innovate and contribute to the development of new ideas and process improvements that drive better customer experiences and improved outcomes for our clients. Our commitment to these principles is set out in our Human Rights Policy, our Inclusion and Belonging Policy, and our Code of Ethical Business Conduct (our "Code"), which require all of our game-changers to adhere to our dedication to an inclusive work environment that fosters respect for all of our team members.

Our team also supports eleven staff resource groups, including LGBTQ+, persons with disabilities, women, women in tech, military veterans, and black professionals, to promote a diverse and inclusive workplace. In 2025, our Chief Executive Officer, Chris Caldwell, was named one of the Best Company CEOs by Comparably, a workplace culture and compensation website, and Comparably recognized Concentrix as one of the Best Companies for Women and our management as one of the top leadership teams.

***Pay Equity and Total Rewards***

People should be paid for what they do and how they do it, regardless of their gender, race, or other characteristics. To deliver on that commitment, we benchmark and set pay ranges based on market data and consider factors such as a game-changer's role and experience, the location of their job, and their performance. We also review our compensation practices, both in terms of our overall workforce and individual game-changers, to ensure our pay is fair and equitable. We have reviewed the compensation of our game-changers to ensure consistent pay practices by conducting a gender pay equity analysis comparing staff in the same role within a country or location.

We require a uniquely talented workforce and are committed to providing total rewards that are market-competitive and performance based, driving innovation and operational excellence. Our compensation programs, practices, and policies reflect our commitment to reward short- and long-term performance that aligns with and drives long-term stockholder value. Total direct compensation is generally positioned within a competitive range of the market median, with differentiation based on tenure, skills, proficiency, and performance to attract and retain key talent.

***Game-Changer Engagement***

We pride ourselves on championing our people. Our company culture emphasizes the satisfaction and well-being of our game-changers and is consistently seeking new ways to enhance engagement. We regularly solicit the opinions and views of our game-changers through a staff satisfaction survey, the results of which inform key initiatives to support engagement and foster retention. The global participation rate for our most recent staff satisfaction survey in 2025 was approximately 86.0%, and our overall positive engagement rating (game-changers that gave a satisfaction score of 4 or 5) was approximately 79.6%. In 2025, we were honored, for the third consecutive year, with the number two spot on the Inspiring Workplaces Group's Global Top 100 Inspiring Workplaces, which recognizes the most forward-thinking and people-first organizations in the world.

***Training and Development***

Human capital development underpins our efforts to execute our strategy and continue to deliver exceptional services globally. We invest in staff career growth and provide game-changers with a wide range of development opportunities, including face-to-face, virtual, social and self-directed learning, mentoring, coaching, and external development. Front-line staff receive continual feedback and reinforcement from supervisors who provide coaching, often in real time, so that staff can more readily apply their training to assist our clients and their customers. In addition, our game-changers have access to approximately 74,000 online courses and 1,600 learning paths through Concentrix University, our virtual learning platform, to develop skills specific to their current roles and promote ongoing career growth.

In fiscal year 2025, our game-changers completed over 4.7 million hours of developmental learning, completing approximately 12 million courses globally. Our game-changers were supported in their growth through our iRise

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

program, which included over 1,700 designated mentors and is designed to accelerate talent readiness by providing our game-changers a platform to connect, learn, and build a strong network with colleagues globally.

We also prioritize investing in the evolving technology and industry skills required by our game-changers. In 2025, we launched our Next Wave AI-readiness accreditation course, a five-part training designed to equip our game-changers with essential AI skills to drive transformation, grow their careers, and meet evolving performance and promotion requirements.

***Health, Safety and Wellness***

The physical health, financial stability, life balance, and mental health of our team is vital to our success. We prioritize employee well-being through a comprehensive, multi-directional approach called WeCare that focuses on three pillars: care, protect, and innovate. This strategy is tailored to meet the needs of the cultures and communities we serve, while adhering to global standards to which each country contributes. Throughout the year, we encourage healthy behaviors through regular communications, educational sessions, voluntary progress tracking, wellness challenges, and other incentives.

We also take an integrated approach to helping our staff manage their work and personal responsibilities, with a strong focus on mental health. We offer 24/7 access to preventive and crisis support resources for both office and remote environments. Our confidential employee assistance programs ("EAPs") provide support for mental health and personal challenges; through our EAPs, we provide access to mental health and wellness benefits such as one-on-one coaching, therapy, live and on-demand group sessions, meditations and programs, and other resources to our game-changers and their dependents. In 2025, we also launched an internal AI wellbeing assistant that supports our game-changers through self-assessments, personalized wellbeing plans, and recommending additional resources and in the Philippines, we launched KALIX, a company-built and fully managed health clinic designed to serve our game-changers.

**Sustainability**

We have a responsibility to improve the lives of our people and the health of our planet. Since we became a public company, we have maintained an Environmental, Social and Governance ("ESG") program with direction and oversight from our board of directors. Our ESG program seeks to use our global reach and the strength of our team of approximately 455,000 game-changers to create significant and sustainable improvements in five impact areas:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our Planet: We are contributing toward a more sustainable planet by reducing our impact and by protecting and restoring the planet as we progress toward our goal of becoming net zero by 2050;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our Game-changers: We elevate our game-changers' experience by developing an inclusive and supportive workplace that prioritizes people's wellbeing, personal growth, inclusion and belonging;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Building Trust: We build and foster trust by acting with integrity in everything we do. Always.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Innovation and Tech: We promote innovation and tech for good and drive positive change through creative solutions that address societal and environmental challenges; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our Communities: We empower and give back to our communities by strengthening and building resilient communities everywhere we operate, and by supporting the causes our game-changers are most passionate about.

We publish an annual Sustainability Report that outlines our long-term ESG goals and how these commitments align with the Sustainable Development Goals established by the United Nations, and updates stakeholders on our progress toward these goals.

**Corporate Political Activities**

Our Code sets forth our policy on political contributions. We are an apolitical business and do not endorse or contribute to any political party, candidate, or cause. In alignment with our policy, we did not make any political contributions in fiscal year 2025.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Available Information** 

Our website is www.concentrix.com. We make available free of charge, on or through our website, our Annual Report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports, if any, or other filings filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after electronically filing or furnishing these reports with the Securities and Exchange Commission (the "SEC"). Our Sustainability Report is also available on our website. Information contained on our website is not a part of this Annual Report on Form 10-K.

The SEC maintains a website at www.sec.gov that contains our Annual Report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports, if any, or other filings filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, and our proxy and information statements.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**ITEM 1A. RISK FACTORS**

*This section discusses the most significant factors that could affect our business, results of operations, and financial condition. You should carefully consider the following risks and the other information contained in this Annual Report on Form 10-K in evaluating our company and our common stock. If any of the risks discussed below occur, our business, financial condition, results of operations, or liquidity could be materially adversely affected and, as a result, the trading price of our common stock could decline. The risks described below are not the only ones we face. Additional risks not presently known to us or that we currently deem immaterial may also harm our business, results of operations, or financial condition.*

*We have grouped these risk factors into three categories:*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *risks related to our business and the industry in which we operate;*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *risks related to our capital structure; and*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *risks related to ownership of our common stock.*

**Risks Related to Our Business and Industry**

**Historically, our revenue and operating results have fluctuated, and we anticipate that in the future they will continue to fluctuate, which could adversely affect the enterprise value of our Company and the trading value of our common stock.**

Our operating results have fluctuated and will likely fluctuate in the future as a result of many factors, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• global macroeconomic conditions, including: economic slowdowns or recessions, consumer demand, interest rate and currency rate fluctuations, inflation and supply chain disruptions; public health crises, political or social unrest, and military conflicts, including the conflicts in Ukraine and Gaza and tensions between India and Pakistan, and their impact on the global economy; tariffs and international trade negotiations, such as between the U.S. and China, between China and India; a U.S. federal government shutdown or budget disruptions; and market volatility, including as a result of political leadership in certain countries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the level of business activity of our clients, which in turn is affected by the level of economic activity in the industries and markets that they serve and the market acceptance and performance of their products and services;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the demand for the end-to-end solutions, technology, and services we provide, as well as other competitive conditions in our industry; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of the business acquisitions and dispositions we make, as well as consolidation of our competitors or clients.

Although we attempt to control our expenses, they are based, in part, on anticipated revenue and client demand forecasts. The reliability of client forecasts is critical to managing our utilization and aligning our expenses with anticipated revenue to achieve our profitability targets. We can provide no assurance that our clients will provide us with reliable demand forecasts or that we will be able to effectively manage our utilization. Further, we may be unable to reduce spending in a timely manner to compensate for an unexpected decrease in revenue.

Our future operating results may be below our expectations or those of our public market analysts or investors, which would likely cause the trading price of our common stock to decline.

**Cyberattacks or the improper disclosure or control of personal or confidential information could result in liability and harm our reputation, which could adversely affect our business.**

Our business is heavily dependent upon information technology networks and systems. Internal or external attacks on our networks and systems or those of our clients, partners, or vendors, including through phishing, password attacks, ransomware, malware, or the increased use of emerging AI technologies, could significantly disrupt our operations and impede our ability to provide critical solutions and services to our clients and their customers, subjecting us to liability under our contracts and damaging our reputation. Cybercriminals and other

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

threat actors, including those supported by nation states, political activists, and organized crime, are well organized and increasingly sophisticated, and we expect they will continue to seek out and attempt to exploit vulnerabilities in our and our clients' networks and systems.

We represent our clients in certain critical operations of their business processes such as sales, marketing, and customer support and manage large volumes of customer information and confidential data. As a result, our business involves the use, storage, and transmission of information about not only our staff, but also our clients and the customers of our clients. While we take measures to protect the security of, and prevent unauthorized access to, our networks and systems and personal and proprietary information, the security controls for our networks and systems, as well as other security practices we follow, may not prevent improper access to, or disclosure of, personally identifiable or proprietary information. If we fail to implement or adhere to effective internal controls and other processes, technology, and training to protect our networks and systems and the information that we store, our clients experience disruptions in their systems or operations, or the confidentiality of data is compromised by a malicious actor, our client relationships may suffer, and we may face negative publicity, significant remediation costs, and possible legal or regulatory action.

Any failure in protecting networks, systems or information could result in legal liability, monetary penalties, or impairment to our reputation in the marketplace, which could have a material adverse effect on our business, financial condition, and results of operations.

**When our staff or contractors fail to adhere to our and our clients' controls and processes, we may be subject to financial liability or our client relationships or reputation may suffer.**

We depend on our staff and contractors to deliver our services to our clients and adhere to the controls and processes we and our clients have established. Although we believe our controls are effective and we require all staff to be trained in cybersecurity, fraud awareness, and their responsibilities under our Code of Ethical Business Conduct, with a team of approximately 455,000, we cannot prevent all misconduct. When any of our staff or contractors negligently disregards or intentionally breaches our or our client's established controls or processes, whether acting alone or in collusion with other internal or external parties, we could be subject to monetary damages, fines, or criminal prosecution. In the past, we have experienced, and in the future, we may again experience, data security incidents resulting from unauthorized access to our and our service providers' systems and unauthorized acquisition of our data and our clients' data. Unauthorized disclosure of sensitive or confidential information of our clients or our clients' customers or financial loss by our clients or our clients' customers as a result of our staff's negligence, fraud, misappropriation, or unauthorized access to or through our information systems or those we develop for clients could result in negative publicity, loss of clients, legal liability, and damage to our reputation, business, results of operations, and financial condition.

**Economic downturns, geopolitical tensions, communicable diseases or any other public health crises, and natural disasters could adversely affect our business, results of operations, and financial condition.** 

We could be negatively impacted by factors that are outside of our control, including economic downturns, geopolitical tensions, the widespread outbreak of communicable diseases or other public health crises, and natural disasters. General global economic downturns and macroeconomic trends, including heightened inflation, tariffs, capital market volatility, interest rate and currency rate fluctuations, and an economic slowdown or recession, may result in unfavorable conditions that could negatively affect our clients' businesses, and, as a result, impact demand for our products and services and our potential for growth. An economic slowdown or recession may also negatively impact the wellbeing of our game-changers and increase the risk of staff misconduct or fraud. Geopolitical tensions and acts of violence or war or other international conflicts may also negatively impact the global financial markets and could lead to or exacerbate an economic slowdown or recession. Even if we do not have operations in countries where such conflicts are taking place, the effect on supply chains, the demand for our clients' products and services or other broader impacts of the conflict could result in a decline in our revenue, supply shortages or delays, particularly of technological equipment, and increased costs.

Outbreaks of communicable diseases may negatively affect our operational and financial performance, including our ability to execute our business strategies and initiatives in the expected time frame. The extent of such future impact is unknown and would depend on many factors, all of which are uncertain and cannot be predicted.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

We also have substantial operations in countries, most notably the Philippines, India, Egypt, Brazil, Türkiye, Colombia, and Malaysia that have experienced severe natural events, such as typhoons, mudslides, droughts, wildfires, earthquakes, and floods, in the recent past. Any natural disaster or extreme weather event in a region where we have operations could severely disrupt the lives of our game-changers and lead to service interruptions, increase our operating costs, or reduce the quality level of services that we are able to provide. Weather patterns are becoming more volatile, and extreme weather events may become more frequent or widespread as a result of the effects of climate change. Our business continuity, crisis management, and disaster recovery plans and our business interruption insurance may not provide sufficient recovery to compensate for losses that we may incur.

An extended disruption to the global economy or business operations caused by global macroeconomic trends, geopolitical tensions or war, communicable diseases or other public health crises, natural disasters, or a regional disruption in an area in which we have significant operations, could materially affect our business, our results of operations, our access to sources of liquidity, the carrying value of our goodwill and intangible assets, and our financial condition.

**Uncertainty around, and disruption from, new and emerging technologies, including the increased adoption and utilization of GenAI and agentic AI, may result in risks and challenges that could impact our business.**

We have and will continue to utilize new and emerging technologies, including AI, GenAI, and agentic AI, in our solutions and services. As with many innovations, AI technologies and solutions present risks and challenges that could significantly disrupt our business model. AI algorithms, training methodologies, or datasets may be flawed or contain insufficient, biased, or inaccurate information. As these technologies evolve, some lower complexity services currently performed by our game-changers have been and may continue to be replaced by tools deployed by clients. If we do not execute our technology strategy effectively, this could result in loss of revenue and reduced margins.

Our success depends, in part, on our ability to continue to acquire, develop, and implement solutions that meet the evolving needs of our clients. The rapid evolution of AI technologies requires us to expend resources to develop, test, and implement solutions that utilize AI, agentic AI, and GenAI effectively, which has and may continue to lead us to incur significant expense to maintain a competitive advantage within the industry. We will also be required to attract, motivate, and retain top professionals with the skills necessary to execute our strategy relating to AI technologies and solutions and other emerging technologies. If we do not employ new technologies, including agentic AI and GenAI, as quickly or efficiently as our competitors, if our competitors develop more cost-effective or client-preferred technologies, it could have a material adverse effect on our ability to win and retain business from clients, which would adversely affect our business.

As we expand our services, products, and solutions into new areas, we may be exposed to operational, legal, regulatory, ethical, and other risks specific to such new areas, which may negatively affect our reputation and demand for our services and solutions. The regulatory landscape surrounding AI technologies is evolving, and the ways in which these technologies will be regulated by governmental authorities, self-regulatory institutions, or other regulatory authorities remain uncertain and may be inconsistent from jurisdiction to jurisdiction. Several jurisdictions in which we operate are considering or have proposed or enacted legislation and policies regulating AI and non-personal data, such as the European Union's AI Act, the U.S.'s Executive Order on AI, and California's Transparency in Frontier Artificial Intelligence Act. Such regulations may result in significant operational costs to modify, maintain, or align our business practices, or constrain our ability to develop, deploy, or maintain these technologies.

**Our delivery center activities are located around the world, which may expose us to business risks and disrupt our operations.**

Our operations are based on a global delivery model with client services provided from delivery centers in 74 countries, with a significant concentration of our workforce located in the Philippines, India, Egypt, Brazil, Türkiye, Colombia, Malaysia, China, South Africa, Morocco, and the United Kingdom. A significant geo-political event in any of the countries in which we operate could disrupt our operations and expose us to risk. Operating globally subjects us to risks in the countries in which we do business, which include political and economic instability, armed conflicts, domestic or foreign terrorism, foreign currency volatility, the time and expense required to comply with

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

different laws and regulations, challenges with hiring and retaining adequate staff, inflation, tariffs, longer payment cycles or difficulties in collecting accounts receivable, and seasonal reductions in business activity.

Socio-economic situations that are specific to the Philippines, India, Egypt, Brazil, Türkiye, Colombia, Malaysia, China, South Africa, Morocco, and the United Kingdom can severely disrupt our operations and impact our ability to fulfill our contractual obligations to our clients. If these countries experience natural disasters, extreme weather events or political unrest, our staff's ability to work may be disrupted, our IT and communication infrastructure may be at risk and the client processes that we manage may be adversely affected. We may also continue to expand our operations internationally to respond to competitive pressure and client and market requirements, which could increase these risks. If we are unable to manage the risks associated with our international operations and expanding such operations, our business could be adversely affected, and our revenue and earnings could decrease.

**Our industry is subject to intense competition and dynamic changes in business model, which in turn could cause our operations to suffer.** 

The CX solutions industry and other adjacent markets we operate in are highly competitive, highly fragmented, and subject to rapid change. We believe that the principal competitive factors in the markets in which we operate are breadth and depth of process and domain expertise, service quality, ability to tailor specific solutions to the needs of clients and their customers, the ability to attract, train, and retain qualified staff, cybersecurity infrastructure, compliance rigor, global delivery capabilities, pricing, partnerships, and marketing and sales capabilities. We compete for business with a variety of companies, including in-house operations of existing and potential clients. If our clients place more focus in this area or utilize new or emerging technologies to internalize these operations, the size of the available market for third-party service providers like us could reduce significantly. Similarly, if competitors offer their services at lower prices to gain market share or provide services that gain greater market acceptance than the services we offer or develop, the demand for our services may decrease. Specialized providers or new entrants can enter markets by developing new products, systems, or services that could impact our business. The opportunity for new entrants in our industry may expand as digital engagement and offerings increase in importance. New competitors, new strategies by existing competitors or clients, and consolidation among clients or competitors could result in significant market share gain by our competitors, which could have an adverse effect on our revenue.

Some emerging technologies, including AI, GenAI, RPA, ML, VOC, IVR, and IoT, may cause an adverse shift in the way certain of our existing business operations are conducted, including by replacing or supplementing human contacts with automated or self-service options, changing client expectations on pricing and pricing models, or by decreasing the size of the available market. We may be unsuccessful at anticipating or responding to new developments on a timely and cost-effective basis, and our use of technology may differ from accepted practices in the marketplace. Certain of our solutions may require lengthy and complex implementations that can be subject to changing client preferences and continuing changes in technology, which can increase costs or adversely affect our business.

**The inability to successfully execute our strategy and deliver value for our clients could harm our client relationships and reputation, which in turn could adversely affect our revenue and our results of operations.**

Our strategy focuses on being a leading global technology and services provider that powers our clients' brand experiences and digital operations. Our success depends, in part, on our ability to continue to acquire, develop, and implement products, services, and solutions that anticipate and respond to rapid and continuing changes in technology and offerings to serve the evolving needs of our clients and their customers. We continue to invest in technology and in our digital capabilities to pursue this strategy. If we are unable to successfully deliver a differentiated combination of solutions, products, and services to our clients, or our solutions do not achieve the desired outcomes, our client relationships and reputation may suffer, which could result in a loss of business with existing clients and hinder our ability to engage new clients. We may also incur significant expenses in an effort to keep pace with clients' preferences for technology or to gain a competitive advantage through technological expertise or new technologies. If we cannot offer new technologies as quickly or efficiently as our competitors, our competitors develop more cost-effective or client-preferred technologies, or market acceptance and adoption of our technologies is less than anticipated, it could have a material adverse effect on our ability to obtain and complete client engagements, which could adversely affect our business.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**We are subject to uncertainties and rapid variability in demand by our clients, and our client contracts include provisions such as termination for convenience, which could cause fluctuations in our revenue and adversely affect our operating results.**

Our revenue depends, in large part, on the volumes, geographic locations, and types of services demanded. The demand for our services can be affected by events outside of our control, including consolidation among our clients, changing marketplace trends, financial challenges faced by our clients, and fluctuations in the use of our clients' products and services. Our solutions can also be provided in different geographies and through different service channels. While we have the capability to provide multi-channel services in countries across the globe, changes in the types of services utilized and the geographic locations where the services are provided can impact our revenue and profitability. There can be no assurance that the current demand for our services will continue or grow, that organizations will not elect to perform such services in-house, or that clients will not elect to move services to lower-cost or lower-margin geographies or customer contact channels.

Our client contracts typically include provisions that, if triggered, could impact our profitability. For example, many of our contracts may be terminated with limited notice for any reason and, to the extent our clients terminate these contracts, we could experience unexpected fluctuations in our revenue and operating results from period to period. Additionally, some contracts have performance-related bonus or penalty provisions, whereby we receive a bonus if we satisfy certain performance levels or pay a penalty for failing to do so. Such performance-related conditions are based on metrics that measure customer satisfaction and the quality, quantity, and efficiency of our handling of the client's customer interactions across multiple channels. Generally, performance-related bonus or penalty provisions account for less than 1% of our annual revenue in the aggregate. However, whether we receive a bonus or are required to pay a penalty varies with our performance and may cause fluctuations in our financial results.

In addition, our clients may not guarantee a minimum volume or be able to provide us with realistic forecasts; generally, we hire staff based on anticipated volumes. The reliability of client forecasts and anticipating client demand is critical to managing our utilization and we can provide no assurance we will be able to anticipate client demand or effectively manage our utilization. If we fail to anticipate volumes correctly, our operations and financial results may suffer. A reduction of volumes and margins, loss of clients, payment of penalties, failure to receive performance-related bonuses, or inability to terminate any unprofitable contracts could have an adverse impact on our results of operations and financial condition.

**We depend on a limited number of clients for a significant portion of our revenue, and the loss of business from one or more of these clients could adversely affect our results of operations.**

Our five largest clients collectively represented approximately 19% of our revenue in fiscal year 2025. This client concentration increases the risk of quarterly fluctuations in our operating results, depending on the seasonal pattern of our top clients' businesses. In addition, our top clients could make greater demands on us with regard to pricing and contractual terms in general.

At any given time, we typically have multiple master service agreements or statements of work with our largest clients. Clients may have the right to terminate such agreements for convenience or may have risk tolerances that limit how much business they retain with a single service provider. While we do not expect all master service agreements and statements of work to terminate at the same time, the loss of significant agreements with one of our largest clients could adversely affect our business, results of operations and financial condition if the lost revenue is not replaced with profitable revenue from that client or other clients.

We often carry significant accounts receivable balances from a limited number of clients that generate a large portion of our revenue. For example, approximately 19% of our accounts receivable balance as of November 30, 2025 was attributable to five clients. A client may become unable or unwilling to timely pay its balance due to a general economic slowdown, economic weakness in its industry, or the financial insolvency of its business. While we closely monitor our accounts receivable balances, a client's financial inability or unwillingness, for any reason, to pay a large accounts receivable balance or many clients' inability or unwillingness to pay accounts receivable balances that are large in the aggregate would adversely impact our income and cash flow.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Our operations, reputation, and results of operations may be damaged through the actions, inactions, or vulnerabilities of third parties.**

We depend on a variety of third parties to enable us to deliver services to our clients, including communications services providers, information technology systems and network providers, electric and other utility providers, transportation providers, and recruiting firms. Although we believe we have a rigorous procurement process to evaluate our vendors and service providers, we depend on these third parties to maintain the confidentiality, availability, and integrity of the products and services they provide. These third parties can damage our reputation or cause financial loss through cybersecurity or data privacy breaches, inadequate information technology infrastructure, insufficient or defective updates to software, non-conformance to servicing standards or our Supplier Code of Conduct, or financial distress that disrupts business operations.

Moreover, with a significant reliance on remote staff, we depend on the communications and other service providers necessary for our staff to perform their work from our facilities and their homes. Power or communications failures could interrupt the operations of our facilities or the ability of our staff to work remotely. Natural disasters, severe weather events, or labor disputes that disrupt transportation services could limit the ability of our staff to reach our facilities or increase the cost of transportation services that we procure for our staff in certain countries. Any prolonged disruption in the operations of our facilities or the ability of our remote staff to deliver services to our clients and their customers, whether due to technical difficulties, power failures, threats to homes or health, or any other reason, could cause service interruptions or reduce the quality level of services that we provide and harm our operating results.

**Our business is subject to many regulatory requirements, and changes in current regulations or their interpretation and enforcement, or the adoption of new regulations, could significantly increase our cost of doing business.**

Our business is subject to many laws and regulatory requirements in the United States and the other countries and jurisdictions in which we operate, covering matters that include but are not limited to: data privacy; labor matters, including immigration and equal employment opportunity ("EEO") compliance; anti-corruption and anti-money laundering laws; taxation; securities and insider trading; the use of AI; healthcare, including HIPAA compliance; banking; outsourcing; consumer protection, including the method and timing of placing outbound telephone calls and the recording or monitoring of telephone calls; collections activities; insurance claims administration; gaming licensing; money transmission; internal and disclosure control obligations; governmental affairs; and trade restrictions, sanctions and tariffs.

Many of these regulations, including those related to data privacy, AI, climate-related disclosures, labor matters, and anti-corruption, change frequently and may conflict among the various jurisdictions and countries in which we provide services. The pace of regulatory change in these areas has accelerated in recent years. The EU GDPR and the UK GDPR, the Corporate Sustainability Reporting Directive ("CSRD"), the AI Act, and the Digital Operational Resilience Act and Network and Information Security 2 Directive in Europe, the Data Privacy Act in the Philippines, the Digital Personal Data Protection Act in India, the California Consumer Privacy Act, the California Climate Corporate Data Accountability Act and Climate-Related Financial Risk Act, and other similar laws have resulted, and will continue to result, in increased compliance costs, and the failure to comply with these laws can result in significant monetary penalties. For example, fines of up to 4% of an entity's annual global revenue can be imposed for violations of the GDPR. We expect that the regulatory burden associated with compliance with privacy laws will continue to expand as more jurisdictions adopt privacy laws with different requirements, and as laws governing the use of AI are adopted by more jurisdictions.

Laws and regulatory requirements may also be subject to interpretation, and the transition of a significant portion of our staff to a remote work environment has increased the uncertainty related to the application and interpretation of certain laws and regulations that have historically been applied to onsite work environments. If our interpretation of any laws or regulatory requirements conflicts with positions taken by regulatory agencies or other government bodies in the future, we may be subject to legal liability or be unable to conduct business in the same manner. Violations of any laws and regulations to which we are subject, including failing to adhere to or successfully implement processes in response to changing regulatory requirements or work practices, could result in liability for damages, fines, criminal prosecution, unfavorable publicity and damage to our reputation, and

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

restrictions on our ability to operate, which could have a material adverse effect on our business, results of operations, and financial condition.

In addition, changes in the policies or laws of the United States or other countries or jurisdictions resulting in, among other things, higher taxation, limitations on the ability of, or increased costs for, companies to utilize offshore outsourcing, currency conversion limitations, restrictions on fund transfers, or the expropriation of private enterprises, could reduce the anticipated benefits of our global operations. Any actions by countries in which we conduct business to reverse policies that encourage international trade or investment could also adversely affect our business.

**If we are unable to retain key personnel, hire, develop, and retain staff with the skills and expertise we need, or manage the costs and utilization rate of our staff, our profitability may be negatively impacted and our operations may be disrupted.**

We are dependent in large part on our ability to retain the services of our key senior executives and other technical and industry experts and personnel. With the exception of our Chief Executive Officer and in countries where employment agreements are customary, we generally do not have employment agreements with our executives or staff. We also do not carry "key person" insurance coverage for any of our key executives. We compete for qualified senior management and technical personnel. The loss of, or inability to hire, key executives or qualified staff could inhibit our ability to operate and grow our business successfully.

The success of our operations and the quality of our services are also highly dependent on our ability to attract and retain skilled personnel in all of our global delivery centers. We face competition in hiring, retaining, developing, and motivating talented and skilled leaders and staff with domain experience, and we have, at times, struggled to hire sufficient technical talent to meet the demand for our services. GenAI, agentic AI, and other technological advancements may further impact our ability to attract and retain sufficient personnel with the required new capabilities and skill sets. Challenges resulting from changes in immigration policies, current and future restrictions on the availability of visas, or delays in the issuance of visas could impair our ability to employ skilled professionals. Our industry is also characterized by high staff attrition rates. Any increase in our staff turnover rate could increase recruiting and training costs, decrease operating effectiveness and productivity, and potentially impact our relationship with our key clients and other employees. Potential labor organizing and works council negotiations in certain of the countries in which we do business could also contribute to rising costs or otherwise disrupt our business.

We generally sign multi-year client contracts with pricing models that are based on prevailing labor costs in the jurisdictions where we perform services. Quickly rising wages during periods of high inflation or changes in laws or governmental regulations related to wages, mandatory time off, severance, healthcare, other staff benefits or other working conditions could increase our costs and limit our ability to adjust in a timely manner. Our profitability is also affected by the utilization rate of our personnel resources. If we are unable to achieve optimum utilization of our personnel resources, we may experience erosion in our profit margin. However, if our utilization is too high, the quality of services provided to our clients may deteriorate and we may also experience higher attrition rates. Rising costs, our inability to manage rising costs, or our inability to adequately motivate our team or utilize our personnel resources efficiently could negatively impact our profitability or disrupt our operations.

**We depend on a variety of communications services and information technology systems and networks, and any failure or increase in the cost of these systems and networks could adversely impact our business and operating results.**

The services we provide to our clients depend on the persistent availability and uncompromised security of our communications, technology, data centers and servers, and information technology systems. Our business uses a wide variety of technologies to allow us to manage large volumes of data and perform services with staff located around the globe. We deploy leading edge digital transformation capabilities such as GenAI self-service applications, AI-based automation bots, omnichannel services, agentic AI infrastructure and internally-developed and third-party software solutions to enhance customer and staff experience across various technology environments and platforms. We operate an extensive internal voice and data network that links our global sites together in a multi-hub model that enables the rerouting of voice and data across the network, and we rely on multiple public communication channels and telephone, internet, and data services provided by various third parties for connectivity

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

to our clients. Maintenance of, and investment in, this technology is critical to keeping our team productive and the success of our service delivery model.

Any failure in technology, or in our ability to manage or optimize our resources, may impair service quality and have a negative impact on our operations. Failures or significant downtime of our IT or telecommunications systems could prevent us from handling client volume, and frequent or prolonged interruption in our ability to provide services could result in contractual performance penalties, damage to our reputation, and the loss of business from existing and potential clients. Any increase in average waiting time or handling time or a lack of promptness or technical expertise from our staff will negatively impact customer satisfaction and our business. Telephone, internet, and data service providers may elect not to renew their contracts with us or increase the cost of such services. If our communications or information technology systems are disrupted or the cost of maintaining those systems increases significantly, our results of operations could be adversely affected.

**Changes in foreign currency exchange rates have impacted and could continue to impact or adversely affect our business and operating results.** 

We operate in 74 countries, and volatility in the value of the currencies used in these countries increases the uncertainty in our revenue and profitability forecasts. While a significant amount of our contracts are priced in U.S. dollars, we recognize a substantial amount of revenue under contracts that are denominated in euros, British pounds, Japanese yen, Australian dollars, and Brazilian real, among other currencies. A significant increase in the value of the U.S. dollar relative to these currencies may have a material adverse impact on the value of our revenue when translated to U.S. dollars.

Our services are delivered from several delivery centers located around the world, with significant operations in the Philippines and India, as well as throughout APAC, EMEA and the Americas. Although our contracts with U.S.-based clients are typically priced in U.S. dollars, a substantial portion of our costs to deliver services under these contracts are denominated in the local currency of the country where services are performed. We also have certain client contracts that are priced in non-U.S. dollar currencies for which a substantial portion of the costs to deliver the services are in other currencies. As a result, our revenue may be earned in currencies that are different from the currencies in which we incur corresponding expenses. Fluctuations in the value of currencies, such as the Philippine peso, the Indian rupee, the Malaysian Ringgit, the Egyptian pound, Colombian peso, and the Canadian dollar, against the U.S. dollar or other currencies in which we bill our clients, and inflation in the local economies in which these delivery centers are located, could increase the operating and labor costs in these delivery centers, which can result in reduced profitability. A significant decrease in the value of the contractual currency, relative to the currencies where services are provided, could have a material adverse impact on our operating results that are not fully offset by gains realized under the hedging contracts we have in place in certain currencies to limit our potential foreign currency exposure.

**We have pursued and intend to continue to pursue strategic acquisitions or investments and may encounter risks associated with these activities, which could harm our business and operating results.**

We have historically pursued, and in the future expect to pursue, acquisitions of, or investments in, businesses, technologies, and assets in new or existing markets, either within or outside the CX solutions industry, that complement or expand our existing business. For example, in September 2023, we completed our combination with Webhelp, a leading provider of CX solutions. We incurred significant transaction costs related to our combination with Webhelp including costs related to integration.

Our acquisition strategy involves a number of risks, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risk that we encounter difficulty in successfully integrating acquired operations, IT and other systems, clients, services, businesses, and staff with our operations on a timely and cost-effective basis;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risk that the acquired businesses will fail to maintain the quality of services or results of operations that we have historically provided or that we expect from the acquired businesses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the announcement or consummation of a transaction may have an adverse impact on relationships with third parties, including existing and potential clients, or may negatively affect our brand identity;

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• loss of key staff of the acquired operations or inability to attract, retain, and motivate staff necessary for our expanded operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• acquired businesses located in regions where we have not historically conducted business may subject us to new operational risks, laws, regulations, staff expectations, customs, and practices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risk that we encounter challenges in scaling critical resources and facilities for the business needs of the expanded enterprise;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• diversion of our capital and management attention away from operational matters and other business issues;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increase in our expenses and working capital requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• in the case of acquisitions that we may make outside of the United States, difficulty in operating internationally and over significant geographical distances;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other financial risks, including unknown liabilities or inconsistent accounting practices of the businesses we acquire or the impairment of goodwill or intangible assets we record in connection with acquisitions; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our due diligence fails to identify significant issues with the acquired company's service quality, financial disclosures, legal liabilities, accounting practices, internal control deficiencies, or other material issues.

We may incur additional costs and certain redundant expenses in connection with our acquisitions and investments, which may have an adverse impact on our operating margins. Future acquisitions may result in dilutive issuances of equity securities, the incurrence of additional debt, large asset write-offs, a decrease in future profitability, or future losses. For example, we have recorded substantial goodwill and amortizable intangible assets as a result of our past acquisitions, and in the future we could be required to record a significant charge to earnings in our financial statements during the period in which any impairment of our goodwill or intangible assets was determined, negatively impacting our results of operations. The incurrence of debt in connection with any future acquisitions could restrict our ability to obtain working capital or other financing necessary to operate our business. Our recent and future acquisitions or investments may not be successful, and if we fail to realize the anticipated benefits of these acquisitions or investments, our business and operating results could be harmed.

**Impairment charges on goodwill, which represents a significant portion of our total assets and is subject to periodic impairment evaluations, could have a material adverse impact on our financial condition and consolidated results of operations.**

We maintain goodwill related to past acquisitions. We periodically assess these assets to determine if they are impaired. Significant negative industry or economic trends, disruptions to our business, inability to effectively integrate acquired businesses, unexpected significant changes or planned changes in use of the assets, divestitures, and sustained market capitalization declines may impair these assets, and the effect of any of these factors may be magnified by macroeconomic or industry challenges.

As required by applicable accounting standards, we review goodwill for impairment either annually or whenever changes in circumstances indicate that the carrying value may not be recoverable. The risk of impairment to goodwill is generally higher during the years immediately following an acquisition, because the fair values of recently acquired assets generally align very closely with the acquisition price. As a result, the difference between the carrying value of the reporting unit and its fair value is smaller following the acquisition. Unless and until this difference between carrying value and fair value grows over time, due to business growth or a decline in the carrying value of the reporting unit, a small decline in the fair value of the reporting unit may cause impairment charges. Required impairment charges may be material due to the magnitude of the asset values involved. Future acquisitions could present similar risks as our past acquisitions. Any charges relating to goodwill impairment, similar to the impairment recorded for our fiscal year ended November 30, 2025, could adversely affect our consolidated results of operations in the periods recognized.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**We may have higher than anticipated tax liabilities, which could result in a material adverse effect on our business.**

Due to the global nature of our operations, we are subject to the complex and varying tax laws and rules of many jurisdictions and have material tax-related contingent liabilities that are difficult to predict or quantify. In preparing our financial statements, we calculate our effective income tax rate based on current tax laws and regulations and our estimated taxable income within each jurisdiction. Our effective tax rate could be adversely affected by several factors, many of which are outside of our control, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in income before taxes in the countries in which we operate that have differing statutory tax rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in tax rates or tax laws and regulations, or the implementation or interpretation of such laws and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the effect of tax rates on accounting for acquisitions and dispositions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• issues arising from tax audits or examinations and any related interest or penalties; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• uncertainty in obtaining tax holiday extensions or the expiration or loss of tax holidays in various jurisdictions.

In the United States, proposed tax law changes could subject us to higher than anticipated tax liabilities, including by increasing the statutory corporate tax rate, imposing a minimum tax on global income, reducing the deduction for global intangible low-taxed income ("GILTI"), eliminating the qualified business asset investment exemption, limiting the deductibility of interest expense, repealing the deduction for foreign-derived intangible income or imposing a surcharge on corporations that employ staff in non-U.S. countries to deliver services to the United States. Any one or more of these changes, if adopted, could have a material adverse effect on our effective tax rate and our results of operations. Outside of the United States, tax law changes could subject us to a global minimum tax on profits, which could result in double taxation and increased tax audit risk due to uncertainty in application.

We report our results of operations based on our determination of the amount of taxes owed in various jurisdictions in which we operate. The determination of our worldwide provision for income taxes and other tax liabilities requires estimation, judgment and calculations where the ultimate tax determination may not be certain.

We are also subject to tax audits, including with respect to transfer pricing, in the United States and other jurisdictions, and our tax positions may be challenged by tax authorities. There can be no assurance that our current tax provisions will be settled for the amounts accrued, that additional tax exposures will not be identified in the future or that additional tax reserves will not be necessary for any such exposures. Any increase in the amount of taxation incurred as a result of challenges to our tax filing positions could result in a material adverse effect on our business, results of operations, and financial condition.

We recognize deferred tax assets and liabilities based on the differences between the consolidated financial statement carrying amounts and the tax basis of assets and liabilities. Significant judgment is required in determining our provision for income taxes. We regularly review our deferred tax assets for recoverability and establish a valuation allowance if it is more likely than not that some portion or all of a deferred tax asset will not be realized. If we are unable to generate sufficient future taxable income, if there is a material change in the actual effective tax rates, or if there is a change to the time period within which the underlying temporary differences become taxable or deductible, we could be required to increase our valuation allowance against our deferred tax assets, which could result in a material increase in our effective tax rate.

**Our results of operations could be adversely affected by litigation and other commitments and contingencies.**

We face risks arising from various unasserted and asserted claims, including, but not limited to, commercial, labor and employment, consumer protection, tax, and patent infringement claims. Certain claims may be structured as class action lawsuits or otherwise allege substantial damages. We may be unable to obtain insurance coverage for certain claims at a reasonable cost, if at all. Unfavorable outcomes in pending or future litigation or the settlement of asserted claims could negatively affect us. Regardless of the outcome, litigation could result in substantial expense and could divert the efforts of our management.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

We have developed proprietary information technology systems, mobile applications, and cloud-based technology and acquired technologies that play an important role in our business. If any claim alleging infringement of intellectual property rights is successful against us and if indemnification is not available or sufficient, we may be required to pay substantial damages to third parties and indemnify our clients for losses arising out of the infringement. In order to continue delivering services to our clients, we may also need to seek and obtain licenses of third party intellectual property rights. We may be unable to obtain such licenses on commercially reasonable terms, if at all, which could disrupt our business and adversely affect our results of operations.

In addition, in the ordinary course of business, we may make certain commitments, including representations, warranties, and indemnities relating to current and past operations and divested businesses, and issue guarantees of third-party obligations. The amounts of such commitments can only be estimated, and the actual amounts for which we are responsible may differ materially from our estimates. If we incur liability as a result of any current or future litigation, commitments or contingencies, and such liability exceeds any amounts accrued, our business, results of operations, and financial condition could be adversely affected.

**Certain stockholders are able to exercise influence over the composition of our board of directors, matters subject to stockholder approval, and our operations, and actual or potential conflicts of interest may develop.**

As of January 16, 2026, affiliates of Groupe Bruxelles Lambert ("GBL") owned approximately 14.2% of our common stock. In connection with the Webhelp Combination, on March 29, 2023, we entered into an Investor Rights Agreement with certain stockholders of Webhelp Parent, which, among other things, provides that GBL has the right to nominate a certain number of directors, up to a maximum of two, depending on the percentage of the outstanding shares of Concentrix common stock held by GBL, our former director, Olivier Duha, and certain of their respective affiliates.

As a result of the Concentrix common stock that is held by affiliates of GBL and Olivier Duha and the Investor Rights Agreement described above, GBL may be able to influence (subject to organizational documents and Delaware law) the composition of our board of directors and thus, potentially, the outcome of corporate actions requiring stockholder approval, such as mergers, business combinations and dispositions of assets, among other corporate transactions. The interests of GBL may not always coincide with the interest of our other stockholders, and GBL may seek to cause us to take actions that might involve risks to our business or adversely affect us or our other stockholders. This concentration of investment and voting power, in addition to the investment and voting power of certain other large stockholders, could discourage others from initiating a potential merger, takeover or other change of control transaction that may otherwise be beneficial to Concentrix and its stockholders, which could adversely affect the market price of Concentrix common stock.

**Risks Related to our Capital Structure**

**Our level of indebtedness could have adverse consequences for our business or our financial condition.**

As of November 30, 2025, we had approximately $4.65 billion of indebtedness prior to debt issuance costs, and we may further increase our indebtedness in the future. Our level of indebtedness could have adverse consequences for us and our stockholders, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• requiring us to dedicate a substantial portion of our cash flow from operations to make principal and interest payments on our indebtedness, thereby reducing the availability of such cash flow to fund working capital, capital expenditures, and other general corporate requirements, and to grow our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• limiting our ability to make strategic acquisitions or take advantage of other business opportunities as they arise, pay cash dividends, or repurchase common stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increasing future debt costs and limiting the future availability of debt financing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increasing our vulnerability to general adverse economic and industry conditions; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• limiting our flexibility in planning for, or reacting to, changes in our business and industry.

To the extent that we incur additional indebtedness, the risks described above could increase, which could have an adverse effect on our business.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**We may be unable to raise additional capital or service our debt on favorable terms, or at all.** 

We have in the past relied on the public debt markets to raise capital. Changes in the credit and capital markets, including market disruptions, limited liquidity, and interest rate fluctuations may increase the cost of financing or restrict our access to these potential sources of future liquidity. Our continued access to these liquidity sources on favorable terms depends on multiple factors, including our operating performance and credit ratings.

Our actual cash requirements in the future may be greater than expected. Our cash flows from operations may not be sufficient to service our outstanding debt or to repay our outstanding debt as it becomes due or within the time frame that we expect. In addition, major debt rating agencies regularly evaluate our debt based on a number of factors. A negative change in our credit ratings could make it more expensive to service our outstanding debt or to raise additional capital in the future.

Additionally, if unfavorable capital market conditions exist when we were to seek additional financing, we may not be able to raise sufficient capital on favorable terms and on a timely basis, if at all. The terms of current and future debt agreements could restrict our business operations or cause future financing to be unavailable due to our covenant restrictions then in effect. We may also be unable to borrow money, sell assets, or otherwise raise funds on acceptable terms, if at all, to service or refinance our debt. If our access to capital were to become significantly constrained or our cost of capital were to increase significantly our financial condition, results of operations, and cash flows could be adversely affected.

**Rising interest rates increase the cost of our outstanding borrowings and could adversely affect our net income.**

Our outstanding borrowings under our senior unsecured credit facility and our accounts receivable securitization facility are variable-rate obligations that expose us to interest rate risk. When interest rates increase, our debt service obligations and our interest expense increase even if our outstanding borrowings remain the same. Our net income and cash flows, including cash available for servicing indebtedness, will correspondingly decrease.

**The terms of our debt arrangements impose restrictions on our ability to operate and could have an adverse effect on our business and results of operations.**

The terms of the agreements under which our indebtedness was incurred may limit or restrict, among other things, our ability to incur additional indebtedness, consummate certain asset sales or acquisitions, and merge, consolidate or sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of our assets.

We are also required to maintain specified financial ratios and satisfy certain financial condition tests under certain of our debt arrangements. Our inability to meet these ratios and tests could result in the acceleration of the repayment of the related debt, termination of the applicable debt arrangement, an increase in our effective cost of funds or the cross-default of other indebtedness. As a result, our ability to operate may be restricted and our ability to respond to business and market conditions may be limited, which could have an adverse effect on our business and operating results.

**Risks Related to Ownership of Our Common Stock**

**The share price and trading volume of our common stock has fluctuated and may continue to fluctuate significantly.**

Since our common stock started trading on Nasdaq under the symbol "CNXC" on December 1, 2020 through our fiscal year ending November 30, 2025, our stock price has ranged from a high of $208.48 to a low of $31.63 per share. The market price of our common stock has, and may continue to, fluctuate significantly due to a number of factors, some of which may be beyond our control, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our financial results;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• developments generally affecting the CX solutions industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the performance of our business and of similar companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our capital structure, including the amount of our indebtedness;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the announcement of acquisitions or dispositions;

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• additions or departures of key personnel;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in market valuations of similar companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• general economic, industry, and market conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the depth and liquidity of the market for our common stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• fluctuations in currency exchange rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our dividend policy and share repurchase activity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• investor perception of our industry, our business, and our company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the passage of legislation or other regulatory developments that adversely affect us or our industry; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of the factors referred to elsewhere in "Risk Factors."

In addition, the stock market regularly experiences significant price and volume fluctuations. This volatility has had a significant impact on the market price of securities issued by many companies, including companies in our industry. The changes may occur without regard to the operating performance of the affected companies. Hence, the price of our common stock could fluctuate based upon factors that have little or nothing to do with our company, and these fluctuations could materially reduce our share price.

Securities class-action litigation may get instituted against companies following periods of volatility in their stock price. Such litigation can result in substantial costs in defense and management's attention and resources, which could adversely affect our business, financial condition, and results of operations and prospects.

**We cannot guarantee the continued payment of dividends on our common stock, or the timing or amount of any such dividends.**

The continued payment of dividends in the future, and the timing and amount thereof, to our stockholders is within the discretion of our board of directors. Our board of directors' decisions regarding the payment of dividends will depend on many factors, such as our financial condition, earnings, capital requirements, debt service obligations, industry practice, legal requirements, regulatory constraints, and other factors that our board of directors deems relevant. Our ability to pay dividends will depend on our ongoing ability to generate cash from operations and on our access to the capital markets. We cannot guarantee that we will continue to pay dividends in the future.

**Certain provisions of our certificate of incorporation and bylaws and of Delaware law make it difficult for stockholders to change the composition of our board of directors and may discourage hostile takeover attempts that some of our stockholders may consider to be beneficial.**

Certain provisions of our certificate of incorporation and bylaws and of Delaware law may have the effect of delaying or preventing a change in control if our board of directors determines that such change in control is not in the best interests of us and our stockholders. These provisions may include, among other things, the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ability of our board of directors to issue shares of preferred stock and to determine the price and other terms, including preferences and voting rights, of those shares without stockholder approval;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• stockholder action can only be taken at a special or regular meeting and not by written consent;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• advance notice procedures for nominating candidates to our board of directors or presenting matters at stockholder meetings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• allowing only our board of directors to fill vacancies on our board of directors; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• restrictions on an "interested stockholder" to engage in certain business combinations with us for a three-year period following the date the interested stockholder became such.

While these provisions have the effect of encouraging persons seeking to acquire control of our company to negotiate with our board of directors, they could enable the board of directors to hinder or frustrate a transaction that some, or a majority, of the stockholders might believe to be in their best interests and, in that case, may prevent or discourage attempts to remove and replace incumbent directors. We are also subject to Delaware laws that could

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

have similar effects. One of these laws prohibits us from engaging in a business combination with a significant stockholder unless specific conditions are met.

**Our bylaws designate the Court of Chancery of the State of Delaware and U.S. federal district courts as the exclusive forums for certain types of actions and proceedings that may be initiated by our stockholders, which limits our stockholders' ability to choose the judicial forum for disputes with us or our directors, officers, or other employees.**

Our bylaws provide that, with certain limited exceptions, any action or proceeding:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• brought in a derivative manner in the name or right of the company or on our behalf;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, employees or agents to us or our stockholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• asserting a claim against us arising pursuant to any provision of the General Corporation Law of the State of Delaware or any provision of our certificate of incorporation or bylaws; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• asserting a claim governed by the internal affairs doctrine,

will be exclusively brought in the Court of Chancery of the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the U.S. federal district court for the District of Delaware).

Furthermore, any complaint asserting a cause of action under the Securities Act against us or any of our directors, officers, employees, or agents will be exclusively brought in U.S. federal district court. Any person or entity purchasing or otherwise acquiring any interest in shares of Concentrix common stock is deemed to have notice of and consented to the exclusive forum provisions.

To the fullest extent permitted by law, the Delaware exclusive forum provision will apply to state and federal law claims other than those claims under the Securities Act for which our bylaws designate U.S. federal district court as the exclusive forum. However, stockholders will not be deemed to have waived our compliance with the U.S. federal securities laws and the rules and regulations thereunder. The enforceability of similar choice of forum provisions in other companies' certificates of incorporation or similar governing documents has been challenged in legal proceedings, and it is possible that a court could find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable, including with respect to claims arising under the U.S. federal securities laws.

This exclusive forum provision may limit the ability of a stockholder to commence litigation in a forum that the stockholder prefers, or may require a stockholder to incur additional costs in order to commence litigation in Delaware or U.S. federal district court, each of which may discourage such lawsuits against us or our directors or officers. Alternatively, if a court were to find this exclusive forum provision inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings described above, we may incur additional costs associated with resolving such matters in other jurisdictions, which could negatively affect our business, results of operations, and financial condition.

**ITEM 1B. UNRESOLVED STAFF COMMENTS**

None.

**ITEM 1C. CYBERSECURITY** 

As a global technology and services leader, our business is heavily dependent upon information technology networks and systems. Protecting our systems, data, and information, as well as the information and data of our game-changers, clients, and partners, is a key priority.

We have established and maintain a corporate-wide information security management system and an integrated risk management framework with practices that are derived from industry standards, including ISO 31000, ISO 27001, HITRUST, PCI DSS, and the National Institute of Standards and Technology ("NIST") Cybersecurity Framework, and data privacy regulations, including the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") and the General Data Protection Regulation ("GDPR"). The data security controls from these standards

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

and regulations are evaluated as a component of our risk management framework, based on the needs of our business and our clients, the nature of our industry, and applicable regulations.

We are one of the few companies globally recognized for our AI governance, privacy and security standards by receiving the ISO/IIEC 42001:2023 Artificial Intelligence Management System certification for our iX suite of products, together with meeting the ISO 31700:2023 Privacy by Design and HITRUST AI requirements.

**Risk Management and Strategy** 

We have implemented and maintain an Information Security Management System ("ISMS") that covers information security, data protection, cybersecurity, application security, and other areas as necessary. As a part of our ISMS, we:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• evaluate our security risk strategy on an ongoing basis to facilitate our response to the changing cybersecurity threat landscape and build a culture of security within Concentrix;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• allocate and evaluate available resources, including technology, infrastructure, and personnel, to support information security initiatives;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• regularly identify security risks and prepare and continuously update mitigation and response plans, including with respect to risks related to the use of our third party service providers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• report, investigate, and respond to suspected or confirmed information security risks; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• maintain a business continuity management process to counter potential interruptions to business activities and a data privacy program to protect personal and sensitive information.

We regularly evaluate the ISMS for compliance with applicable regulatory, legislative, and contractual requirements, as well as recent trends and developments in security.

Our management team gathers information to support our efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents from various sources, including reports from internal security personnel, threat intelligence, and other information obtained from governmental, public, or private sources, including external consultants engaged by us, and alerts and reports produced by the information security tools we utilize. Our Cyber Defense Operations Center (the "CDOC") is a security operations center that operates 24 hours a day, seven days a week and is our first line of defense against cybersecurity threats. The CDOC continually monitors our information technology security infrastructure for anomalous behavior and other indications of potential threats to protect our data and systems.

We regularly conduct internal and external audits, reviews, assessments, and evaluations to evaluate our compliance posture and the effectiveness of our physical, technical, and organizational measures for protecting us and our systems. Elements of our cybersecurity program are also periodically audited as part of external certification audits. Third-party managed security providers and cybersecurity experts provide us with 24x7 monitoring, threat hunting, risk assessments, penetration testing, and attack surface management to support our Cyber Security Framework. Key findings from cybersecurity audits and third-party risk assessments are summarized and communicated to our senior leadership and the Audit Committee, and remediation actions are implemented to enhance our overall cybersecurity program. We contractually require our vendors to comply with cybersecurity and data privacy requirements, and we perform risk assessments of vendors, including their ability to protect data from unauthorized access.

To facilitate the success of our risk management framework, multidisciplinary teams throughout the Company, including members of the legal department, operations, and senior management, are deployed to support risk mitigation and our response to threats and potential cybersecurity incidents. We also regularly conduct training and education to upgrade our game-changers' knowledge of security risks and vulnerabilities. In fiscal year 2025, our game-changers completed mandatory security awareness training resulting in a company-wide pass percentage of approximately 95%. In March 2025, we held a Cyber Fraud Awareness Month, which promoted best practices and vigilance in protecting information and data to prevent cyber-attacks, and educated game-changers on how to identify sophisticated social engineering attacks, and report phishing or suspicious messages through our dedicated reporting channel.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

We are currently not aware of any cybersecurity incidents or threats that have materially impacted us or our business, financial condition, and results of operations. However, we and our clients routinely face risks of cybersecurity incidents, and there can be no assurance that our security efforts and measures, and those of our third-party providers, will prevent or mitigate a cybersecurity threat or incident that could adversely affect our business. For a discussion of these risks and others that we face, see "Risk Factors" in this Annual Report on Form 10-K.

**Governance** 

Our board of directors, directly and indirectly through its committees, has oversight responsibility for our risk management process, including risks related to cybersecurity and artificial intelligence. Our board of directors has delegated to the Audit Committee oversight responsibility for the Company's risk assessment and management activities, including with respect to information technology, cybersecurity, and privacy.

As part of our integrated enterprise risk management program, management reports periodically to the Audit Committee on its assessment of our risks and risk management practices, including with respect to ongoing or new cyber and information security risks. Management also reports quarterly to the Audit Committee and annually to the full board of directors on the status of our cybersecurity program, which includes key cybersecurity controls, audits, and compliance, and on any significant projects or areas of focus for the cybersecurity team.

Our cybersecurity risk management framework is implemented by our global security team, which is led by our EVP, Information Technology and Global Security, our SVP, Information Systems and Global Security, and our GVP, Governance, Risk, and Compliance. As the leaders of our global security efforts, these roles and their teams support the establishment and maintenance of our corporate-wide information security program to protect our information assets and to oversee our cybersecurity and insider risk and compliance teams. Our SVP, Information Systems and Global Security, and our GVP, Governance, Risk, and Compliance report to our EVP, Information Technology and Global Security, and our EVP, Information Technology and Global Security reports to our Chief Executive Officer.

Our EVP, Information Technology and Global Security has over 40 years of global information technology leadership experience, including hands-on management and technology innovation experience. He provides strategic direction for the design, implementation strategy, and Governance of Concentrix Global Infrastructure, Information Security and Application development. Our SVP, Information Systems and Global Security has an undergraduate degree in Information Technology and over 25 years of global experience in cybersecurity strategy and risk management in various leadership roles at large companies and within government, with extensive experience in the development of and enforcement of security policies, protection of sensitive data, responding to cyber and fraud incidents, and integrating security across operations. Our SVP, IT Infrastructure has over 30 years of experience in managing a large, geographically dispersed team that designs, plans, implements, and maintains a complex IT infrastructure and operations. He has also played a critical role in the development of security technologies at Concentrix. Our GVP, Governance, Risk, and Compliance has over 23 years of global experience in information security with specialization in risk management, security tools and technologies, compliance, and privacy. His experience in information security spans advisory and consulting, policy, processes and standards, engineering, and operational support for clients and the internal organization.

**ITEM 2. PROPERTIES**

We lease our principal executive offices in Newark, California. As of November 30, 2025, we occupied approximately 483 facilities, located in 74 countries across six continents, comprising service and delivery centers and administrative facilities covering approximately 25.4 million square feet, of which approximately 1.4 million square feet was owned and the remainder was leased.

**ITEM 3. LEGAL PROCEEDINGS**

From time to time, we are involved in legal proceedings in the ordinary course of business. We do not believe that these proceedings will have a material adverse effect on the results of our operations, our financial position or the cash flows of our business.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable**.**

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Part II**

**ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES** 

Our common stock is listed on Nasdaq under the symbol "CNXC". As of January 16, 2026, there were 61,597,304 shares of common stock outstanding held by approximately 2,764 stockholders of record.

**Dividends**

During fiscal years 2025 and 2024, the Company paid the following dividends per share approved by the Company's board of directors:

---

| | | | |
|:---|:---|:---|:---|
| **Announcement Date** | **Record Date** | **Per Share Dividend Amount** | **Payment Date** |
| January 24, 2024 | February 5, 2024 | $0.3025 | February 15, 2024 |
| March 26, 2024 | April 26, 2024 | $0.3025 | May 7, 2024 |
| June 26, 2024 | July 26, 2024 | $0.3025 | August 6, 2024 |
| September 25, 2024 | October 25, 2024 | $0.33275 | November 5, 2024 |
| January 15, 2025 | January 31, 2025 | $0.33275 | February 11, 2025 |
| March 26, 2025 | April 25, 2025 | $0.33275 | May 6, 2025 |
| June 26, 2025 | July 25, 2025 | $0.33275 | August 5, 2025 |
| September 25, 2025 | October 24, 2025 | $0.36 | November 4, 2025 |

---

Our board of directors expects that cash dividends will be paid on a quarterly basis in the future. However, any decision to pay future cash dividends will be subject to our board of directors' approval, and will depend on many factors, such as our financial condition, earnings, capital requirements, debt service obligations, restrictive covenants in our debt agreements, industry practice, legal requirements, regulatory constraints, and other factors that our board of directors deems relevant. Our ability to pay dividends will depend on our ongoing ability to generate cash from operations and on our access to the capital markets. We cannot guarantee that we will continue to pay dividends in the future.

**Share Repurchases**

In September 2021, our board of directors authorized the repurchase of up to $500 million of our common stock from time to time as market and business conditions warrant, including through open market purchases or Rule 10b5-1 trading plans. In January 2025, the Company's board of directors extended the share repurchase program by authorizing an increase of the amount remaining for share repurchases under the existing share repurchase authorization to $600 million. The repurchase program has no termination date and may be suspended or discontinued at any time. As of November 30, 2025, we had repurchased 7,447,427 shares under the share repurchase program for approximately $514.7 million in the aggregate. At November 30, 2025, we had approximately $439.5 million remaining for share repurchases under the existing authorization from our board of directors.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

The following table summarizes the Company's purchases of common stock during the fourth quarter of the fiscal year ended November 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total number of shares** <br>**purchased** <sup>(1) (2)</sup> | **Average price paid<br>per share** | **Total number of shares purchased as**<br>**part of publicly announced program**<sup>(2)</sup> | **Maximum dollar amount that may yet be** <br>**purchased under the program (in thousands)**<sup>(3)</sup> |
| September 1, 2025 - September 30, 2025 | 267252 | $53.23 | 264597 | $481318 |
| October 1, 2025 - October 31, 2025 | 787716 | $46.10 | 434858 | $461270 |
| November 1, 2025 - November 30, 2025 | 610044 | $35.75 | 609882 | $439468 |
| Total | 1665012 | $43.35 | 1309337 |  |

---

<sup>(1)</sup> Includes shares withheld upon the vesting of certain equity awards to satisfy tax withholding obligations.

<sup>(2)</sup> Includes shares repurchased as part of the Company's share repurchase program initiated in September of 2021.

<sup>(3)</sup> In January 2025, the Company's board of directors extended the share repurchase program by authorizing an increase of the amount remaining for share repurchases under the existing share repurchase authorization to $600,000. The repurchase program has no termination date and may be suspended or discontinued at any time.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Stock Price Performance Graph** 

The stock price performance graph below compares our cumulative total stockholder return for the period from December 1, 2020 through November 30, 2025 with the cumulative total return of the S&P Midcap 400 Index for the same period and a Peer Group comprised of CX-focused technology and service providers that are publicly traded companies: Majorel Group Luxembourg S.A. (from initial public offering in September 2021 through acquisition by Teleperformance on November 23, 2023), TaskUs Inc. (from initial public offering in June 2021), TDCX Inc. (from initial public offering in October 2021 through becoming a private company in June 2024), Teleperformance S.A., TELUS International (from initial public offering in February 2021 through becoming a private company in October 2025), and TTEC Holdings, Inc., in each case assuming a $100 initial investment.

![3226](cnxc-20251130_g2.jpg)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 1, 2020** | **November 30, 2021** | **November 30, 2022** | **November 30, 2023** | **November 30, 2024** | **November 30, 2025** |
| Concentrix Corporation | $100.00 | $158.10 | $116.55 | $89.51 | $42.81 | $36.89 |
| S&P Midcap 400 | $100.00 | $123.43 | $117.47 | $116.82 | $153.39 | $164.58 |
| Peer Group | $100.00 | $121.30 | $72.41 | $35.76 | $26.18 | $25.83 |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**ITEM 6. [RESERVED]**

**ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

This Management's Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our historical consolidated financial statements and the notes to those consolidated financial statements. It contains forward-looking statements, which are subject to risk, uncertainties, and other factors that could cause actual results to differ materially from those projected or implied in the forward-looking statements. Please see "Risk Factors" and "Note Regarding Forward-Looking Statements" in this Annual Report on Form 10-K for a discussion of the uncertainties, risks and assumptions associated with these statements.

The following discussion compares our results for the fiscal year ended November 30, 2025 to the fiscal year ended November 30, 2024. The discussion comparing our results for the fiscal year ended November 30, 2024 to the fiscal year ended November 30, 2023 is included within Management's Discussion and Analysis of Financial Condition and Results of Operations in our 2024 Annual Report on Form 10-K filed with the SEC on January 28, 2025, and is incorporated by reference herein.

Unless otherwise indicated or except where the context otherwise requires, references to "we," "our," "us," "the Company," or "Concentrix," in this Management's Discussion and Analysis of Financial Condition and Results of Operations refer to Concentrix Corporation and its subsidiaries.

**Overview and Basis of Presentation**

Concentrix is a global technology and services leader that powers exceptional brand experiences and digital operations for more than 2,000 clients across the globe. We design, build, and run fully integrated, end-to-end solutions, including customer experience ("CX") process optimization, technology innovation and design engineering, front- and back-office automation, analytics, and business transformation services to clients in five primary industry verticals. Our differentiated portfolio of solutions supports Fortune Global 500 clients across the globe in their efforts to deliver an optimized, consistent brand experience across all channels of communication, including voice, chat, email, GenAI- and agentic AI-powered self-service, social media, asynchronous messaging, and custom applications. We strive to deliver exceptional services globally supported by our deep industry knowledge, technology and security practices, talented people, and digital and analytics expertise.

We generate revenue from performing services and providing technology that is generally tied to our clients' products and services. Any shift in business, demand, or the size of the market for our clients' products or services, or any failure of technology or failure of acceptance of our clients' products or services in the market may impact our business. The staff turnover rate in our business is high, as is the risk of losing experienced team members. High staff turnover rates may increase costs and decrease operating efficiencies and productivity. For more information on the risks associated with our business, please see "Risk Factors" in this Annual Report on Form 10-K.

*Webhelp Combination* 

On September 25, 2023, we completed our acquisition (the "Webhelp Combination") of all of the issued and outstanding capital stock (the "Shares") of Marnix Lux SA ("Webhelp"), from the holders thereof (the "Sellers"). The purchase consideration for the acquisition of the Shares was valued at approximately $3,774.8 million, net of cash and restricted cash acquired.

**Revenue and Cost of Revenue**

We generate revenue through the provision of technology and services to our clients pursuant to client contracts. Our client contracts typically consist of a master services agreement, supported in most cases by multiple statements of work, which contain the terms and conditions of each contracted solution. Our client contracts can range from less than one year to over five years in term and are subject to early termination by our clients for any reason, typically with 30 to 90 days' notice.

Our technology and services are generally characterized by flat unit prices. Approximately 99% of our revenue is recognized as services are performed, based on staffing hours or the number of client customer transactions handled using contractual rates. Remaining revenue from the sale of these solutions are typically recognized as the services are provided over the duration of the contract using contractual rates.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

Our cost of revenue consists primarily of personnel costs related to the delivery of our technology and services. The costs of our revenue can be impacted by the mix of client contracts, where we deliver the technology and services, additional lead time for programs to be fully scalable, and transition and initial set-up costs. Our cost of revenue as a percentage of revenue has also fluctuated in the past, based primarily on our ability to achieve economies of scale, the management of our operating expenses, and the timing and costs incurred related to our acquisitions and investments.

In fiscal years 2025 and 2024, approximately 89% and 88%, respectively, of our consolidated revenue was generated from our non-U.S. operations, and approximately 54% and 50%, respectively, of our consolidated revenue was priced in U.S. dollars. We expect that a significant amount of our revenue will continue to be generated from our non-U.S. operations while being priced in U.S. dollars. We have certain client contracts that are priced in non-U.S. dollar currencies for which a substantial portion of the costs to deliver the services are in other currencies. Accordingly, our revenue may be earned in currencies that are different from the currencies in which we incur corresponding expenses. Fluctuations in the value of currencies, such as the Philippine peso, the Indian rupee, the Egyptian pound, the Columbian peso, and the Canadian dollar, against the U.S. dollar or other currencies in which we bill our clients, and inflation in the local economies in which these delivery centers are located, can impact the operating and labor costs in these delivery centers, which can result in reduced profitability. As a result, our revenue growth, costs, and profitability have been impacted, and we expect will continue to be impacted, by fluctuations in foreign currency exchange rates and inflation.

**Margins**

Our gross margins fluctuate and can be impacted by the mix of client contracts, services provided, shifts in the geography from which our technology and services are delivered, client volume trends, the amount of lead time that is required for programs or services to become fully scaled, and transition and set-up costs. Our operating margin fluctuates based on changes in gross margins as well as overall volume levels, as we are generally able to gain scale efficiencies in our selling, general and administrative costs as our volumes increase.

**Economic and Industry Trends**

The industry in which we operate is competitive, including on the basis of pricing terms, delivery capabilities, and quality of services. Labor in various markets is also subject to competitive pressures that can result in increased labor costs. These factors subject us to pricing and labor cost pressures that can negatively affect our revenue, gross profit, and operating income.

Our business operates globally in 74 countries across six continents. We have significant concentrations in the Philippines, India, Egypt, Brazil, Türkiye, the United States, Colombia, Malaysia, Morocco, China, South Africa, the United Kingdom, and elsewhere throughout EMEA, Latin America, and Asia-Pacific. Accordingly, we historically have and expect to continue to be impacted by economic strength or weakness in these geographies and by the strengthening or weakening of local currencies relative to the U.S. dollar.

In January 2025, the U.S. government began imposing, or threatening to impose, new or increased tariffs on certain countries, materials, and industries, and in response, certain impacted countries have imposed or threatened various retaliatory tariffs or other trade restrictions on imports from the United States. The tariff environment remains dynamic, and we cannot predict with certainty the effect of future changes in global trade policy and tariffs on our clients' operations and demand for our services in future periods.

**Seasonality**

Our revenue and margins fluctuate with the underlying trends in our clients' businesses and trends in the level of consumer activity. As a result, our revenue and margins are typically higher in the fourth fiscal quarter of the year than in any other fiscal quarter.

 **Critical Accounting Policies and Estimates**

The discussion and analysis of our consolidated financial condition and results of operations are based on our consolidated financial statements, which have been prepared in conformity with GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of any contingent assets and liabilities at the financial statement date and reported amounts of

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

revenue and expenses during the reporting period. On an ongoing basis, we review and evaluate our estimates and assumptions. Our estimates are based on our historical experience and a variety of other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making our judgment about the carrying values of assets and liabilities that are not readily available from other sources. Actual results could differ from these estimates under different assumptions or conditions.

We believe the following critical accounting policies involve the more significant judgments, estimates and/or assumptions used in the preparation of our consolidated financial statements.

***Revenue Recognition*** 

We recognize revenue from our client contracts over time as the promised technology and services are delivered to clients for an amount that reflects the consideration to which we are entitled in exchange for the technology and services. We recognize revenue over time as the client simultaneously receives and consumes the benefits provided by us as we perform the services. We account for a contract with a client when it has written approval, the contract is committed, the rights of the parties, including payment terms, are identified, the contract has commercial substance, and the consideration is probable of collection. Revenue is presented net of taxes collected from clients and remitted to government authorities. We generally invoice a client after the performance of services, or in accordance with the specific contractual provisions. Payments are due as per contract terms and do not contain a significant financing component. In most cases, our contracts consist of a single performance obligation comprised of a series of distinct services that are substantially the same and that have the same pattern of transfer (i.e., distinct days of service).

Service contracts are most significantly based on a fixed unit-price per transaction or other objective measure of output. Revenue on unit-price transactions is recognized over time using an objective measure of output such as staffing hours or the number of transactions processed by service advisors.

Certain client contracts include additional payments from the client based upon the achievement of certain agreed-upon service levels and performance metrics. Certain contracts also provide for a reduction in consideration paid to the Company in the event that certain agreed-upon service levels or performance metrics are not achieved. Revenue based on such arrangements is accounted for as variable consideration when the likely amount of revenue to be recognized can be estimated to the extent that it is unlikely that a significant reversal will occur.

***Goodwill***

As of November 30, 2025, we had goodwill of $3,671.7 million recorded on our consolidated balance sheet. We test goodwill for impairment annually at the reporting unit level on the first day of the fiscal fourth quarter or more frequently if events or changes in circumstances indicate that it may be impaired. Impairment of goodwill is tested at the reporting unit level, which we have determined to be the same level as our single operating segment, and is the consolidated company. For purposes of the goodwill impairment test, we can elect to perform a quantitative or qualitative analysis. If the qualitative analysis is elected, goodwill is tested for impairment at the reporting unit level by performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. The factors that are considered in the qualitative analysis include: macroeconomic conditions; industry and market considerations; cost factors such as increases in labor, or other costs that would have a negative effect on earnings and cash flows; and other relevant entity-specific events and information.

If we elect to perform or are required to perform a quantitative analysis, then the reporting unit's carrying value is compared to its fair value. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value and the excess is recognized as an impairment loss.

As of September 1, 2025, the date of our annual impairment test, we performed a quantitative impairment test. We also reconciled the fair value of our reporting unit to our market capitalization. The result of the analysis demonstrated that our reporting unit's fair value was in excess of its carrying value.

Subsequent to our annual impairment testing date of September 1, 2025, we experienced a sustained decrease in the market price of our common stock. After considering all available evidence in the evaluation of goodwill

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

impairment indicators, we determined it appropriate to perform an interim quantitative assessment on November 1, 2025.

The fair value of our reporting unit was consistently estimated using an equal weighting of the income and market valuation approaches. The income approach applied a fair value methodology to our reporting unit based on discounted cash flows. This analysis requires significant judgments and assumptions, including estimation of our future cash flows, which is dependent on internally developed forecasts, including future levels of revenue growth, and adjusted earnings before interest, taxes, depreciation, and amortization ("EBITDA") margin, and determination of a weighted average cost of capital, or a discount rate. The discount rate assumption is based on the overall after-tax rate of return required by a market participant whose weighted-average cost of capital includes both equity and debt, including a risk premium. The discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other factors. We also applied a market approach. Under the market approach, we utilized a guideline public company method, which involves calculating valuation multiples based on financial data from comparable publicly traded companies and considerations of recent transactions in the technology industry. Multiples derived from these companies and transactions provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay for a company. These multiples are then applied to the financial data for our reporting unit to arrive at an indication of fair value. The market multiple was applied to adjusted EBITDA.

Based on this subsequent fourth quarter impairment assessment as described, the carrying value of our reporting unit was determined to exceed the fair value, resulting in a non-cash goodwill impairment charge of $1,523.3 million for the fiscal year ended November 30, 2025.

We recorded no impairment charges related to goodwill during the fiscal years ended November 30, 2024 and 2023.

Determining the fair value of our reporting unit requires us to make significant judgments, estimates, and assumptions. The Company believes these estimates and assumptions are reasonable. However, future changes in the judgments, assumptions, and estimates that are used in the impairment testing for goodwill, including discount rates or future cash flow projections, could result in significantly different estimates of the fair value. As a result of these factors, and the impact of macroeconomic conditions, goodwill for our single reporting unit may be more susceptible to impairment risk.

Although assumptions change to reflect changing business and market conditions, our overall valuation methodology and the types of assumptions we use have remained consistent. While we strive to use the best available information to prepare the cash flow and discount rate assumptions, actual future cash flows or market conditions could differ significantly and result in future impairment charges related to the recorded goodwill balance.

***Recently Issued Accounting Pronouncements***

For a summary of recent accounting pronouncements and the anticipated effects on our consolidated financial statements, see Note 2—Summary of Significant Accounting Policies to the consolidated financial statements included elsewhere in this Annual Report on Form 10-K.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Results of Operations – Fiscal Years Ended November 30, 2025 and 2024**

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** |
| | **(in thousands)** | **(in thousands)** |
| Revenue | $9825771 | $9618900 |
| Cost of revenue | 6390760 | 6170013 |
| Gross profit | 3435011 | 3448887 |
| Selling, general and administrative expenses | 2825468 | 2852500 |
| Impairment charges | 1527726 |  |
| Operating income (loss) | (918183) | 596387 |
| Interest expense and finance charges, net | 290349 | 321828 |
| Other income, net | (26310) | (24715) |
| Income (loss) before income taxes | (1182222) | 299274 |
| Provision for income taxes | 96702 | 48057 |
| Net income (loss) | $(1278924) | $251217 |

---

***Revenue***

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Percent Change** |
| | **2025** | **2024** | **2025 to 2024** |
| | **(in thousands)** | **(in thousands)** | |
| **Industry vertical:** |  |  |  |
| Technology and consumer electronics | $2666072 | $2674040 | (0.3)% |
| Retail, travel and e-commerce | 2433885 | 2361866 | 3.0% |
| Communications and media | 1592373 | 1527922 | 4.2% |
| Banking, financial services and insurance | 1536223 | 1455641 | 5.5% |
| Healthcare | 725283 | 727389 | (0.3)% |
| Other | 871935 | 872042 | 0.0% |
| Total | $9825771 | $9618900 | 2.2% |

---

We generate revenue by delivering our technology and services to our clients categorized in the above industry verticals. Our solutions focus on customer engagement, process optimization, and back-office automation.

Our revenue increased 2.2% in fiscal year 2025. The increase in revenue resulted primarily from increases in revenue in our retail, travel and e-commerce, communications and media, and banking, financial services and insurance verticals. Changes in foreign currency exchange rates had a de minimis impact on revenue growth for fiscal year 2025.

Revenue increased in our retail, travel and e-commerce, communications and media, and banking, financial services and insurance verticals, while revenue decreased slightly in our technology and consumer electronics and healthcare verticals and remained flat in our other vertical. Revenue in our technology and consumer electronics vertical decreased 0.3%, which included a decrease as a result of foreign currency exchange rates and a decrease in underlying business with a client in this vertical, partially offset by increases in business with several clients in the vertical. Revenue in our retail, travel and e-commerce vertical increased 3.0%, which included increases in underlying business, primarily from several larger clients in this vertical. Revenue in our communication and media vertical increased 4.2%, which included increases in underlying business primarily from several larger clients in the vertical. Revenue in our banking, financial services and insurance vertical increased 5.5%, which included increases in underlying business from the majority of clients in the vertical. Revenue in our healthcare vertical decreased 0.3%, which included slight decreases in underlying business, primarily from a larger client in the vertical, partially

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

offset by increases in business with several other clients in the vertical. Revenue in our other vertical remained flat over prior year and included a decrease in underlying business, primarily related to an automotive client, partially offset by increases in business with several other clients in the vertical.

***Cost of Revenue, Gross Profit and Gross Margin Percentage***

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Percent Change** |
| | **2025** | **2024** | **2025 to 2024** |
| | **($ in thousands)** | **($ in thousands)** | |
| Cost of revenue | $6390760 | $6170013 | 3.6% |
| Gross profit | $3435011 | $3448887 | (0.4)% |
| Gross margin % | 35.0% | 35.9% |  |

---

Cost of revenue consists primarily of personnel costs. Gross margins can be impacted by resource location, client mix and pricing, additional lead time for programs to be fully scalable, and transition and initial set-up costs.

Our cost of revenue increased by 3.6% in fiscal year 2025, compared to fiscal year 2024, primarily due to the increases in underlying revenue due to volumes. These increases were partially offset by a $63.7 million, or 1.0%, reduction in the cost of revenue due to changes in foreign currency exchange rates. The foreign currency impacts on our cost of revenue were caused primarily by the weakening of several currencies against the U.S. dollar.

Our gross profit decreased by 0.4% in fiscal year 2025, compared to fiscal year 2024, primarily due to decreases in gross profit associated with underlying business partially offset by a net favorable foreign currency impact of $64.8 million. Our gross margin percentage decreased from 35.9% in fiscal year 2024 to 35.0% in fiscal year 2025 due to the changes to revenue and gross profit previously described.

***Selling, General and Administrative Expenses***

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Percent Change** |
| | **2025** | **2024** | **2025 to 2024** |
| | **($ in thousands)** | **($ in thousands)** | |
| Selling, general and administrative expenses | $2825468 | $2852500 | (0.9)% |
| Percentage of revenue | 28.8% | 29.7% |  |

---

Our selling, general and administrative expenses consist primarily of support personnel costs such as salaries, commissions, bonuses, employee benefits, and share-based compensation costs. Selling, general and administrative expenses also include the cost of our global delivery facilities, utility expenses, hardware and software costs related to our technology infrastructure, legal and professional fees, depreciation on our technology and facility equipment, amortization of intangible assets resulting from acquisitions, marketing expenses, and acquisition-related and integration expenses.

Our selling, general and administrative expenses decreased by 0.9% in fiscal year 2025, compared to fiscal year 2024. Contributing to the decrease was a reduction in acquisition-related, integration and restructuring expenses of approximately $67.2 million, partially offset by underlying expenses associated with increased business. Changes in foreign currency exchange rates had a de minimis impact on the year over year change. As a percentage of revenue, selling, general and administrative expenses decreased from 29.7% for fiscal year 2024 to 28.8% for fiscal year 2025 due to the net effect of the changes previously described.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

***Impairment Charges***

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Percent Change** |
| | **2025** | **2024** | **2025 to 2024** |
| | **($ in thousands)** | **($ in thousands)** | |
| Impairment charges | $1527726 | $— | NM |
| Percentage of revenue | 15.5% | 0.0% |  |

---

NM: Not Meaningful - Change greater than 100%

Impairment charges primarily consist of goodwill impairment charges. During fiscal year 2025, we recorded a non-cash goodwill impairment charge of $1,523.3 million. No such charges were recorded in fiscal year 2024. See Note 5—Goodwill and Intangible Assets to the consolidated financial statements for more information.

***Operating Income (Loss)***

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Percent Change** |
| | **2025** | **2024** | **2025 to 2024** |
| | **($ in thousands)** | **($ in thousands)** | |
| Operating income (loss) | $(918183) | $596387 | NM |
| Operating margin | (9.3)% | 6.2% |  |

---

NM: Not Meaningful - Change greater than 100%

Our operating income (loss) changed during fiscal year 2025, compared to fiscal year 2024, primarily due to the impairment charges and a decrease in gross profit, partially offset by a decrease in selling, general and administrative expenses.

Our operating margin decreased during fiscal year 2025, compared to fiscal year 2024, primarily due to the impairment charges as a percentage of revenue and a decrease in gross margin, partially offset by a decrease in selling, general and administrative expenses as a percentage of revenue.

***Interest Expense and Finance Charges, Net***

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Percent Change** |
| | **2025** | **2024** | **2025 to 2024** |
| | **($ in thousands)** | **($ in thousands)** | |
| Interest expense and finance charges, net | $290349 | $321828 | (9.8)% |
| Percentage of revenue | 3.0% | 3.3% |  |

---

Amounts recorded in interest expense and finance charges, net consist primarily of interest expense on our senior notes issued in August 2023, interest expense on our senior credit facility, which includes our revolver and term loans, including our three-year and five-year delayed draw term loans drawn on in September 2025, interest expense on borrowings under our accounts receivable securitization facility (the "Securitization Facility"), and interest expense on the promissory note issued by us to certain Sellers in connection with the Webhelp Combination (the "Sellers' Note").

The decrease in interest expense and finance charges, net during fiscal year 2025 compared to fiscal year 2024, was primarily due to a decrease in interest expense on our senior credit facility of $28.7 million. This decrease was a result of the decrease in outstanding borrowings and a decrease in the effective interest rate on the borrowings during fiscal year 2025, prior to drawing on the three-year and five-year delayed draw term loans in September 2025. Also contributing to the decrease in interest expense and finance charges, net was a decrease in interest expense on the Sellers' Note of $4.8 million in fiscal year 2025 due to the maturity date of September 2025, while fiscal year 2024 had a full year of expense. These decreases were partially offset by an increase in interest expense on our Securitization Facility of $5.6 million primarily due to an increase in outstanding borrowings in comparison to fiscal year 2024.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

***Other Income, Net***

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Percent Change** |
| | **2025** | **2024** | **2025 to 2024** |
| | **($ in thousands)** | **($ in thousands)** | |
| Other income, net | $(26310) | $(24715) | 6.5% |
| Percentage of revenue | (0.3)% | (0.3)% |  |

---

Amounts recorded as other income, net primarily include foreign currency transaction gains and losses other than cash flow hedges, investment gains and losses, the non-service component of pension costs, other non-operating gains and losses, and changes in acquisition contingent consideration related to the Webhelp Combination.

Other income, net in fiscal year 2025 was $26.3 million compared to $24.7 million in fiscal year 2024. The change in other income, net over fiscal year 2024 was primarily due a year over year net benefit of $27.1 million related to net changes in foreign currency transaction gains (losses) and a $1.8 million decrease in other non-operating expenses, offset by a year over year net decrease of $27.3 million related to the change in acquisition contingent consideration associated with the Webhelp Combination.

***Provision for Income Taxes***

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Percent Change** |
| | **2025** | **2024** | **2025 to 2024** |
| | **($ in thousands)** | **($ in thousands)** | |
| Provision for income taxes | $96702 | $48057 | 101.2% |
| Percentage of income before income taxes | (8.2)% | 16.1% |  |

---

Our provision for income taxes consists of our current and deferred tax expense resulting from our income earned in domestic and international jurisdictions.

Our provision for income taxes increased for fiscal year 2025, compared to fiscal year 2024, primarily due to the geographical mix of income, capital loss generated in fiscal year 2024, and the effect of foreign tax rate changes on deferred tax liabilities.

Our effective tax rate decreased in comparison to the prior year primarily due to the loss from the non-cash goodwill impairment charge included in pre-tax loss.

See Note 12—Income Taxes to the consolidated financial statements included elsewhere in this Annual Report on Form 10-K for further details.

***Certain Non-GAAP Financial Information***

In addition to disclosing financial results that are determined in accordance with GAAP, we also disclose certain non-GAAP financial information, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP operating income, which is operating income (loss), adjusted to exclude impairment charges, acquisition-related, integration and restructuring expenses, step-up depreciation, amortization of intangible assets, and share-based compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP operating margin, which is non-GAAP operating income, as defined above, divided by revenue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted earnings before interest, taxes, depreciation, and amortization, or adjusted EBITDA, which is non-GAAP operating income, as defined above, plus depreciation (exclusive of step-up depreciation).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA margin, which is adjusted EBITDA, as defined above, divided by revenue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP net income, which is net income (loss) excluding the tax-effected impact of impairment charges, acquisition-related, integration and restructuring expenses, step-up depreciation, amortization of intangible assets, share-based compensation, certain debt costs, imputed interest related to the Sellers' Note,

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

certain legal settlement costs, change in acquisition contingent consideration and foreign currency losses (gains), net. Non-GAAP net income also excludes the income tax effect of certain tax law changes and certain legal entity restructuring activities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Free cash flow, which is cash flows from operating activities less capital expenditures, and adjusted free cash flow, which is free cash flow excluding the effect of changes in the outstanding factoring balance. We believe that free cash flow is a meaningful measure of cash flows since capital expenditures are a necessary component of ongoing operations. We believe that adjusted free cash flow is a meaningful measure of cash flows because it removes the effect of factoring which changes the timing of the receipt of cash for certain receivables. However, free cash flow and adjusted cash flow have limitations because they do not represent the residual cash flow available for discretionary expenditures. For example, free cash flow and adjusted free cash flow do not incorporate payments for business acquisitions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP diluted earnings per common share ("EPS"), which is diluted EPS excluding the per share, tax-effected impact of impairment charges, acquisition-related and integration expenses, including related restructuring costs, step-up depreciation, amortization of intangible assets, share-based compensation, certain debt costs, imputed interest related to the Sellers' Note, certain legal settlement costs, change in acquisition contingent consideration and foreign currency losses (gains), net. Non-GAAP EPS also excludes the per share income tax effect of certain tax law changes and certain legal entity restructuring activities. Non-GAAP EPS also reflects a per share adjustment to exclude non-GAAP net income attributable to participating securities.

We believe that providing this additional information is useful to the reader to better assess and understand our base operating performance, especially when comparing results with previous periods and for planning and forecasting in future periods, primarily because management typically monitors the business adjusted for these items in addition to GAAP results. Management also uses these non-GAAP measures to establish operational goals and, in some cases, for measuring performance for compensation purposes. These non-GAAP financial measures exclude amortization of intangible assets. Our acquisition activities have resulted in the recognition of intangible assets, which consist primarily of customer relationships, technology, and trade names. Finite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in our statements of operations. Although intangible assets contribute to our revenue generation, the amortization of intangible assets does not directly relate to the services performed for our clients. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of our acquisition activity. Accordingly, we believe excluding the amortization of intangible assets, along with the other non-GAAP adjustments, which neither relate to the ordinary course of our business nor reflect our underlying business performance, enhances our and our investors' ability to compare our past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within our GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired, or the estimated useful life of an intangible asset is revised. These non-GAAP financial measures also exclude share-based compensation expense. Given the subjective assumptions and the variety of award types that companies can use when calculating share-based compensation expense, management believes this additional information allows investors to make additional comparisons between our operating results and those of our peers. As these non-GAAP financial measures are not calculated in accordance with GAAP, they may not necessarily be comparable to similarly titled measures employed by other companies. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures and should be used as a complement to, and in conjunction with, data presented in accordance with GAAP.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** |
| | **($ in thousands except per share amounts)** | **($ in thousands except per share amounts)** |
| Operating income (loss) | $(918183) | $596387 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment charges | 1527726 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related, integration and restructuring expenses<sup>(1)</sup> | 101468 | 156771 |
| &nbsp;&nbsp;&nbsp;&nbsp;Step-up depreciation | 10326 | 9907 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 434332 | 458925 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 97875 | 95922 |
| Non-GAAP operating income | $1253544 | $1317912 |
| Net income (loss) | $(1278924) | $251217 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense and finance charges, net | 290349 | 321828 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | 96702 | 48057 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income, net | (26310) | (24715) |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment charges | 1527726 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related, integration and restructuring expenses<sup>(1)</sup> | 101468 | 156771 |
| &nbsp;&nbsp;&nbsp;&nbsp;Step-up depreciation | 10326 | 9907 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 434332 | 458925 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 97875 | 95922 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation (exclusive of step-up depreciation) | 215775 | 237013 |
| Adjusted EBITDA | $1469319 | $1554925 |
| Operating margin | (9.3)% | 6.2% |
| Non-GAAP operating margin | 12.8% | 13.7% |
| Adjusted EBITDA margin | 15.0% | 16.2% |
| Net income (loss) | $(1278924) | $251217 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment charges | 1527726 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related and integration expenses <sup>(1)</sup> | 101468 | 156771 |
| &nbsp;&nbsp;&nbsp;&nbsp;Step-up depreciation | 10326 | 9907 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt costs <sup>(2)</sup> | 1323 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Imputed interest related to Sellers' Note included in interest expense and finance charges, net | 14577 | 16895 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal settlement costs <sup>(3)</sup> | 2000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in acquisition contingent consideration included in other income, net | (1958) | (29268) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency gains, net <sup>(4)</sup> | (28959) | (1850) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 434332 | 458925 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 97875 | 95922 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes related to the above <sup>(5)</sup> | (155034) | (173963) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax effect of change in tax law | 5699 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax effect of legal entity restructuring  | 12960 | (12254) |
| Non-GAAP net income | $743411 | $772302 |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

---

| | | |
|:---|:---|:---|
|  | **Fiscal Year Ended** | **Fiscal Year Ended** |
|  | **November 30, 2025** | **November 30, 2024** |
| Diluted earnings (loss) per common share ("EPS") | $(20.36) | $3.71 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment charges | 24.22 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related, integration and restructuring expenses <sup>(1)</sup> | 1.61 | 2.41 |
| &nbsp;&nbsp;&nbsp;&nbsp;Step-up depreciation | 0.16 | 0.15 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt costs <sup>(2)</sup> | 0.02 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Imputed interest related to Sellers' Note included in interest expense and finance charges, net | 0.23 | 0.26 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal settlement costs <sup>(3)</sup> | 0.03 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in acquisition contingent consideration included in other income, net | (0.03) | (0.45) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency gains, net <sup>(4)</sup> | (0.46) | (0.03) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 6.89 | 7.05 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 1.55 | 1.47 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes related to the above <sup>(5)</sup> | (2.46) | (2.67) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax effect of change in tax law | 0.09 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax effect of legal entity restructuring | 0.21 | (0.19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for participating securities | (0.48) | (0.29) |
| Non-GAAP Diluted EPS | $11.22 | $11.42 |

---

<sup>(1)</sup> For fiscal years 2025 and 2024, acquisition-related, integration and restructuring expenses, primarily included integration costs associated with our combination with Webhelp and restructuring costs. These costs primarily include severance and employee-related costs, costs associated with facilities consolidation, including lease terminations to integrate the businesses, and information technology system consolidation costs.

<sup>(2)</sup> For the fiscal year 2025, debt costs included debt extinguishment costs associated with the amendment and restatement of our senior credit facility and our voluntary prepayment of a portion of our outstanding term loans.

<sup>(3)</sup> For the fiscal year 2025, legal settlement costs consist of amounts incurred to settle certain litigation arising outside of the ordinary course of business.

<sup>(4)</sup> Foreign currency gains, net are included in other income, net and primarily consist of gains and losses recognized on the revaluation and settlement of foreign currency transactions and realized and unrealized gains and losses on derivative contracts that do not qualify for hedge accounting.

<sup>(5)</sup> The tax effect of taxable and deductible non-GAAP adjustments was calculated using the tax-deductible portion of the expenses and applying the entity specific, statutory tax rates applicable to each item during the respective periods.

**Client Concentration**

In fiscal years 2025 and 2024, no client accounted for more than 10% of our consolidated revenue.

**Liquidity and Capital Resources**

Our primary uses of cash are working capital, capital expenditures to expand our delivery footprint and enhance our technology solutions, debt repayments, acquisitions, and acquisition-related and integration expenses. Our financing needs for these uses of cash have been a combination of operating cash flows and third-party debt arrangements. Our working capital needs are primarily to finance accounts receivable. When our revenue is increasing, our net investment in working capital typically increases. Conversely, when revenue is decreasing, our net investment in working capital typically decreases. To increase our market share and better serve our clients, we may further expand our operations through investments or acquisitions. We expect that such expansion would require an initial investment in working capital, personnel, facilities, and operations. These investments or

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

acquisitions would likely be funded primarily by our existing cash and cash equivalents, available liquidity, including capacity on our debt arrangements, or the issuance of securities.

In September 2021, considering our strong free cash flow, low leverage, and adequate liquidity to support capital return to stockholders while maintaining flexibility to pursue acquisitions, our board of directors authorized a share repurchase program. Under the share repurchase program, the board of directors authorized the repurchase of up to $500 million of our common stock from time to time as market and business conditions warrant, including through open market purchases or Rule 10b5-1 trading plans. In January 2025, our board of directors extended our share repurchase program by authorizing an increase of the amount remaining for share repurchases under the existing share repurchase authorization to $600 million. The share repurchase program has no termination date and may be suspended or discontinued at any time. During the fiscal years ended November 30, 2025 and 2024, we repurchased 3,556,736 and 2,200,819 shares, respectively, of our common stock under the share repurchase program for approximately $168.7 million and $136.1 million, respectively, in the aggregate. At November 30, 2025, approximately $439.5 million remained available for share repurchases under the existing authorization from our board of directors.

During December 2025, we repurchased 256,511 shares of our common stock under the share repurchase program for an aggregate purchase price of $9.9 million.

During fiscal years 2025 and 2024, we paid the following dividends per share approved by our board of directors:

---

| | | | |
|:---|:---|:---|:---|
| **Announcement Date** | **Record Date** | **Per Share Dividend Amount** | **Payment Date** |
| January 24, 2024 | February 5, 2024 | $0.3025 | February 15, 2024 |
| March 26, 2024 | April 26, 2024 | $0.3025 | May 7, 2024 |
| June 26, 2024 | July 26, 2024 | $0.3025 | August 6, 2024 |
| September 25, 2024 | October 25, 2024 | $0.33275 | November 5, 2024 |
| January 15, 2025 | January 31, 2025 | $0.33275 | February 11, 2025 |
| March 26, 2025 | April 25, 2025 | $0.33275 | May 6, 2025 |
| June 26, 2025 | July 25, 2025 | $0.33275 | August 5, 2025 |
| September 25, 2025 | October 24, 2025 | $0.36 | November 4, 2025 |

---

On January 13, 2026, we announced a cash dividend of $0.36 per share to stockholders of record as of the close of business on January 30, 2026, payable on February 10, 2026.

We expect that future cash dividends will be paid on a quarterly basis. However, any decision to pay future cash dividends will be subject to our board of directors' approval, and will depend on many factors, such as our financial condition, earnings, capital requirements, debt service obligations, restrictive covenants in our debt agreements, industry practice, legal requirements, regulatory constraints, and other factors that our board of directors deems relevant. Our ability to pay dividends will depend on our ongoing ability to generate cash from operations and on our access to the capital markets. We cannot guarantee that we will continue to pay a dividend in the future.

***Debt Arrangements***

*Senior Notes*

On August 2, 2023, we issued and sold (i) $800 million aggregate principal amount of 6.650% Senior Notes due 2026 (the "2026 Notes"), (ii) $800 million aggregate principal amount of 6.600% Senior Notes due 2028 (the "2028 Notes") and (iii) $550 million aggregate principal amount of 6.850% Senior Notes due 2033 (the "2033 Notes" and, together with the 2026 Notes and 2028 Notes, the "Senior Notes"). The Senior Notes were sold in a registered public offering pursuant to our Registration Statement on Form S-3, which became effective upon filing, and a Prospectus Supplement dated July 19, 2023, to a Prospectus dated July 17, 2023.

The Senior Notes were issued pursuant to, and are governed by, an indenture, dated as of August 2, 2023 (the "Base Indenture"), between Concentrix and U.S. Bank Trust Company, National Association, as trustee (the "Trustee"), as supplemented by a first supplemental indenture dated as of August 2, 2023 between Concentrix and the Trustee relating to the 2026 Notes, a second supplemental indenture dated as of August 2, 2023 between

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

Concentrix and the Trustee relating to the 2028 Notes, and a third supplemental indenture dated as of August 2, 2023 between Concentrix and the Trustee relating to the 2033 Notes (such supplemental indentures, together with the Base Indenture, the "Indenture"). The Indenture contains customary covenants and restrictions, including covenants that limit Concentrix Corporation's and certain of its subsidiaries' ability to create or incur liens on shares of stock of certain subsidiaries or on principal properties, engage in sale/leaseback transactions or, with respect to Concentrix Corporation, consolidate or merge with, or sell or lease substantially all its assets to, another person. The Indenture also provides for customary events of default.

The principal amount outstanding on the 2026 Notes as of November 30, 2025 was classified as long-term debt within the consolidated balance sheet based on the Company's ability and intent to refinance on a long-term basis.

In connection with the closing of the Webhelp Combination, we entered into cross-currency swap arrangements with certain financial institutions for a total notional amount of $500 million of the Senior Notes. In addition to aligning the currency of a portion of our interest payments to our euro-denominated cash flows, the arrangements effectively converted $250 million aggregate principal amount of the 2026 Notes and $250 million aggregate principal amount of the 2028 Notes into synthetic fixed euro-based debt at weighted average interest rates of 5.12% and 5.18%, respectively.

Concurrent with entering into the cross-currency interest rate swaps with certain financial institutions, Marnix SAS, an indirect wholly owned subsidiary of Concentrix Corporation, entered into corresponding U.S. dollar denominated intercompany loan agreements with certain other subsidiaries of Concentrix with identical terms and notional amounts as the underlying $500 million U.S. dollar denominated senior notes, with reciprocal cross-currency interest rate swaps.

*Restated Credit Agreement*

On April 11, 2025, we entered into an Amendment and Restatement Agreement (the "Amendment Agreement") with the lenders party thereto, Bank of America, N.A., as the administrative agent, the L/C issuer and the swing line lender, and JPMorgan Chase Bank, N.A., as the existing administrative agent, the existing L/C issuer and the existing swing line lender, to amend and restate the Company's Amended and Restated Credit Agreement dated as of April 21, 2023 (the "Existing Credit Agreement" and, as so amended and restated by the Amendment Agreement, the "Restated Credit Agreement"). The Amendment Agreement appoints Bank of America, N.A. as the Administrative Agent under the Restated Credit Agreement, as successor to JPMorgan Chase Bank, N.A.

The Restated Credit Agreement provides for (i) an unsecured three-year term loan facility in an aggregate principal amount not to exceed $750 million (the "New Term Loan Facility"), (ii) an unsecured three-year delayed draw term loan facility in an aggregate principal amount not to exceed $250 million (the "3-Year DD Term Loan Facility"), which was drawn in full in September 2025, (iii) an unsecured five-year delayed draw term loan facility in an aggregate principal amount not to exceed $500 million (the "5-Year DD Term Loan Facility", and together with the 3-Year DD Term Loan Facility, the "Delayed Draw Term Loans"), which was drawn in full in September 2025, and (iv) a senior unsecured revolving credit facility not to exceed an aggregate principal amount of $1.1 billion (the "Revolving Credit Facility"). The Restated Credit Agreement also provided for the conversion and continuation of loans in an aggregate principal amount of $750 million under our prior unsecured term loan facility into loans under an unsecured term loan facility with the same maturity as such converted and continued loans (the "Continued Term Loan Facility"). Aggregate borrowing capacity under the Restated Credit Agreement may be increased by up to an additional $500 million by increasing the amount of the revolving credit facility commitments or by incurring additional term loans, in each case subject to the satisfaction of certain conditions set forth in the Restated Credit Agreement, including the receipt of additional commitments for such increase(s).

The maturity date of the New Term Loan Facility and the 3-Year DD Term Loan Facility is September 30, 2028. The maturity date of the 5-Year DD Term Loan Facility and the Revolving Credit Facility is April 11, 2030, subject, in the case of the Revolving Credit Facility, to two one-year extensions upon our prior notice to the lenders and the agreement of the lenders to extend such maturity date. The maturity date of the Continued Term Loan Facility remains December 27, 2026.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

The outstanding principal amount of each of the New Term Loan Facility and the Delayed Draw Term Loans is payable in quarterly installments in an amount equal to 1.25% of the existing principal balance of the applicable term loan, commencing on September 30, 2025, in the case of the New Term Loan Facility, and on March 31, 2026, in the case of the Delayed Draw Term Loans, with the outstanding principal amount of the New Term Loan Facility, the Delayed Draw Term Loans, and the Continued Term Loan Facility due in full on the applicable maturity date.

In September 2025, in connection with the issuance of the Delayed Draw Term Loans of $750 million, we entered into an interest rate swap to fix the interest component associated with the debt, creating synthetic fixed-rate debt. Concurrent with entering the interest rate swaps, we entered into cross-currency swap arrangements with certain financial institutions for a total notional amount equivalent to $750 million. In addition to aligning the currency of our interest payments to the Company's euro-denominated cash flows, the arrangements, together with intercompany loans and additional intercompany cross-currency interest rate swap arrangements, effectively converted the Delayed Draw Term Loans into synthetic fixed euro-based debt at weighted average interest rates of 3.43% for the three-year term and 3.69% for the five-year term.

Borrowings under the Restated Credit Agreement bear interest, in the case of SOFR rate loans, at a per annum rate equal to the applicable SOFR rate (but not less than 0.0%), plus an applicable margin, based on the credit ratings of Concentrix' senior unsecured non-credit enhanced long-term indebtedness for borrowed money plus a credit spread adjustment to the SOFR rate of 0.10%. The applicable margin ranges from 1.000% to 1.500% for the New Term Loan Facility and the 3-Year DD Term Loan Facility, 1.100% to 1.600% for the 5-Year DD Term Loan Facility, 1.125% to 2.000% for the Continued Term Loan Facility, and 0.875% to 1.500% for the Revolving Credit Facility. Borrowings under the Restated Credit Agreement that are base rate loans bear interest at a per annum rate (but not less than 1.0%) equal to (i) the greatest of (A) the "prime rate" (as defined in the Restated Credit Agreement) in effect on such day, (B) the Federal Funds Rate (as defined in the Restated Credit Agreement) in effect on such day plus 0.500%, and (C) the adjusted one-month term SOFR rate plus 1.0% per annum, plus (ii) an applicable margin, based on the credit ratings of Concentrix' senior unsecured non-credit enhanced long-term indebtedness for borrowed money. The applicable margin ranges from 0.000% to 0.500% for the New Term Loan Facility, the 3-Year DD Term Loan Facility, and the Revolving Credit Facility, 0.100% to 0.600% for the 5-Year DD Term Loan Facility, and 0.125% to 1.000% for the Continued Term Loan Facility.

The Restated Credit Agreement contains certain loan covenants that are customary for credit facilities of this type and that restrict the ability of Concentrix and its subsidiaries to take certain actions, including the creation of liens, mergers, consolidations, or other fundamental changes to the nature of their business, and, solely with respect to subsidiaries of Concentrix, incurrence of indebtedness. In addition, the Restated Credit Agreement contains financial covenants that require Concentrix to maintain at the end of each fiscal quarter, (i) a consolidated leverage ratio (as defined in the Restated Credit Agreement) not to exceed 3.75 to 1.00 (or for certain periods following certain qualified acquisitions, 4.25 to 1.00) and (ii) a consolidated interest coverage ratio (as defined in the Restated Credit Agreement) no less than 3.00 to 1.00. The Restated Credit Agreement also contains various customary events of default, including payment defaults, defaults under certain other indebtedness, and a change of control of Concentrix.

As of November 30, 2025 and 2024, the outstanding principal balance on our term loans was $1,966 million and $1,500 million, respectively. During the fiscal year November 30, 2025, we voluntarily prepaid $275 million of the principal balance on our term loans, without penalty. We also made a required quarterly payment of $9.4 million during the fiscal year ended November 30, 2025.

None of our subsidiaries guarantee the obligations under the Restated Credit Agreement.

At November 30, 2025 and 2024, no amounts were outstanding under our revolving credit facility.

*Securitization Facility*

Under our Securitization Facility, Concentrix Corporation and certain of its U.S. based subsidiaries sell or otherwise transfer all of their accounts receivable to a special purpose bankruptcy-remote subsidiary of Concentrix Corporation that grants a security interest in the receivables to the lenders in exchange for available borrowings. On January 14, 2025, we entered into an amendment to the Securitization Facility to (i) increase the commitment of the lenders to provide available borrowings from up to $600 million to up to $700 million and (ii) extend the

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

termination date of the Securitization Facility from April 24, 2026 to January 14, 2027. For borrowings that are funded by certain lenders through the issuance of commercial paper, the amendment also reduced the spread to the applicable commercial paper rate from 0.80% to 0.75%. Other borrowings bear interest at a per annum rate equal to the applicable SOFR rate (subject to a SOFR related adjustment of 0.10%), plus a spread of 0.90%. Borrowing availability under the Securitization Facility may be limited by our accounts receivable balances, changes in the credit ratings of our clients comprising the receivables, client concentration levels in the receivables, and certain characteristics of the accounts receivable being transferred (including factors tracking performance of the accounts receivable over time).

The Securitization Facility contains various affirmative and negative covenants, including a consolidated leverage ratio covenant that is consistent with the Restated Credit Agreement and customary events of default, including payment defaults, defaults under certain other indebtedness, a change in control of Concentrix Corporation, and certain events negatively affecting the overall credit quality of the transferred accounts receivable.

*Sellers' Note*

On September 25, 2023, as part of the consideration for the Webhelp Combination, we issued the Sellers' Note in the aggregate principal amount of €700 million to certain Sellers. Pursuant to the Sellers' Note, the unpaid principal amount outstanding accrued interest at a rate of two percent (2%) per annum, and all principal and accrued interest was due and payable on September 25, 2025. The stated rate of interest was below our expected borrowing rate. As a result, we discounted the Sellers' Note by €31,500. The discounted value was amortized into interest expense over the two-year term.

On September 25, 2025, we used the proceeds of the Delayed Draw Term Loans and cash on hand to repay the principal balance and accrued interest on the Sellers' Note. The principal amount outstanding on the Sellers' Note as of November 30, 2024 was classified as long-term debt within the consolidated balance sheet based on our ability and intent to refinance on a long-term basis.

As of November 30, 2025 and 2024, we were in compliance with the debt covenants related to our debt arrangements.

***Cash Flows – Fiscal Years Ended November 30, 2025 and 2024***

The following summarizes our cash flows for the fiscal years ended November 30, 2025 and 2024, as reported in our consolidated statement of cash flows in the accompanying consolidated financial statements.

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** |
| | **($ in thousands)** | **($ in thousands)** |
| Net cash provided by operating activities | $806967 | $667492 |
| Net cash used in investing activities | (250383) | (244266) |
| Net cash used in financing activities | (491443) | (492532) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 26382 | (17577) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $91523 | $(86883) |
| Cash, cash equivalents and restricted cash at beginning of year | 429604 | 516487 |
| Cash, cash equivalents and restricted cash at end of year | $521127 | $429604 |

---

*Operating Activities*

Net cash provided by operating activities was $807.0 million for fiscal year 2025, compared to $667.5 million for fiscal year 2024. The increase in net cash provided by operating activities over the prior year was primarily related to an increase in net income prior to non-cash goodwill impairment charges and a decrease in acquisition-related and integration costs.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

*Investing Activities*

Net cash used in investing activities for fiscal year 2025 was $250.4 million. The net cash used in investing activities consisted primarily of purchases of property and equipment of $234.5 million and acquisitions, net of cash acquired of $15.9 million.

Net cash used in investing activities in fiscal year 2024 was $244.3 million. The net cash used in investing activities consisted primarily of purchases of property and equipment of $238.8 million and payment of deferred cash consideration of $4.5 million related to the Webhelp Combination.

*Financing Activities*

Net cash used in financing activities in fiscal year 2025 was $491.4 million, consisting primarily of $828.3 million for payments on other debt, primarily related to the repayment of the Sellers' Note, $168.7 million for share repurchases under our share repurchase program, $20.0 million for shares withheld upon vesting of share-based awards to satisfy tax withholding obligations, $89.6 million for dividends paid, and $9.2 million related to a change in funds held for clients. These payments were partially offset by net borrowings of $465.6 million made on term loan borrowings under our senior credit facility and net borrowings of $166.0 million under our Securitization Facility.

Net cash used in financing activities in fiscal year 2024 was $492.5 million, consisting primarily of principal payments of $450.0 million made on term loan borrowings under our senior credit facility, share repurchases of $149.5 million, including repurchases under our share repurchase program and shares withheld upon vesting of share-based awards to satisfy tax withholding obligations, dividends paid of $83.8 million, a change in funds held for clients of $32.2 million, and cash paid related to acquired earnout liabilities of $22.7 million. These payments were partially offset by net borrowings of $242.5 million under our Securitization Facility.

***Free Cash Flow and Adjusted Free Cash Flow (non-GAAP measures)***

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** |
| | **($ in thousands)** | **($ in thousands)** |
| Net cash provided by operating activities | $806967 | $667492 |
| Purchases of property and equipment | (234496) | (238762) |
| Free cash flow (a non-GAAP measure) | $572471 | $428730 |
| Change in outstanding factoring balances | 53933 | 45788 |
| Adjusted free cash flow (a non-GAAP measure) | $626404 | $474518 |

---

Our free cash flow was $572.5 million in fiscal year 2025, compared to $428.7 million in fiscal year 2024. The increase in free cash flow in fiscal year 2025 over the prior year primarily reflects an increase in net cash provided by operating activities and a decrease in capital expenditures.

Our adjusted free cash flow was $626.4 million in fiscal year 2025, compared to $474.5 million in fiscal year 2024. The increase in adjusted free cash flow in fiscal year 2025 over the prior year primarily reflects an increase in free cash flow combined with an increase in the change in outstanding factoring balances.

***Capital Resources***

As of November 30, 2025, we had total liquidity of $1,592.4 million, which includes undrawn capacity on our revolving credit facility of $1,100.0 million, undrawn capacity of $163.0 million under our Securitization Facility, and cash and cash equivalents.

Our cash and cash equivalents, including cash held for sale, totaled $329.4 million and $240.6 million as of November 30, 2025 and 2024, respectively. Of our total cash and cash equivalents, 98% were held by our non-U.S. legal entities as of each of November 30, 2025 and 2024. The cash and cash equivalents held by our non-U.S. legal entities are no longer subject to U.S. federal tax on repatriation into the United States; repatriation of some non-U.S. balances is restricted by local laws. Historically, we have fully utilized and reinvested all non-U.S. cash to fund our international operations and expansions; however, we have recorded deferred tax liabilities related to non-U.S.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

withholding taxes on the earnings of certain previously acquired non-U.S. entities that are likely to be repatriated in the future. If in the future our intentions change, and we repatriate the cash back to the United States, we will report in our consolidated financial statements the impact of the state and withholding taxes depending upon the planned timing and manner of such repatriation.

We believe that our available cash and cash equivalents balances, the cash flows expected to be generated from operations, and our sources of liquidity will be sufficient to satisfy our current and planned working capital and investment needs for the next twelve months. We also believe that our longer-term working capital, planned capital expenditures, and other general corporate funding requirements will be satisfied through cash flows from operations and, to the extent necessary, from our borrowing facilities and future financing activities.

***Material Cash Requirements, including Contractual Obligations to Third Parties***

The following table summarizes our material cash requirements from known contractual or other obligations as of November 30, 2025 that are not disclosed elsewhere in this Annual Report on Form 10-K:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** |
| | **Total** | **Less than 1 Year** | **1 - 3 Years** | **3 - 5 Years** | **>5 Years** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Certain Contractual Obligations:** | | | | | |
| Interest on financing agreements <sup>(a)</sup> | $777061 | $259531 | $308948 | $108115 | $100467 |
| Defined benefit plan funding <sup>(b)</sup> | 68832 |  | 3769 | 5972 | 59091 |

---

(a) Cash obligations for required interest payments on our variable-rate debt obligations are based on the interest rates as of November 30, 2025.

(b) Includes projected contributions to achieve minimum funding objectives for our cash balance pension plan.

As of November 30, 2025, we have established a reserve of $95.0 million for unrecognized tax benefits. As we are unable to reasonably predict the timing of settlement related to these unrecognized tax benefits, the table above excludes such liabilities.

We currently expect our fiscal year 2026 capital expenditures to be approximately $240 million to $250 million, which includes investments to support our growth and maintenance capital expenditures.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

**Market Risk**

We are and will be exposed to a variety of market risks, including the effects of changes in foreign currency exchange rates and interest rates. Market risk is the potential loss arising from changes in market rates and prices. Our risk management strategy includes managing these risks through our regular operating and financing activities and, when appropriate, through the use of derivative financial instruments. We utilize derivative financial instruments to hedge economic exposures, as well as reduce earnings and cash flow volatility resulting from shifts in market rates. In using derivative financial instruments to hedge our exposures to changes in exchange rates, we expose ourselves to counterparty credit risk. We manage our exposure to counterparty credit risk by entering into derivative financial instruments with investment grade-rated institutions that can be expected to perform fully under the terms of the agreements and by diversifying the financial institutions with which we enter into such agreements. There can be no guarantee that the risk management activities that we have entered into will be sufficient to fully offset market risk or reduce earnings and cash flow volatility resulting from shifts in market rates. See Note 6 of the consolidated financial statements included elsewhere in this Annual Report on Form 10-K for additional discussion of our financial risk management.

**Foreign Currency Risk**

While approximately 54% of our revenue is priced in U.S. dollars, we recognize a substantial amount of revenue under contracts that are denominated in euros, British pounds, Japanese yen, and Brazilian real, among other currencies. A significant increase in the value of the U.S. dollar relative to these currencies may have a material adverse effect on the value of those services when translated into U.S. dollars.

We serve many of our U.S.-based, European and British clients from our delivery centers located around the world. As a result, a substantial portion of the costs to deliver these services are denominated in the local currency of the country where the services are performed. This creates foreign exchange exposure for us. As of November 30, 2025, we have hedged a portion of our exposure related to the anticipated cash flow requirements denominated in certain foreign currencies by entering into hedging contracts with institutions to acquire a total of PHP 43,480.0 million at a fixed price of $750.4 million at various dates through November 2027; and INR 28,430.0 million at a fixed price of $320.1 million at various dates through November 2027. The fair value of these derivative instruments as of November 30, 2025 is presented in Note 7 of the consolidated financial statements included elsewhere in this Annual Report on Form 10-K. The potential loss in fair value at November 30, 2025 for such contracts resulting from a hypothetical 10% adverse change in the underlying foreign currency exchange rates is approximately $105.0 million. This loss would be substantially mitigated by corresponding gains on the underlying foreign currency exposures.

Other foreign currency exposures arise from transactions denominated in a currency other than the functional currency. We periodically enter into hedging contracts that are not denominated as hedges. The purpose of these derivative instruments is to mitigate the risk of foreign currency exposure related to receivables, payables, and intercompany transactions that are denominated in currencies that are different from the functional currencies of our respective legal entities that are party to the transactions.

**Interest Rate Risk**

At November 30, 2025, our outstanding debt under our Restated Credit Agreement and our Securitization Facility is variable rate debt, which exposes the Company to changes in interest rates. Holding other variables constant, including the total amount of outstanding indebtedness, a one hundred basis point increase in interest rates on our variable-rate debt would cause an estimated increase in interest expense of approximately $24.4 million per year.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA**

**Index to Consolidated Financial Statements**

---

| | |
|:---|:---|
| | Page |
| Audited Consolidated Financial Statements of Concentrix Corporation: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Management's Report on Internal Control over Financial Reporting](#ic6c7f84d93cf4ade8f96643eb3cd05dd_82)</u> | <u>[52](#ic6c7f84d93cf4ade8f96643eb3cd05dd_82)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Report](#ife1ac8cbe1ff49209915f6e829a5f4d7_135689)[s](#ife1ac8cbe1ff49209915f6e829a5f4d7_135689)[of Independent Registered Public Accounting Firm](#ife1ac8cbe1ff49209915f6e829a5f4d7_135689)</u> (PCAOB ID:42) | <u>[53](#ife1ac8cbe1ff49209915f6e829a5f4d7_135689)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[R](#ife1ac8cbe1ff49209915f6e829a5f4d7_135690)[eport of Independ](#ife1ac8cbe1ff49209915f6e829a5f4d7_135690)[ent Registered Public Accounting Firm](#ife1ac8cbe1ff49209915f6e829a5f4d7_135690)</u> (PCAOB ID: 185) | <u>[56](#ife1ac8cbe1ff49209915f6e829a5f4d7_135690)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Balance Sheets as of November 30, 2025 and 2024](#ic6c7f84d93cf4ade8f96643eb3cd05dd_88)</u> | <u>[57](#ic6c7f84d93cf4ade8f96643eb3cd05dd_88)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Operations for the Years Ended November 30, 2025, 2024 and 2023](#ic6c7f84d93cf4ade8f96643eb3cd05dd_91)</u> | <u>[58](#ic6c7f84d93cf4ade8f96643eb3cd05dd_91)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Comprehensive Income](#ic6c7f84d93cf4ade8f96643eb3cd05dd_94)[(](#ic6c7f84d93cf4ade8f96643eb3cd05dd_94)[L](#ic6c7f84d93cf4ade8f96643eb3cd05dd_94)[oss)](#ic6c7f84d93cf4ade8f96643eb3cd05dd_94)[for](#ic6c7f84d93cf4ade8f96643eb3cd05dd_94)[the Years Ended November 30, 2025, 2024 and 2023](#ic6c7f84d93cf4ade8f96643eb3cd05dd_91)</u> | <u>[59](#ic6c7f84d93cf4ade8f96643eb3cd05dd_94)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Stockholders' Equity for](#ic6c7f84d93cf4ade8f96643eb3cd05dd_97)[the Years Ended November 30, 2025, 2024 and 2023](#ic6c7f84d93cf4ade8f96643eb3cd05dd_91)</u> | <u>[60](#ic6c7f84d93cf4ade8f96643eb3cd05dd_97)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Cash Flows for](#ic6c7f84d93cf4ade8f96643eb3cd05dd_100)[the Years Ended November 30, 2025, 2024 and 2023](#ic6c7f84d93cf4ade8f96643eb3cd05dd_91)</u> | <u>[61](#ic6c7f84d93cf4ade8f96643eb3cd05dd_100)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to Consolidated Financial Statements](#ic6c7f84d93cf4ade8f96643eb3cd05dd_103)</u> | <u>[63](#ic6c7f84d93cf4ade8f96643eb3cd05dd_103)</u> |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Management's Report on Internal Control over Financial Reporting**

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of ours are being made only in accordance with authorizations of management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, our management has concluded that, as of November 30, 2025, our internal control over financial reporting was effective at the reasonable assurance level based on those criteria.

The effectiveness of our internal control over financial reporting as of November 30, 2025 has been audited by Ernst & Young LLP, an independent registered public accounting firm, as stated in their report which appears beginning on the following page of this Annual Report on Form 10-K.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Report of Independent Registered Public Accounting Firm**

To the Stockholders and the Board of Directors of Concentrix Corporation

**Opinion on Internal Control Over Financial Reporting**

We have audited Concentrix Corporation's internal control over financial reporting as of November 30, 2025, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Concentrix Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of November 30, 2025, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of November 30, 2025, the related consolidated statements of operations, comprehensive income (loss), stockholders' equity and cash flows for the year ended November 30, 2025, and the related notes and our report dated January 28, 2026, expressed an unqualified opinion thereon.

**Basis for Opinion**

The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

**Definition and Limitations of Internal Control Over Financial Reporting**

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Ernst & Young LLP

Cincinnati, Ohio

January 28, 2026

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Report of Independent Registered Public Accounting Firm**

To the Stockholders and the Board of Directors of Concentrix Corporation

**Opinion on the Financial Statements**

We have audited the accompanying consolidated balance sheet of Concentrix Corporation (the Company) as of November 30, 2025, the related consolidated statements of operations, comprehensive income (loss), stockholders' equity, and cash flows for the year ended November 30, 2025, and the related notes and financial statement Schedule II - Valuation and Qualifying Accounts (collectively, the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at November 30, 2025, and the results of its operations and its cash flows for the year ended November 30, 2025, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of November 30, 2025, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated January 28, 2026 expressed an unqualified opinion thereon.

**Basis for Opinion**

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

**Critical Audit Matter**

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the account or disclosures to which it relates.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

---

| | |
|:---|:---|
| | ***Evaluation of goodwill for impairment***  |
| *Description of the Matter* | At November 30, 2025, the Company's goodwill was $3.7 billion for its single reporting unit. As discussed in Note 2 to the consolidated financial statements, goodwill is tested annually for impairment at the reporting unit level on the first day of the fiscal fourth quarter or more frequently if events or changes in circumstances indicate that it may be impaired. The goodwill impairment test involves estimating the fair value of the reporting unit using a discounted cash flow model and the guideline public company approach. As discussed in Note 5 to the consolidated financial statements, subsequent to the annual goodwill impairment assessment, the Company experienced a sustained decrease in the market price of its common stock which necessitated an interim goodwill impairment test as of November 1, 2025. As a result of the interim quantitative goodwill impairment assessment, the fair value of the Company's reporting unit was less than its carrying value and the Company recorded a goodwill impairment charge of $1.5 billion. <br>Auditing the Company's interim goodwill impairment charge was complex and required significant auditor judgment due to the high degree of estimation uncertainty involved in forecasting future revenue growth rates, adjusted earnings before income taxes, depreciation and amortization (EBITDA) margin projections, and calculating the weighted average cost of capital. These significant assumptions are forward looking and could be affected by future economic and market conditions and the performance of the Company's reporting unit. |
| *How We Addressed the Matter in Our Audit* | We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company's interim goodwill impairment charge. Our procedures included, among others, testing controls over management's review of the valuation models and significant assumptions described above.<br>To test the estimated fair value of the Company's reporting unit used in the interim goodwill impairment charge, we performed audit procedures that included, among others, assessing the methodologies used to determine the fair value of the Company's reporting unit, testing the significant assumptions discussed above and testing the underlying data used by the Company in its analysis. We evaluated the Company's assumptions around future revenue growth rates and adjusted EBITDA margin projections by comparing those assumptions to recent historical performance, financial forecasts, and current and forecasted economic and industry trends. We evaluated management's historical accuracy of forecasting revenue and adjusted EBITDA margins by comparing past forecasts to subsequent actual activity. We also performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the Company's reporting unit that would result from changes in the assumptions. In addition, we involved our valuation specialists to assist in our evaluation of the methodologies and certain significant assumptions used by the Company, specifically the weighted average cost of capital. |

---

/s/ Ernst & Young LLP

We have served as the Company's auditor since 2025.

Cincinnati, Ohio

January 28, 2026

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Report of Independent Registered Public Accounting Firm**

To the Stockholders and Board of Directors

Concentrix Corporation:

*Opinion on the Consolidated Financial Statements* 

We have audited the accompanying consolidated balance sheet of Concentrix Corporation and subsidiaries (the Company) as of November 30, 2024, the related consolidated statements of operations, comprehensive income (loss), stockholders' equity, and cash flows for each of the years in the two-year period ended November 30, 2024, and the related notes and financial statement Schedule II - Valuation and Qualifying Accounts (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of November 30, 2024, and the results of its operations and its cash flows for each of the years in the two-year period ended November 30, 2024, in conformity with U.S. generally accepted accounting principles.

*Basis for Opinion*

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ KPMG LLP

We served as the Company's auditor from 2019 to 2025.

Cincinnati, Ohio

January 28, 2025 except for Note 16, as to which the date is January 28, 2026

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**CONCENTRIX CORPORATION**

**CONSOLIDATED BALANCE SHEETS**

**(currency and share amounts in thousands, except par value)**

---

| | | |
|:---|:---|:---|
| | **November 30, 2025** | **November 30, 2024** |
| **ASSETS** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $327347 | $240571 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 1999021 | 1926737 |
| &nbsp;&nbsp;&nbsp;Other current assets | 758135 | 675116 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 3084503 | 2842424 |
| Property and equipment, net | 735550 | 714517 |
| Goodwill | 3671746 | 4986967 |
| Intangible assets, net | 1960338 | 2286940 |
| Deferred tax assets | 317453 | 218396 |
| Other assets | 991496 | 942194 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $10761086 | $11991438 |
| **LIABILITIES AND EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $244771 | $209812 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt | 65625 | 2522 |
| &nbsp;&nbsp;&nbsp;Accrued compensation and benefits | 764962 | 706619 |
| &nbsp;&nbsp;&nbsp;Other accrued liabilities | 997198 | 977314 |
| &nbsp;&nbsp;&nbsp;Income taxes payable | 123794 | 99546 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 2196350 | 1995813 |
| Long-term debt, net | 4572889 | 4733056 |
| Other long-term liabilities | 950983 | 910271 |
| Deferred tax liabilities | 296519 | 312574 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 8016741 | 7951714 |
| Commitments and contingencies (Note 13) |  |  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock, $0.0001 par value, 10,000 shares authorized and no shares issued and outstanding as of November 30, 2025 and 2024, respectively |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, $0.0001 par value, 250,000 shares authorized; 70,316 and 68,849 shares issued as of November 30, 2025 and 2024, respectively, and 61,739 and 64,238 shares outstanding as of November 30, 2025 and 2024, respectively | 7 | 7 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 3783972 | 3683608 |
| &nbsp;&nbsp;&nbsp;Treasury stock, 8,577 and 4,611 shares as of November 30, 2025 and 2024, respectively | (610162) | (421449) |
| &nbsp;&nbsp;&nbsp;Retained earnings (deficit) | (177010) | 1191871 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (252462) | (414313) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 2744345 | 4039724 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $10761086 | $11991438 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**CONCENTRIX CORPORATION**

**CONSOLIDATED STATEMENTS OF OPERATIONS**

**(currency and share amounts in thousands, except per share amounts)**

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| Revenue | $9825771 | $9618900 | $7114706 |
| Cost of revenue | 6390760 | 6170013 | 4536771 |
| Gross profit | 3435011 | 3448887 | 2577935 |
| Selling, general and administrative expenses | 2825468 | 2852500 | 1916608 |
| Impairment charges | 1527726 |  |  |
| Operating income (loss) | (918183) | 596387 | 661327 |
| Interest expense and finance charges, net | 290349 | 321828 | 201004 |
| Other expense (income), net | (26310) | (24715) | 52095 |
| Income (loss) before income taxes | (1182222) | 299274 | 408228 |
| Provision for income taxes | 96702 | 48057 | 94386 |
| Net income (loss) | $(1278924) | $251217 | $313842 |
| Earnings (loss) per common share: |  |  |  |
| &nbsp;&nbsp;Basic | $(20.36) | $3.72 | $5.72 |
| &nbsp;&nbsp;Diluted | $(20.36) | $3.71 | $5.70 |
| Weighted-average common shares outstanding: |  |  |  |
| &nbsp;&nbsp;Basic | 63012 | 64977 | 53801 |
| &nbsp;&nbsp;Diluted | 63012 | 65074 | 54010 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**CONCENTRIX CORPORATION**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)**

**(currency in thousands)**

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| Net income (loss) | $(1278924) | $251217 | $313842 |
| Other comprehensive income (loss): |  |  |  |
| &nbsp;&nbsp;&nbsp;Unrealized gains (losses) of defined benefit plans, net of taxes of $(1003), $(2078), and $(894) for fiscal years ended November 30, 2025, 2024 and 2023, respectively | 3702 | 5988 | (2800) |
| &nbsp;&nbsp;&nbsp;Unrealized gains (losses) on hedges during the period, net of taxes of $2,051, $9,514, and $(4938) for fiscal years ended November 30, 2025, 2024 and 2023, respectively | (3578) | (34029) | 10610 |
| &nbsp;&nbsp;&nbsp;Reclassification of net losses on hedges to net income (loss), net of taxes of $(2322), $(1230), and $(4594) for fiscal years ended November 30, 2025, 2024 and 2023, respectively | 6818 | 3659 | 13793 |
| &nbsp;&nbsp;&nbsp;Total change in unrealized gains (losses) on hedges, net of taxes | 3240 | (30370) | 24403 |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments for fiscal years ended November 30, 2025, 2024 and 2023 | 154909 | (198204) | 102419 |
| Other comprehensive income (loss) | 161851 | (222586) | 124022 |
| Comprehensive income (loss) | $(1117073) | $28631 | $437864 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**CONCENTRIX CORPORATION**

**CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

**(currency and share amounts in thousands)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Concentrix Corporation Stockholders' Equity** | **Concentrix Corporation Stockholders' Equity** | **Concentrix Corporation Stockholders' Equity** | **Concentrix Corporation Stockholders' Equity** | **Concentrix Corporation Stockholders' Equity** | **Concentrix Corporation Stockholders' Equity** | **Concentrix Corporation Stockholders' Equity** | **Concentrix Corporation Stockholders' Equity** |
| | **Common Stock** | **Common Stock** | | **Treasury stock** | **Treasury stock** | | | |
| | **Shares** | **Amount** |<br>**Additional paid-in capital** | **Shares** | **Amount** |<br>**Retained earnings (deficit)** |<br>**Accumulated other comprehensive income (loss)** |<br>**Total** |
| Balances, November 30, 2022 | 52367 | $5 | $2428313 | 1271 | $(190779) | $774114 | $(315749) | $2695904 |
| Other comprehensive income |  |  |  |  |  |  | 124022 | 124022 |
| Common stock issued as acquisition purchase consideration | 14862 | 2 | 1084894 |  |  |  |  | 1084896 |
| Share-based compensation activity | 654 |  | 69314 |  |  |  |  | 69314 |
| Repurchase of common stock for tax withholdings on equity awards |  |  |  | 169 | (17231) |  |  | (17231) |
| Repurchase of common stock |  |  |  | 709 | (63958) |  |  | (63958) |
| Dividends |  |  |  |  |  | (63495) |  | (63495) |
| Net income |  |  |  |  |  | 313842 |  | 313842 |
| Balances, November 30, 2023 | 67883 | 7 | 3582521 | 2149 | (271968) | 1024461 | (191727) | 4143294 |
| Other comprehensive loss |  |  |  |  |  |  | (222586) | (222586) |
| Share-based compensation activity | 966 |  | 101087 |  |  |  |  | 101087 |
| Repurchase of common stock for tax withholdings on equity awards |  |  |  | 261 | (13385) |  |  | (13385) |
| Repurchase of common stock |  |  |  | 2201 | (136096) |  |  | (136096) |
| Dividends |  |  |  |  |  | (83807) |  | (83807) |
| Net income |  |  |  |  |  | 251217 |  | 251217 |
| Balances, November 30, 2024 | 68849 | 7 | 3683608 | 4611 | (421449) | 1191871 | (414313) | 4039724 |
| Other comprehensive income |  |  |  |  |  |  | 161851 | 161851 |
| Share-based compensation activity | 1467 |  | 100364 |  |  |  |  | 100364 |
| Repurchase of common stock for tax withholdings on equity awards |  |  |  | 409 | (20005) |  |  | (20005) |
| Repurchase of common stock |  |  |  | 3557 | (168708) |  |  | (168708) |
| Dividends |  |  |  |  |  | (89957) |  | (89957) |
| Net loss |  |  |  |  |  | (1278924) |  | (1278924) |
| Balances, November 30, 2025 | 70316 | $7 | $3783972 | 8577 | $(610162) | $(177010) | $(252462) | $2744345 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**CONCENTRIX CORPORATION**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(currency in thousands)**

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| **Cash flows from operating activities:** |  |  |  |
| Net income (loss) | $(1278924) | $251217 | $313842 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income (loss) to net cash provided by operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;Impairment charges | 1527726 |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation | 226101 | 246920 | 173463 |
| &nbsp;&nbsp;&nbsp;Amortization | 434332 | 458925 | 214832 |
| &nbsp;&nbsp;&nbsp;Non-cash share-based compensation | 96386 | 96057 | 62113 |
| &nbsp;&nbsp;&nbsp;Provision for credit losses | 5738 | 7057 | 10236 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | (154877) | (235248) | (121711) |
| &nbsp;&nbsp;&nbsp;Loss on call options |  |  | 14629 |
| &nbsp;&nbsp;&nbsp;Amortization of debt discount and issuance costs | 23548 | 25276 | 6089 |
| &nbsp;&nbsp;&nbsp;Pension and other post-retirement benefit costs | 16565 | 16097 | 11328 |
| &nbsp;&nbsp;&nbsp;Pension and other post-retirement plan contributions | (4058) | (4442) | (12143) |
| &nbsp;&nbsp;&nbsp;Change in acquisition contingent consideration | (1958) | (29268) | 15681 |
| &nbsp;&nbsp;&nbsp;Other | 2152 | 1791 | 306 |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | (23078) | (63851) | (45895) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 28474 | (25819) | 9341 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating assets and liabilities | (91160) | (77220) | 25897 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 806967 | 667492 | 678008 |
| **Cash flows from investing activities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Purchases of property and equipment | (234496) | (238762) | (180532) |
| &nbsp;&nbsp;&nbsp;Premiums paid for call options |  |  | (14629) |
| &nbsp;&nbsp;&nbsp;Acquisitions of business, net of cash and restricted cash acquired | (15887) | (5504) | (1914079) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (250383) | (244266) | (2109240) |
| **Cash flows from financing activities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from the Restated Credit Facility - Term Loan | 1500000 |  | 294702 |
| &nbsp;&nbsp;&nbsp;Repayments of the Restated Credit Facility - Term Loan | (1034375) | (450000) | (194702) |
| &nbsp;&nbsp;&nbsp;Repayments of the Prior Credit Facility - Term Loan |  |  | (25000) |
| &nbsp;&nbsp;&nbsp;Proceeds from the Credit Facility - Revolver | 238500 |  |  |
| &nbsp;&nbsp;&nbsp;Repayments of the Credit Facility - Revolver | (238500) |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from the Securitization Facility | 2347700 | 2191000 | 1964000 |
| &nbsp;&nbsp;&nbsp;Repayments of the Securitization Facility | (2181700) | (1948500) | (2192000) |
| &nbsp;&nbsp;&nbsp;Proceeds from the issuance of Senior Notes |  |  | 2136987 |
| &nbsp;&nbsp;&nbsp;Other debt proceeds |  | 6369 |  |
| &nbsp;&nbsp;&nbsp;Other debt repayments | (828315) | (7558) |  |
| &nbsp;&nbsp;&nbsp;Cash paid for debt issuance costs | (4755) | (600) | (30519) |
| &nbsp;&nbsp;&nbsp;Acquisition deferred consideration payment | (6454) |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for acquired earnout liabilities |  | (22737) | (13309) |
| &nbsp;&nbsp;&nbsp;Proceeds from exercise of stock options | 3978 | 5030 | 7201 |
| &nbsp;&nbsp;&nbsp;Repurchase of common stock for tax withholdings on equity awards | (20005) | (13385) | (17231) |
| &nbsp;&nbsp;&nbsp;Repurchase of common stock | (168708) | (136096) | (63958) |
| &nbsp;&nbsp;&nbsp;Dividends paid | (89618) | (83807) | (63495) |
| &nbsp;&nbsp;&nbsp;Change in funds held for clients | (9191) | (32248) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | (491443) | (492532) | 1802676 |
| Effect of exchange rate changes on cash, cash equivalents, cash held for sale and restricted cash | 26382 | (17577) | (12420) |
| Net increase (decrease) in cash, cash equivalents, cash held for sale and restricted cash | 91523 | (86883) | 359024 |
| Cash, cash equivalents, cash held for sale and restricted cash at beginning of year | 429604 | 516487 | 157463 |
| Cash, cash equivalents, cash held for sale and restricted cash at end of year | $521127 | $429604 | $516487 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**CONCENTRIX CORPORATION**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(currency in thousands)**

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| **Supplemental disclosures of cash flow information:** |  |  |  |
| Interest paid on borrowings | $299615 | $282270 | $142598 |
| Income taxes paid | $270328 | $298445 | $217252 |
| **Supplemental disclosure of non-cash investing activities:** |  |  |  |
| Accrued costs for property and equipment purchases | $28781 | $24856 | $26374 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**CONCENTRIX CORPORATION**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(currency and share amounts in thousands, except per share amounts)**

**NOTE 1—BACKGROUND AND BASIS OF PRESENTATION:**

**Background**

Concentrix Corporation ("Concentrix" or the "Company"), is a global technology and services leader that powers exceptional brand experiences and digital operations for more than 2,000 clients across the globe. The Company designs, builds, and runs fully integrated, end-to-end solutions, including customer experience ("CX") process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five primary industry verticals: technology and consumer electronics; retail, travel and e-commerce; communications and media; banking, financial services and insurance; and healthcare.

**Basis of presentation (including principles of consolidation)**

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") and include the accounts of the Company, its majority-owned subsidiaries and entities over which the Company has control. All intercompany balances and transactions have been eliminated in consolidation.

On September 25, 2023, the Company completed its acquisition (the "Webhelp Combination") of all of the issued and outstanding capital stock of Marnix Lux SA ("Webhelp"), from the holders thereof (the "Sellers"). The total purchase price consideration, net of cash and restricted cash acquired, for the acquisition of Webhelp was $3.8 billion, which was funded by proceeds from the Company's August 2023 offering and sale of senior notes, term loan borrowings under the Company's senior credit facility, the issuance of a promissory note by Concentrix Corporation to certain Sellers (the "Sellers' Note"), the issuance of shares of common stock, par value $0.0001 per share, of Concentrix Corporation, and cash on hand. The total cash consideration paid for Webhelp was $2.4 billion, less cash and restricted cash acquired of $0.5 billion. Subsequent to September 25, 2023, the results of Webhelp have been included in the consolidated results of the Company for all periods presented.

**NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:**

**Use of estimates**

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting period. The Company evaluates these estimates on a regular basis and bases them on historical experience and on various assumptions that the Company believes are reasonable. Actual results could differ from the estimates.

**Segment reporting**

Concentrix' operations are based on an integrated global delivery model whereby services under a client contract in one location may be provided from delivery centers located in one or more different countries, with a significant portion of the Company's workforce located in the Philippines and India. Given the homogeneity of end-to-end solutions and technology and the integrated delivery model, the Company operates in a single operating segment, based on how the chief operating decision maker ("CODM") views and evaluates the Company's operations in making operational and strategic decisions and assessments of financial performance (including for purposes of allocating resources and assessing performance). The Company's President and Chief Executive Officer has been identified as the CODM.

**Cash equivalents**

The Company considers all highly liquid debt instruments purchased with an original maturity or remaining maturity at the date of purchase of three months or less to be cash equivalents. Cash equivalents consist principally of money market deposit accounts that are stated at cost, which approximates fair value. The Company is exposed to

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

credit risk in the event of default by financial institutions to the extent that cash balances with financial institutions are in excess of amounts that are insured.

**Accounts receivable and allowance for credit losses**

Accounts receivable are comprised primarily of amounts owed to the Company by clients and are presented net of an allowance for credit losses. The allowance for credit losses is an estimate to cover the losses resulting from uncertainty regarding collections from customers to make payments for outstanding balances. In estimating the required allowance, the Company considers the overall quality and aging of the accounts receivable and credit evaluations of its clients' financial condition. The Company also evaluates the collectability of accounts receivable based on specific client circumstances, current economic trends, historical experience with collections and the value and adequacy of any collateral received from clients.

**Unbilled receivables**

For the majority of service contracts, the Company performs the services prior to billing the client, and this amount is captured as an unbilled receivable included in accounts receivable, net on the consolidated balance sheet. Billing usually occurs in the month after the Company performs the services or in accordance with the specific contractual provisions.

**Accounts receivable factoring**

The Company has factoring programs with certain clients to sell accounts receivable to financial institutions under non-recourse agreements in exchange for cash proceeds. These trade receivable financing agreements are accounted for as a true sale of assets under the provisions of Accounting Standards Codification 860, *Transfer and Servicing* ("ASC 860"). In accordance with ASC 860, the trade receivable financing arrangements are deemed a true sale as the Company retains no rights or interest and has no obligations with respect to the trade receivables. In some instances, the Company may continue to service the transferred receivables after factoring has occurred. However, any servicing of the trade receivable does not constitute significant continuing involvement. As defined in the trade receivable financing arrangements, the financial institution is responsible for any credit risk associated with the sold trade receivables.

Sales of trade receivables under the various factoring programs were $1.3 billion, $1.4 billion, and $0.3 billion during the years ended November 30, 2025, 2024 and 2023, respectively, which also approximates cash collections on trade receivables during each fiscal year. As noted above, the Company acts as a servicer (collects customer cash on behalf of the financial institution) for certain of its trade receivables factoring arrangements. The servicing fees associated with these trade receivables factoring arrangements were not material to the Company for the years ended November 30, 2025, 2024, and 2023. The loss on the sale of trade receivables under the various trade receivables factoring arrangements was not material to the Company for the years ended November 30, 2025, 2024, and 2023. As of November 30, 2025 and 2024, trade receivables in the amount of $119,000 and $162,000, respectively, were sold to the financial institutions and not included in trade receivables in the consolidated balance sheets.

**Derivative financial instruments**

The Company accounts for its derivative instruments as either assets or liabilities and carries them at fair value.

For derivative instruments that hedge the exposure to variability in expected future cash flows that are designated as cash flow hedges, the gain or loss on the derivative instrument is reported as a component of "Accumulated other comprehensive income (loss)," in stockholders' equity and reclassified into earnings in the same line associated with the forecasted transactions, in the same period or periods during which the hedged transaction affects earnings. To receive hedge accounting treatment, cash flow hedges must be highly effective in offsetting changes to expected future cash flows on hedged transactions.

For derivative instruments that are not designated as cash flow hedges, gains and losses on derivative instruments are reported in the consolidated statements of operations in the current period.

**Software costs**

The Company develops software platforms for internal use. The Company capitalizes costs incurred to develop software subsequent to the software product reaching the application development stage. The Company also

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

capitalizes the costs incurred to extend the life of existing software, or the cost of significant enhancements that are added to the features of existing software. The capitalized development costs primarily comprise payroll costs and related software costs. Capitalized costs are amortized over the economic life of the software using the straight-line method.

**Property and equipment**

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon the shorter of the estimated useful lives of the assets, or the lease term of the respective assets, if applicable. Maintenance and repairs are charged to expense as incurred, and improvements are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in operations in the period realized. The ranges of estimated useful lives for property and equipment categories are as follows:

---

| | |
|:---|:---|
| Equipment and furniture | 3 - 10 years |
| Software | 3 - 7 years |
| Leasehold improvements | 2 - 15 years |
| Buildings and building improvements | 10 - 39 years |

---

**Leases**

The Company enters into leases as a lessee for property and equipment in the ordinary course of business. When procuring services, or upon entering into a contract with its clients, the Company determines whether an arrangement contains a lease at its inception. As part of that evaluation, the Company considers whether there is an implicitly or explicitly identified asset in the arrangement and whether the Company, as the lessee, or the client, if the Company is the lessor, has the right to control the use of that asset. When the Company is the lessee, all leases with a term of more than 12 months are recognized as right-of-use ("ROU") assets and associated lease liabilities in the consolidated balance sheet. Lease liabilities are measured at the lease commencement date and determined using the present value of the lease payments not yet paid, at the Company's incremental borrowing rate, which approximates the rate at which the Company would borrow on a secured basis in the country where the lease was executed. The interest rate implicit in the lease is generally not determinable in the transactions where the Company is the lessee. The ROU asset equals the lease liability adjusted for any initial direct costs, prepaid rent and lease incentives. The Company's variable lease payments generally relate to payments tied to various indexes, non-lease components and payments above a contractual minimum fixed amount.

Operating leases are included in other assets, net, other accrued liabilities and other long-term liabilities in the consolidated balance sheet. Substantially all of the Company's leases are classified as operating leases, and lease expense is recorded on a straight-line basis over the lease term. The Company recognizes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company made a policy election to not recognize leases with a lease term of 12 months or less in the consolidated balance sheet. Lease expenses are recorded within selling, general, and administrative expenses in the consolidated statements of operations. Operating lease payments are presented within "Cash flows from operating activities" in the consolidated statements of cash flows.

For all asset classes, the Company has elected the lessee practical expedient to combine lease and non-lease components (e.g., maintenance services) and account for the consolidated unit as a single lease component. Variable lease payments are recognized in the periods in which the obligations for those payments are incurred. The Company's lease agreements do not contain any material residual guarantees or material restrictive covenants.

**Goodwill and intangible assets**

The Company tests goodwill for impairment annually at the reporting unit level on the first day of the fiscal fourth quarter or more frequently if events or changes in circumstances indicate that it may be impaired. For purposes of the goodwill impairment test, the Company can elect to perform a quantitative or qualitative analysis. If the qualitative analysis is elected, goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

than its carrying value. The factors that are considered in the qualitative analysis include: macroeconomic conditions; industry and market considerations; cost factors such as increases in labor, or other costs that would have a negative effect on earnings and cash flows; and other relevant entity-specific events and information.

If the Company elects to perform or is required to perform a quantitative analysis, then the reporting unit's carrying value is compared to its fair value. As part of this analysis, the Company reconciles the fair value of its reporting unit to its market capitalization. Additionally, under a quantitative assessment, the fair value of the Company's single reporting unit is estimated using an income approach and a market approach with equal weighting. The income approach applies a fair value methodology to the Company's reporting unit based on a discounted cash flow analysis. A number of significant judgments are involved in the application of the discounted cash flow analysis, including estimation of future cash flows, which is dependent on internally developed forecasts, including future levels of revenue and earnings growth, estimation of the long-term rate of growth for the Company's business, and determination of a discount rate. The market approach is performed using the guideline public company method which involves calculating valuation multiples based on financial data from comparable publicly traded companies and considerations of recent transactions in the market and industry. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value and the excess is recognized as an impairment loss. See Note 5—Goodwill and Intangible Assets for more information.

Intangible assets consist of customer relationships, technology, trade names and non-compete agreements. Amortization is based on the pattern over which the economic benefits of the intangible assets will be consumed or, when the consumption pattern is not apparent, by using the straight-line method over the following useful lives:

---

| | |
|:---|:---|
| Customer relationships | 10 - 15 years |
| Technology | 5 years |
| Trade names | 3 - 5 years |
| Non-compete agreements | 3 years |

---

**Impairment of long-lived assets**

The Company reviews the recoverability of its long-lived assets, such as intangible assets subject to amortization, property and equipment and certain other assets, including lease right-of-use assets, when events or changes in circumstances occur that indicate the carrying value of the asset or asset group may not be recoverable. The assessment of possible impairment is based on the Company's ability to recover the carrying value of the asset or asset group from the expected future pre-tax cash flows, undiscounted and without interest charges, of the related operations. If these cash flows are less than the carrying value of such assets, an impairment loss is recognized for the difference between estimated fair value and carrying value.

**Held for sale**

In November 2025, the Company entered into a definitive agreement to sell one of its subsidiaries. The Company completed the sale in December 2025. The Company appropriately classified assets and liabilities related to the subsidiary as current assets and liabilities held for sale on its consolidated balance sheet as of November 30, 2025. The assets and liabilities and related transaction were not material. The loss on the sale was not material.

**Concentration of credit risk**

Financial instruments that potentially subject the Company to significant concentration of credit risk consist principally of cash and cash equivalents, accounts receivable and derivative instruments.

The Company's cash and cash equivalents and derivative instruments are transacted and maintained with financial institutions with high credit standing, and their compositions and maturities are regularly monitored by management. Through November 30, 2025, the Company has not experienced any credit losses on such deposits and derivative instruments.

Accounts receivable comprise amounts due from clients. The Company performs ongoing credit evaluations of its clients' financial condition and limits the amount of credit extended when deemed necessary, but generally requires no collateral. The Company also maintains allowances for credit losses. In estimating the required

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

allowances, the Company takes into consideration the overall quality and aging of its receivable portfolio and specifically identified client risks.

In fiscal years 2025, 2024, and 2023, no client accounted for more than 10% of the Company's consolidated revenue.

As of November 30, 2025 and 2024, no client comprised more than 10% of the Company's total accounts receivable balance.

**Revenue recognition**

The Company generates revenue primarily from the provision of integrated, end-to-end solutions and technology, including CX process optimization to its clients. The Company recognizes revenue from services contracts over time as the promised services are delivered to clients for an amount that reflects the consideration to which the Company is entitled in exchange for those services. The Company recognizes revenue over time as the client simultaneously receives and consumes the benefits provided by the Company as the Company performs the services. The Company accounts for a contract with a client when it has written approval, the contract is committed, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of collection. Revenue is presented net of taxes collected from clients and remitted to government authorities. The Company generally invoices a client after performance of services, or in accordance with specific contractual provisions. Payments are due as per contract terms and do not contain a significant financing component.

The Company determines whether the services performed during the initial phases of an arrangement, such as setup activities, are distinct. In most cases, the arrangement is a single performance obligation comprised of a series of distinct services that are substantially the same and that have the same pattern of transfer (i.e., distinct days of service).

Service contracts are most significantly based on a fixed unit-price per transaction or other objective measure of output. Revenue on unit-price transactions is recognized over time using an objective measure of output such as staffing hours or the number of transactions processed by service advisors. Client contract terms can range from less than one year to more than five years.

Certain client contracts include incentive payments from the client upon achieving certain agreed-upon service levels and performance metrics or service level agreements that could result in credits or refunds to the client. Revenue relating to such arrangements is accounted for as variable consideration when the likely amount of revenue to be recognized can be estimated to the extent that it is probable that a significant reversal of any incremental revenue will not occur.

**Cost of revenue**

Recurring direct operating costs for services are recognized as incurred. Cost of services revenue consists primarily of personnel costs and transition and initial set-up costs.

**Selling, general and administrative expenses**

Selling, general and administrative expenses are charged to income as incurred. Expenses of promoting and selling products and services are classified as selling expense and include such items as compensation, sales commissions and travel. General and administrative expenses include such items as compensation, cost of delivery centers, legal and professional costs, office supplies, non-income taxes, insurance and utility expenses. In addition, selling, general and administrative expenses include other operating items such as allowances for credit losses, depreciation and amortization of intangible assets.

**Advertising**

Costs related to advertising and service promotion expenditures are charged to "Selling, general and administrative expenses" as incurred. To date, net costs related to advertising and promotion expenditures have not been material.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Income taxes**

The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts in the financial statements using enacted tax rates and laws that will be in effect when the difference is expected to reverse. Tax on global low-taxed intangible income is accounted for as a current expense in the period in which the income is includable in a tax return using the "period cost" method. Valuation allowances are provided against deferred tax assets that are not likely to be realized.

The Company recognizes tax benefits from uncertain tax positions only if that tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. The Company recognizes interest and penalties related to unrecognized tax benefits in the provisions for income taxes.

**Foreign currency translations**

The functional currencies of the legal entities' financial statements included in these consolidated financial statements are the local currencies of the legal entities and are translated into United States ("U.S.") dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the month. Translation adjustments resulting from the translation of the legal entities' accounts are included in "Accumulated other comprehensive income (loss)." Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the functional currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within "Other expense (income), net."

**Other comprehensive income (loss)**

The primary components of other comprehensive income (loss) for the Company include foreign currency translation adjustments arising from the Company's foreign legal entities, unrealized gains and losses on qualifying hedges, and changes in unrecognized pension and post-retirement benefits.

**Share-based compensation**

Share-based compensation cost for stock options, restricted stock awards and restricted stock units is determined based on the fair value at the measurement date. The Company recognizes share-based compensation cost as expense for these awards ratably on a straight-line basis over the requisite service period. Share-based compensation for performance-based restricted stock units is measured based on fair value at the initial measurement date and is adjusted each reporting period, as necessary, to reflect changes in management's assessment of the probability that performance conditions will be satisfied. The Company recognizes share-based compensation cost associated with its performance-based restricted stock units over the requisite service period if it is probable that the performance conditions will be satisfied. Share-based compensation cost for equity awards that include a market performance condition are determined using a Monte Carlo simulation valuation model and expense is recognized for these awards ratably on a straight-line basis over the requisite service period. The Company accounts for expense reductions that result from the forfeiture of unvested awards in the period that the forfeitures occur.

**Pension and post-retirement benefits**

The funded status of the Company's pension and other post-retirement benefit plans is recognized in the consolidated balance sheets. The funded status is measured as the difference between the fair value of plan assets and the benefit obligation at November 30, the measurement date. For defined benefit pension plans, the benefit obligation is the projected benefit obligation ("PBO") and, for the other post-retirement benefit plans, the benefit obligation is the accumulated post-retirement benefit obligation ("APBO"). The PBO represents the actuarial present value of benefits expected to be paid upon retirement. For active plans, the present value reflects estimated future compensation levels. The APBO represents the actuarial present value of post-retirement benefits attributed to employee services already rendered. The fair value of plan assets represents the current market value of assets held by an irrevocable trust fund for the sole benefit of participants. The measurement of the benefit obligation is based

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

on the Company's estimates and actuarial valuations. These valuations reflect the terms of the plans and use participant-specific information such as compensation, age and years of service, as well as certain key assumptions that require significant judgment, including, but not limited to, estimates of discount rates, expected return on plan assets, inflation, rate of compensation increases, interest crediting rates and mortality rates. The assumptions used are reviewed on an annual basis.

**Earnings (loss) per common share**

Basic and diluted earnings (loss) per common share are calculated using the two-class method. The two-class method is an earnings allocation proportional to the respective ownership among holders of common stock and participating securities. The Company's restricted stock awards and, effective in the fourth quarter of fiscal year 2023, restricted stock units are considered participating securities because holders have a non-forfeitable right to receive dividends. Basic earnings per common share is computed by dividing net income attributable to the Company's common stockholders by the weighted-average common shares outstanding during the period. Diluted earnings per common share also considers the dilutive effect of in-the-money stock options and non-participating securities, calculated using the treasury stock method.

**Treasury stock**

Repurchases of shares of common stock are accounted for at cost and are included as a component of stockholders' equity in the consolidated balance sheets.

**Accounting pronouncements recently issued**

In November 2023, the Financial Accounting Standards Board (the "FASB") issued accounting standards update ("ASU") 2023-07, which enhances the disclosures required for reportable segments in annual and interim consolidated financial statements. The Company adopted this ASU during the fiscal year ended November 30, 2025. See Note 16—Segment Reporting for more information.

In December 2023, the FASB issued ASU 2023-09, which requires enhanced income tax disclosures, including disaggregation of information in the rate reconciliation table and disaggregated information related to income taxes paid. The amendments in ASU 2023-09 are effective for the Company for the fiscal year ending November 30, 2026. The Company is currently evaluating the impact that this update will have on its disclosures in the consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, which requires the disaggregation of certain expenses in the notes to the financial statements, to provide enhanced transparency into the expense captions presented on the face of the income statement. ASU 2024-03 is effective for the Company for annual reporting periods beginning with the fiscal year ending November 30, 2028 and for interim periods beginning in fiscal year 2029. Early adoption is permitted. The amendments in this ASU may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that this update will have on its disclosures in the consolidated financial statements.

In September 2025, the FASB issued ASU 2025-06, which amends the guidance in ASC 350-40, *Intangibles -Goodwill and Other - Internal-Use Software*. The amendments modernize the recognition and disclosure framework for internal-use software costs, removing the previous "development stage" model and introducing a more judgment-based approach. ASU 2025-06 is effective for the Company for annual reporting periods beginning with the fiscal year ending November 30, 2029 and for interim reporting periods beginning in that fiscal year. The Company is currently evaluating the impact that this update will have on the consolidated financial statements.

No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the consolidated financial statements.

**NOTE 3—SHARE-BASED COMPENSATION:** 

In November 2020, TD SYNNEX Corporation ("TD SYNNEX"), as the former sole stockholder of Concentrix, approved the Concentrix Corporation 2020 Stock Incentive Plan (the "Concentrix Stock Incentive Plan") and the Concentrix Corporation 2020 Employee Stock Purchase Plan (the "Concentrix ESPP"), each to be effective upon completion of Concentrix' spin-off from TD SYNNEX, which occurred on December 1, 2020. 4,000 shares of Concentrix common stock were reserved for issuance under the Concentrix Stock Incentive Plan, and 1,000 shares of Concentrix common stock were authorized for issuance under the Concentrix ESPP. In December 2021, 2022 and

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

2023, respectively, 523, 520, and 664 additional shares of Concentrix common stock were reserved for issuance under the Concentrix Stock Incentive Plan resulting from an automatic annual increase pursuant to the terms of the plan (the "Evergreen Provision").

On October 28, 2024, the stockholders of Concentrix approved an amendment and restatement of the Concentrix Stock Incentive Plan (the "2020 Plan") at a Special Meeting of Stockholders that (i) increased the number of authorized shares thereunder by 3,000 shares and (ii) removed the Evergreen Provision, among other amendments. The amendment and restatement of the Concentrix Stock Incentive Plan was previously approved by the Company's board of directors.

The Company recorded share-based compensation expense of $97,875, $95,922, and $62,493 for the fiscal years ended November 30, 2025, 2024 and 2023, respectively. Share-based compensation expense is included in selling, general and administrative expenses in the consolidated statements of operations.

**Employee Stock Options**

The Company uses the Black-Scholes valuation model to estimate the fair value of stock options. The Black-Scholes option-pricing model was developed for use in estimating the fair value of short-lived exchange traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of subjective assumptions, including the option's expected life and the price volatility of the underlying stock. The stock options have ten-year terms and vesting terms of five years. The Company did not grant any stock options during the fiscal years 2025, 2024 and 2023.

A summary of the changes in the employee stock options during fiscal years 2023, 2024, and 2025 is presented below.

---

| | | |
|:---|:---|:---|
| | **Options Outstanding** | **Options Outstanding** |
| | **Number of shares** <br>**(in thousands)** | **Weighted-**<br>**average exercise**<br>**price per share** |
| Balance as of November 30, 2022 | 395 | $52.60 |
| Options granted |  |  |
| Options exercised | (100) | 45.50 |
| Options cancelled | (1) | 30.70 |
| Balance as of November 30, 2023 | 294 | 54.45 |
| Options granted |  |  |
| Options exercised | (56) | 42.60 |
| Balance as of November 30, 2024 | 238 | 57.21 |
| Options granted |  |  |
| Options exercised | (18) | 44.58 |
| Options cancelled | (2) | 55.12 |
| Balance as of November 30, 2025 | 218 | $58.28 |

---

As of November 30, 2025, 218 options were outstanding with a weighted-average life of 3.02 years and an aggregate pre-tax intrinsic value of $0. As of November 30, 2025, all of the options were fully vested and exercisable.

**Restricted Stock Awards, Restricted Stock Units and Performance-Based Restricted Stock Units** 

The fair value of restricted stock awards and restricted stock units granted under the Concentrix Stock Incentive Plan in fiscal years 2025, 2024 and 2023 were determined based on the trading price of Concentrix common stock on the date of grant. The awards are expensed on a straight-line basis over the vesting term, typically three or four years. The holders of restricted stock awards are entitled to the same voting, dividend and other rights as holders of Concentrix common stock.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

In fiscal years 2025, 2024, and 2023, the Company granted performance-based restricted stock units to the Company's senior executive team. The performance-based restricted stock units will vest, if at all, upon the achievement of certain annual financial targets during the three-year periods ending November 30, 2027, November 30, 2026 and November 30, 2025, respectively. For the awards with a final performance period ending on November 30, 2025, approximately 12% of the awards vested.

In April 2024, the Company granted performance-based restricted stock units under the Concentrix Stock Incentive Plan. The performance-based restricted stock units will vest, if at all, upon the achievement of certain financial targets during the three-year period ending November 30, 2026.

A summary of the changes in the non-vested restricted stock awards, restricted stock units, and performance-based stock units (exclusive of performance-based awards with market conditions as described further below) during fiscal years 2023, 2024 and 2025 is presented below.

---

| | | |
|:---|:---|:---|
| | **Number of shares**<br>**(in thousands)** | **Weighted-average,**<br>**grant-date**<br>**fair value per share** |
| Non-vested as of November 30, 2022 | 1395 | $124.69 |
| Awards granted | 60 | 135.01 |
| Units granted <sup>(1)</sup> | 1828 | 74.64 |
| Performance-based units vested in excess of target <sup>(2)</sup> | 17 | 159.97 |
| Awards and units vested | (513) | 122.76 |
| Awards and units cancelled/forfeited | (114) | 138.88 |
| Non-vested as of November 30, 2023 | 2673 | 92.80 |
| Units granted <sup>(1)</sup> | 2824 | 52.94 |
| Awards and units vested | (849) | 92.02 |
| Awards and units cancelled/forfeited | (337) | 84.94 |
| Non-vested as of November 30, 2024 | 4311 | 68.35 |
| Units granted <sup>(1)</sup> | 1817 | 47.81 |
| Awards and units vested | (1374) | 72.75 |
| Awards and units cancelled/forfeited | (474) | 68.82 |
| Non-vested as of November 30, 2025 | 4280 | $58.18 |

---

(1)For performance-based restricted stock units, the target number of shares that can be awarded upon full vesting of the grants is included.

(2)Amounts represent performance-based awards that vested in excess of the target number of shares for the fiscal year 2021 performance-based grants.

In January 2025, the Company granted performance-based restricted stock units under the 2020 Plan that will vest, if at all, upon the achievement of certain total shareholder return goals during the three-year period ending January 25, 2028. These performance-based restricted stock units are market condition awards and had a grant date

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

weighted-average fair value of $41.28 per share, valued using a Monte-Carlo simulation model. Below is a summary of the changes in these awards during fiscal year 2025.

---

| | | |
|:---|:---|:---|
| | **Number of shares**<br>**(in thousands)** | **Weighted-average,**<br>**grant-date**<br>**fair value per share** |
| Non-vested as of November 30, 2024 |  | $— |
| Units granted  | 326 | 41.28 |
| Units cancelled/forfeited | (21) | 41.28 |
| Non-vested as of November 30, 2025 | 305 | $41.28 |

---

In October 2025, the Company granted cash-settled restricted stock units under the Concentrix Stock Incentive Plan. These units will be settled in cash and are accounted for as liability-type awards. The expense is recognized over the requisite service period with remeasurement at the end of each reporting period at fair value until settlement. The requisite service period is based on the vesting provisions of the awards which generally occur in three equal annual installments beginning one year after the grant date. Below is a summary of the changes in these units during fiscal year 2025.

---

| | | |
|:---|:---|:---|
| | **Number of shares**<br>**(in thousands)** | **Weighted-average,**<br>**grant-date**<br>**fair value per share** |
| Non-vested as of November 30, 2024 |  | $— |
| Units granted | 622 | 46.93 |
| Units cancelled/forfeited | (2) | 46.93 |
| Non-vested as of November 30, 2025 | 620 | $46.93 |

---

As of November 30, 2025, there was $191,887 of total unamortized share-based compensation expense related to non-vested restricted stock awards, restricted stock units and performance-based restricted stock units granted under the Concentrix Stock Incentive Plan. That cost is expected to be recognized over an estimated weighted-average amortization period of 2.14 years.

**NOTE 4—BALANCE SHEET COMPONENTS:**

**Cash, cash equivalents, cash held for sale and restricted cash:**

The following table provides a reconciliation of cash, cash equivalents, cash held for sale and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows:

---

| | | |
|:---|:---|:---|
| | **As of November 30,** | **As of November 30,** |
| | **2025** | **2024** |
| Cash and cash equivalents | $327347 | $240571 |
| Cash held for sale | 2057 |  |
| Restricted cash included in other current assets | 191723 | 189033 |
| Cash, cash equivalents, cash held for sale and restricted cash | $521127 | $429604 |

---

Restricted cash balances relate primarily to funds held for clients, restrictions placed on cash deposits by banks as collateral for the issuance of bank guarantees and the terms of a government grant, and letters of credit for leases. Of the restricted cash balance, $187,139 and $179,949 related to funds held for clients as of November 30, 2025 and 2024, respectively. As of November 30, 2025 and 2024, the Company has a corresponding current liability recorded in other accrued liabilities on the consolidated balance sheet related to these funds.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Accounts receivable, net:**

Accounts receivable, net is comprised of the following as of November 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **As of November 30,** | **As of November 30,** |
| | **2025** | **2024** |
| Billed accounts receivable | $1102601 | $1080778 |
| Unbilled accounts receivable | 913863 | 860266 |
| Less: Allowance for credit losses | (17443) | (14307) |
| Accounts receivable, net | $1999021 | $1926737 |

---

**Allowance for credit losses:**

Presented below is a progression of the allowance for credit losses:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| Balance at beginning of period | $14307 | $12533 | $4797 |
| Net additions  | 5738 | 7057 | 10236 |
| Write-offs  | (2602) | (5283) | (2500) |
| Balance at end of period | $17443 | $14307 | $12533 |

---

**Property and equipment, net:**

The following table summarizes the carrying amounts and related accumulated depreciation for property and equipment as of November 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **As of November 30,** | **As of November 30,** |
| | **2025** | **2024** |
| Land | $28391 | $28235 |
| Equipment, computers, and software | 969841 | 853558 |
| Furniture and fixtures | 172154 | 151477 |
| Buildings, building improvements, and leasehold improvements | 704074 | 617880 |
| Construction-in-progress | 39098 | 44566 |
| Total property and equipment, gross | $1913558 | $1695716 |
| Less: Accumulated depreciation | (1178008) | (981199) |
| Property and equipment, net | $735550 | $714517 |

---

Shown below are the countries where 10% or more and other significant concentrations of the Company's property and equipment, net are located as of November 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **As of November 30,** | **As of November 30,** |
| | **2025** | **2024** |
| **Property and equipment, net:** |  |  |
| Philippines | $105475 | $82864 |
| United States | 93773 | 118732 |
| India | 57585 | 49339 |
| France | 56386 | 59645 |
| Others | 422331 | 403937 |
| Total | $735550 | $714517 |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Accumulated other comprehensive loss:**

The components of accumulated other comprehensive loss ("AOCL"), net of taxes, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Unrecognized**<br>**gains (losses) on**<br>**defined benefit**<br>**plan, net**<br>**of taxes** | **Unrealized gains**<br>**(losses)**<br>**on** <br>**hedges, net of**<br>**taxes** | **Foreign currency**<br>**translation**<br>**adjustment and other,**<br>**net of taxes** | **Total** |
| Balances at November 30, 2023 | $(11271) | $4489 | $(184945) | $(191727) |
| Other comprehensive income (loss) before reclassification | 5988 | (34029) | (198204) | (226245) |
| Reclassification of losses from other comprehensive income (loss) |  | 3659 |  | 3659 |
| Balances at November 30, 2024 | $(5283) | $(25881) | $(383149) | $(414313) |
| Other comprehensive income (loss) before reclassification | 3702 | (3578) | 154909 | 155033 |
| Reclassification of losses from other comprehensive income (loss) |  | 6818 |  | 6818 |
| Balances at November 30, 2025 | $(1581) | $(22641) | $(228240) | $(252462) |

---

Refer to Note 6—Derivative Instruments for the location of gains and losses on cash flow hedges reclassified from other comprehensive income (loss) to the consolidated statements of operations. Reclassifications of amortization of actuarial (gains) losses of defined benefit plans is recorded in "Other expense (income), net" in the consolidated statement of operations.

**NOTE 5—GOODWILL AND INTANGIBLE ASSETS:**

**Goodwill**

The Company tests goodwill for impairment annually on the first day of its fourth fiscal quarter and at other times if events have occurred or circumstances exist that indicate the carrying value of goodwill may no longer be recoverable. Goodwill impairment testing is performed at the reporting unit level. Based on the current year assessment, the Company concluded that no impairment charges were necessary for the Company's reporting unit as of its annual impairment testing date of September 1, 2025. Subsequent to September 1, 2025, the Company experienced a sustained decrease in the market price of its common stock resulting in the market capitalization being significantly less than the carrying value of the reporting unit. After considering all available evidence in the evaluation of goodwill impairment indicators, the Company determined it appropriate to perform an interim quantitative assessment as of November 1, 2025. The quantitative impairment testing performed consisted of the income and market approach and was reconciled to the Company's market capitalization. The income approach applied a fair value methodology to our reporting unit based on discounted cash flows. This analysis requires significant judgments and assumptions, including estimation of our future cash flows, which is dependent on internally developed forecasts, including future levels of revenue growth, and adjusted earnings before interest, taxes, depreciation, and amortization ("EBITDA") margin, and determination of a weighted average cost of capital. We also applied a market approach. Under the market approach, we utilized a guideline public company method, which involves calculating valuation multiples based on financial data from comparable publicly traded companies and considerations of recent transactions in the technology industry. Multiples derived from these companies and transactions provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay for a company. These multiples are then applied to the financial data for our reporting unit to arrive at an indication of fair value. The market multiple was applied to adjusted EBITDA.

As a result of the quantitative analysis performed, the carrying value of the Company's reporting unit exceeded its fair value, resulting in a non-cash goodwill impairment charge of $1,523,266. This charge was recorded within the impairment charges caption of the consolidated statement of operations for the fiscal year ended November 30, 2025. No subsequent impairment indicators were identified. The Company did not have any impairment charges related to goodwill during the fiscal years ended November 30, 2024 or prior.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

Below is a progression of goodwill for fiscal years 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** |
| Balance at beginning of year | $4986967 | $5078668 |
| Acquisitions | 17370 | 2000 |
| Acquisition measurement period adjustments |  | 60630 |
| Assets held for sale | (2570) |  |
| Impairment charge | (1523266) |  |
| Foreign currency translation | 193245 | (154331) |
| Balance at end of year | $3671746 | $4986967 |

---

The Company is required to provide additional disclosures about fair value measurements as part of the consolidated financial statements for each major category of assets and liabilities measured at fair value on a non-recurring basis (including impairment assessments). Goodwill was valued using Level 3 inputs, which are unobservable by nature, and included internal estimates of future cash flows (income approach). Significant increases (decreases) in any of those unobservable inputs in isolation would result in a significantly higher (lower) fair value measurement.

**Other Intangible Assets**

The Company's other intangible assets, primarily acquired through business combinations, are subject to amortization and are evaluated periodically if events or circumstances indicate a possible inability to recover their carrying amounts. Impairment charges, related to a subsidiary that met held for sale criteria as of November 30, 2025, were not material for the fiscal year end November 30, 2025. There were no impairment charges recorded for the fiscal years ended November 30, 2024 and 2023. As of November 30, 2025 and 2024, the Company's other intangible assets consisted of the following:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **As of November 30, 2025** | **As of November 30, 2025** | **As of November 30, 2025** | **As of November 30, 2024** | **As of November 30, 2024** | **As of November 30, 2024** |
| | **Gross**<br>**amounts** | **Accumulated**<br>**amortization** | **Net**<br>**amounts** | **Gross**<br>**amounts** | **Accumulated**<br>**amortization** | **Net**<br>**amounts** |
| Customer relationships | $3736591 | $(1822119) | $1914472 | $3594694 | $(1399588) | $2195106 |
| Technology | 79603 | (64089) | 15514 | 79645 | (50119) | 29526 |
| Trade names | 123484 | (93132) | 30352 | 113758 | (51503) | 62255 |
| Non-compete agreements | 2200 | (2200) |  | 2200 | (2147) | 53 |
|  | $3941878 | $(1981540) | $1960338 | $3790297 | $(1503357) | $2286940 |

---

Amortization expense for intangible assets was $434,332, $458,925, and $214,832 for the fiscal years ended November 30, 2025, 2024 and 2023, respectively, and the related estimated expense for the five subsequent fiscal years and thereafter is as follows:

---

| | |
|:---|:---|
| **Fiscal Years Ending November 30,** | **Amortization Expense** |
| 2026 | $393559 |
| 2027 | 297133 |
| 2028 | 251871 |
| 2029 | 209650 |
| 2030 | 177687 |
| Thereafter | 630438 |
| Total | $1960338 |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

The remaining weighted average amortization period for customer relationships and other intangible assets is approximately 12 years.

**NOTE 6—DERIVATIVE INSTRUMENTS:**

In the ordinary course of business, the Company is exposed to foreign currency risk and credit risk. The Company enters into transactions, and owns monetary assets and liabilities, that are denominated in currencies other than the legal entity's functional currency. The Company may enter into forward contracts, option contracts, or other derivative instruments to offset a portion of the risk on expected future cash flows, earnings, net investments in certain non-U.S. legal entities and certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. Generally, the Company does not use derivative instruments to cover equity risk and credit risk. The Company's hedging program is not used for trading or speculative purposes.

All derivatives are recognized on the consolidated balance sheets at their fair values. Changes in the fair value of derivatives are recorded in the consolidated statements of operations, or as a component of AOCL in the consolidated balance sheets, as discussed below. The cash flow effects of the Company's cash flow and fair value derivative instruments are reflected in operating activities on the consolidated statements of cash flows.

**Cash Flow Hedges**

To mitigate the impact on gross margins from fluctuations in foreign currency exchange rates, certain of the Company's legal entities with functional currencies that are not U.S. dollars may hedge a portion of forecasted revenue or costs not denominated in the entities' functional currencies. These instruments mature at various dates through November 2027. Gains and losses on cash flow hedges are recorded in AOCL until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of "Revenue" in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of foreign currency costs are recognized as a component of "Cost of revenue" or "Selling, general and administrative expenses" in the same period as the related costs are recognized. Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCL associated with such derivative instruments are reclassified into earnings in the period of de-designation. Any subsequent changes in fair value of such derivative instruments are recorded in earnings unless they are re-designated as hedges of other transactions.

**Non-Designated Derivatives**

The Company uses short-term forward contracts to offset the foreign exchange risk of assets and liabilities denominated in currencies other than the functional currencies of the Company's legal entities that own the assets or liabilities. These contracts, which are not designated as hedging instruments, mature or settle within twelve months. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.

**Interest rate swaps and cross-currency interest rate swaps**

In connection with the closing of the Webhelp Combination, the Company entered into cross-currency swap arrangements with certain financial institutions for a total notional amount of $500,000 of the Company's senior notes. In addition to aligning the currency of a portion of the Company's interest payments to the Company's euro-denominated cash flows, the arrangements, together with intercompany loans and additional intercompany cross-currency interest rate swap arrangements described below, effectively converted $250,000 aggregate principal amount of the Company's 6.650% Senior Notes due 2026 and $250,000 aggregate principal amount of the Company's 6.660% Senior Notes due 2028 into synthetic fixed euro-based debt at weighted average interest rates of 5.12% and 5.18%, respectively.

Concurrent with entering into the cross-currency interest rate swaps with certain financial institutions, Marnix SAS, an indirect wholly owned subsidiary of Concentrix, entered into corresponding U.S. dollar denominated intercompany loan agreements with certain other subsidiaries of Concentrix with identical terms and notional

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

amounts as the underlying $500,000 U.S. dollar denominated senior notes, with reciprocal cross-currency interest rate swaps.

The cross-currency interest rate swaps are designated as fair value hedges.

In September 2025, in connection with the issuance of the delayed draw term loans of total principal of $750,000, the Company entered into an interest rate swap to fix the interest component associated with this debt, creating synthetic fixed-rate debt. Concurrent with entering the interest rate swaps, the Company entered into cross-currency swap arrangements with certain financial institutions for a total notional amount equivalent to $750,000. In addition to aligning the currency of the Company's interest payments to the Company's euro-denominated cash flows, the arrangements, together with intercompany loans and additional intercompany cross-currency interest rate swap arrangements, effectively converted the delayed draw term loans into synthetic fixed euro-based debt at weighted average interest rates of 3.43% for the three-year term and 3.69% for the five-year term.

The interest rate swap is designated as a cash flow hedge and the cross-currency swaps are designated as fair value hedges.

**Fair Values of Derivative Instruments in the Consolidated Balance Sheets**

The fair values of the Company's derivative instruments are disclosed in Note 7—Fair Value Measurements and summarized in the table below:

---

| | | |
|:---|:---|:---|
| | **Value as of** | **Value as of** |
|<br>**Balance Sheet Line Item** | **November 30, 2025** | **November 30, 2024** |
| Derivative instruments not designated as hedging instruments: |  |  |
| Foreign exchange forward contracts (notional value) | $— | $458482 |
| &nbsp;&nbsp;&nbsp;Other current assets |  | 13935 |
| &nbsp;&nbsp;&nbsp;Other accrued liabilities |  | 167 |
| Derivative instruments designated as fair value hedges: |  |  |
| Cross-currency interest rate swaps (notional value) | $1112706 | $471604 |
| &nbsp;&nbsp;&nbsp;Other assets | 5343 |  |
| &nbsp;&nbsp;&nbsp;Other current liabilities and other long-term liabilities | 49319 | 7468 |
| Derivative instruments designated as cash flow hedges: |  |  |
| Interest rate swaps (notional value) | $750000 | $— |
| &nbsp;&nbsp;&nbsp;Other long-term liabilities | 3357 |  |
| Foreign exchange forward contracts (notional value) | $1049896 | $1049787 |
| &nbsp;&nbsp;&nbsp;Other current assets and other assets | 914 | 578 |
| &nbsp;&nbsp;&nbsp;Other accrued liabilities and other long-term liabilities | 21424 | 22155 |

---

**Volume of activity**

The notional amounts of foreign exchange forward contracts represent the gross amounts of foreign currency, including, principally, the Philippine peso and the Indian rupee, that will be bought or sold at maturity. The notional amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company's exposure to credit or market loss. The Company's exposure to credit loss and market risk will vary over time as currency exchange rates change.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**The Effect of Derivative Instruments on AOCL and the Consolidated Statements of Operations**

The following table shows the location of the gains and losses, before taxes, of the Company's derivative instruments designated as cash flow hedges, fair value hedges, and not designated as hedging instruments in other comprehensive income ("OCI"), and the consolidated statements of operations for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| |<br>**Locations of gain (loss) in statement of operations** | **2025** | **2024** | **2023** |
| **Derivative instruments designated as cash flow and fair value hedges:** |  |  |  |  |
| <u>Gains (losses) recognized in OCI:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign exchange forward contracts |  | $(8072) | $(38459) | $19199 |
| &nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps |  | 5800 | (5084) | (3651) |
| &nbsp;&nbsp;&nbsp;Interest rate swaps |  | (3357) |  |  |
| Total |  | $(5629) | $(43543) | $15548 |
| <u>Gains (losses) reclassified from AOCL into income:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign exchange forward contracts |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain (loss) reclassified from AOCL into income | Revenue for services | $— | $— | $222 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain (loss) reclassified from AOCL into income | Cost of revenue | (6484) | (4028) | (13864) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain (loss) reclassified from AOCL into income | Selling, general and administrative expenses | (2656) | (861) | (4745) |
| Total |  | $(9140) | $(4889) | $(18387) |
| **Derivative instruments not designated as hedging instruments:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Gain (loss) recognized from foreign exchange forward contracts, net<sup>(1)</sup> | Other expense (income), net | $6429 | $9940 | $(13007) |
| &nbsp;&nbsp;&nbsp;Gain (loss) recognized from foreign exchange call options contracts, net | Other expense (income), net |  |  | (14629) |
| Total |  | $6429 | $9940 | $(27636) |

---

(1)&nbsp;&nbsp;&nbsp;&nbsp;The gains and losses largely offset the currency gains and losses that resulted from changes in the assets and liabilities denominated in nonfunctional currencies.

There were no material gain or loss amounts excluded from the assessment of effectiveness. Existing net losses in AOCL that are expected to be reclassified into earnings in the normal course of business within the next twelve months are $14,504.

**Offsetting of Derivatives**

In the consolidated balance sheets, the Company does not offset derivative assets against liabilities in master netting arrangements.

Credit exposure for derivative financial instruments is limited to the amounts, if any, by which the counterparties' obligations under the contracts exceed the Company's obligations to the counterparties. The Company manages the potential risk of credit losses by selecting counterparties from a limited group of financial institutions with high credit standing.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**NOTE 7—FAIR VALUE MEASUREMENTS:**

Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The authoritative guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are from sources independent of the Company. Unobservable inputs reflect the Company's assumptions about the factors market participants would use in valuing the asset or liability developed based upon the best information available in the circumstances. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is broken down into three levels:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table summarizes the valuation of the Company's investments and financial instruments that are measured at fair value on a recurring basis:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **As of November 30, 2025** | **As of November 30, 2025** | **As of November 30, 2025** | **As of November 30, 2025** | **As of November 30, 2024** | **As of November 30, 2024** | **As of November 30, 2024** | **As of November 30, 2024** |
| | | **Fair value measurement category** | **Fair value measurement category** | **Fair value measurement category** | | **Fair value measurement category** | **Fair value measurement category** | **Fair value measurement category** |
| |<br>**Total** | **Level 1** | **Level 2** | **Level 3** |<br>**Total** | **Level 1** | **Level 2** | **Level 3** |
| **Assets measured at fair value:** | | | | | | | | |
| Cash and cash equivalents, including cash held for sale | $329404 | $329404 | $— | $— | $240571 | $240571 | $— | $— |
| Restricted cash | 191723 | 191723 |  |  | 189033 | 189033 |  |  |
| Forward foreign currency exchange contracts | 914 |  | 914 |  | 14513 |  | 14513 |  |
| Cross-currency interest rate swaps | 5343 |  | 5343 |  |  |  |  |  |
| **Liabilities measured at fair value:** |  |  |  |  |  |  |  |  |
| Forward foreign currency exchange contracts | 21424 |  | 21424 |  | 22322 |  | 22322 |  |
| Cross-currency interest rate swaps | 49319 |  | 49319 |  | 7468 |  | 7468 |  |
| Interest rate swaps | 3357 |  | 3357 |  |  |  |  |  |
| Acquisition contingent consideration | 7866 |  |  | 7866 | 13373 |  |  | 13373 |
| **Liabilities measured at other than fair value:** |  |  |  |  |  |  |  |  |
| Long term debt (senior notes) |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Fair value | 2184727 |  | 2184727 |  | 2202221 |  | 2202221 |  |
| &nbsp;&nbsp;Carrying amount | 2139537 |  |  |  | 2135576 |  |  |  |

---

The Company's cash and cash equivalents, including cash held for sale, consist primarily of cash on hand, including bank deposits, money market fund securities, and term deposits with maturity periods of three months or less. The carrying values of cash equivalents approximate fair value since they are near their maturity. Restricted cash balances relate primarily to funds held for clients. The carrying values of restricted cash balances approximate

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

fair value since they are highly liquid and short-term in nature. The Company does not adjust the quoted market price for such financial instruments. The fair values of forward exchange contracts are measured based on the foreign currency spots, forward rates, and volatility. Fair values of long-term foreign currency exchange contracts are measured using valuations based upon quoted prices for similar assets and liabilities in active markets and are valued by reference to similar financial instruments, adjusted for terms specific to the contracts. The fair values of the cross-currency interest rate swaps are determined using a market approach that is based on observable inputs other than quoted market prices, including contract terms, interest rates, currency rates, and other market factors. The estimated fair value of the acquisition contingent consideration entered into in connection with the Webhelp Combination is determined using a Monte-Carlo simulation model. The inputs include the closing price of Concentrix common stock as of the reporting period end date, Concentrix-specific historical equity volatility, and the risk-free rate. The inputs for this liability are unobservable, and therefore, are classified within Level 3 of the fair value hierarchy. Changes in the fair value of this liability are recorded in other expense (income), net on the consolidated statement of operations.

The effect of nonperformance risk on the fair value of derivative instruments was not material as of November 30, 2025 and 2024.

The carrying values of term deposits with maturities less than one year, accounts receivable and accounts payable approximate fair value due to their short maturities and interest rates that are variable in nature. The carrying values of the outstanding balance on the term loans under the Company's senior credit facility and the outstanding balance on the Company's accounts receivable securitization facility (the "Securitization Facility") approximate their fair values since they bear interest rates that are similar to existing market rates. The fair values of the 2026 Notes, 2028 Notes, and 2033 Notes (as defined in Note 8) are based on quoted prices in active markets and are classified within Level 2 of the fair value hierarchy. The Company does not adjust the quoted market prices for such financial instruments.

During fiscal years 2025, 2024 and 2023, there were no transfers between the fair value measurement category levels.

**NOTE 8—BORROWINGS:**

Borrowings consist of the following:

---

| | | |
|:---|:---|:---|
| | **As of November 30,** | **As of November 30,** |
| | **2025** | **2024** |
| Credit Facility - current portion of term loans component | $65625 | $— |
| Other loans |  | 2522 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt | $65625 | $2522 |
| 6.650% Senior Notes due 2026 | $800000 | $800000 |
| 6.600% Senior Notes due 2028 | 800000 | 800000 |
| 6.850% Senior Notes due 2033 | 550000 | 550000 |
| Credit Facility - term loans component | 1900000 | 1500000 |
| Securitization Facility | 537000 | 371000 |
| Sellers' Note |  | 740466 |
| Other loans |  | 3643 |
| Long-term debt, before unamortized debt discount and issuance costs | 4587000 | 4765109 |
| Less: unamortized debt discount and issuance costs | (14111) | (32053) |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt, net | $4572889 | $4733056 |

---

**Senior Notes**

On August 2, 2023, the Company issued and sold (i) $800,000 aggregate principal amount of 6.650% Senior Notes due 2026 (the "2026 Notes"), (ii) $800,000 aggregate principal amount of 6.600% Senior Notes due 2028 (the

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

"2028 Notes") and (iii) $550,000 aggregate principal amount of 6.850% Senior Notes due 2033 (the "2033 Notes" and, together with the 2026 Notes and 2028 Notes, the "Senior Notes"). The Senior Notes were sold in a registered public offering pursuant to the Company's Registration Statement on Form S-3, which became effective upon filing, and a Prospectus Supplement dated July 19, 2023, to a Prospectus dated July 17, 2023.

The Senior Notes were issued pursuant to, and are governed by, an indenture, dated as of August 2, 2023 (the "Base Indenture"), between Concentrix and U.S. Bank Trust Company, National Association, as trustee (the "Trustee"), as supplemented by a first supplemental indenture dated as of August 2, 2023 between Concentrix and the Trustee relating to the 2026 Notes, a second supplemental indenture dated as of August 2, 2023 between Concentrix and the Trustee relating to the 2028 Notes, and a third supplemental indenture dated as of August 2, 2023 between Concentrix and the Trustee relating to the 2033 Notes (such supplemental indentures, together with the Base Indenture, the "Indenture"). The Indenture contains customary covenants and restrictions, including covenants that limit Concentrix Corporation's and certain of its subsidiaries' ability to create or incur liens on shares of stock of certain subsidiaries or on principal properties, engage in sale/leaseback transactions or, with respect to Concentrix Corporation, consolidate or merge with, or sell or lease substantially all its assets to, another person. The Indenture also provides for customary events of default.

The principal amount outstanding on the 2026 Notes as of November 30, 2025 was classified as long-term debt within the consolidated balance sheet based on the Company's ability and intent to refinance on a long-term basis.

**Restated Credit Agreement**

On April 11, 2025, Concentrix Corporation entered into an Amendment and Restatement Agreement (the "Amendment Agreement") with the lenders party thereto, Bank of America, N.A., as the administrative agent, the L/C issuer and the swing line lender, and JPMorgan Chase Bank, N.A., as the existing administrative agent, the existing L/C issuer and the existing swing line lender, to amend and restate the Company's Amended and Restated Credit Agreement dated as of April 21, 2023 (the "Existing Credit Agreement" and, as so amended and restated by the Amendment Agreement, the "Restated Credit Agreement"). The Amendment Agreement appoints Bank of America, N.A. as the Administrative Agent under the Restated Credit Agreement, as successor to JPMorgan Chase Bank, N.A.

The Restated Credit Agreement provides for (i) an unsecured three-year term loan facility in an aggregate principal amount not to exceed $750,000 (the "New Term Loan Facility"), (ii) an unsecured three-year delayed draw term loan facility in an aggregate principal amount not to exceed $250,000 (the "3-Year DD Term Loan Facility"), which was drawn in full in September 2025, (iii) an unsecured five-year delayed draw term loan facility in an aggregate principal amount not to exceed $500,000 (the "5-Year DD Term Loan Facility", and together with the 3-Year DD Term Loan Facility, the "Delayed Draw Term Loans"), which was drawn in full in September 2025, and (iv) a senior unsecured revolving credit facility not to exceed an aggregate principal amount of $1.1 billion (the "Revolving Credit Facility"). The Restated Credit Agreement also provided for the conversion and continuation of loans in an aggregate principal amount of $750,000 under the Company's prior unsecured term loan facility into loans under an unsecured term loan facility with the same maturity as such converted and continued loans (the "Continued Term Loan Facility"). Aggregate borrowing capacity under the Restated Credit Agreement may be increased by up to an additional $500,000 by increasing the amount of the revolving credit facility commitments or by incurring additional term loans, in each case subject to the satisfaction of certain conditions set forth in the Restated Credit Agreement, including the receipt of additional commitments for such increase(s).

The maturity date of the New Term Loan Facility and the 3-Year DD Term Loan Facility is September 30, 2028. The maturity date of the 5-Year DD Term Loan Facility and the Revolving Credit Facility is April 11, 2030, subject, in the case of the Revolving Credit Facility, to two one-year extensions upon Concentrix' prior notice to the lenders and the agreement of the lenders to extend such maturity date. The maturity date of the Continued Term Loan Facility remains December 27, 2026.

The outstanding principal amount of each of the New Term Loan Facility and the Delayed Draw Term Loans is payable in quarterly installments in an amount equal to 1.25% of the existing principal balance of the applicable term loan, commencing on September 30, 2025, in the case of the New Term Loan Facility, and on March 31, 2026,

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

in the case of the Delayed Draw Term Loans, with the outstanding principal amount of the New Term Loan Facility, the Delayed Draw Term Loans, and the Continued Term Loan Facility due in full on the applicable maturity date.

Borrowings under the Restated Credit Agreement bear interest, in the case of SOFR rate loans, at a per annum rate equal to the applicable SOFR rate (but not less than 0.00%), plus an applicable margin, based on the credit ratings of Concentrix' senior unsecured non-credit enhanced long-term indebtedness for borrowed money plus a credit spread adjustment to the SOFR rate of 0.10%. The applicable margin ranges from 1.000% to 1.500% for the New Term Loan Facility and the 3-Year DD Term Loan Facility, 1.100% to 1.600% for the 5-Year DD Term Loan Facility, 1.125% to 2.000% for the Continued Term Loan Facility, and 0.875% to 1.500% for the Revolving Credit Facility. Borrowings under the Restated Credit Agreement that are base rate loans bear interest at a per annum rate (but not less than 1.0%) equal to (i) the greatest of (A) the "prime rate" (as defined in the Restated Credit Agreement) in effect on such day, (B) the Federal Funds Rate (as defined in the Restated Credit Agreement) in effect on such day plus 0.500%, and (C) the adjusted one-month term SOFR rate plus 1.0% per annum, plus (ii) an applicable margin, based on the credit ratings of Concentrix' senior unsecured non-credit enhanced long-term indebtedness for borrowed money. The applicable margin ranges from 0.000% to 0.500% for the New Term Loan Facility, the 3-Year DD Term Loan Facility, and the Revolving Credit Facility, 0.100% to 0.600% for the 5-Year DD Term Loan Facility, and 0.125% to 1.000% for the Continued Term Loan Facility.

The Restated Credit Agreement contains certain loan covenants that are customary for credit facilities of this type and that restrict the ability of Concentrix and its subsidiaries to take certain actions, including the creation of liens, mergers, consolidations or other fundamental changes to the nature of their business, and, solely with respect to subsidiaries of Concentrix, incurrence of indebtedness. In addition, the Restated Credit Agreement contains financial covenants that require Concentrix to maintain at the end of each fiscal quarter, (i) a consolidated leverage ratio (as defined in the Restated Credit Agreement) not to exceed 3.75 to 1.00 (or for certain periods following certain qualified acquisitions, 4.25 to 1.00) and (ii) a consolidated interest coverage ratio (as defined in the Restated Credit Agreement) no less than 3.00 to 1.00. The Restated Credit Agreement also contains various customary events of default, including payment defaults, defaults under certain other indebtedness, and a change of control of Concentrix.

As of November 30, 2025 and 2024, the outstanding principal balance on the Company's term loans was $1,965,625 and $1,500,000, respectively. During the fiscal year ended November 30, 2025, the Company voluntarily prepaid $275,000 of the principal balance on the Company's term loans, without penalty. The Company also made a required quarterly principal payment of $9,375 during the fourth quarter of fiscal year 2025.

None of Concentrix' subsidiaries guarantee the obligations under the Restated Credit Agreement.

As of November 30, 2025 and 2024, no amounts were outstanding under the Company's revolving credit facility.

**Securitization Facility**

Under the Securitization Facility, Concentrix Corporation and certain of its U.S. based subsidiaries (the "Originators") sell or otherwise transfer all of their accounts receivable to a special purpose bankruptcy-remote subsidiary of the Company (the "Borrower") that grants a security interest in the receivables to the lenders in exchange for available borrowings. On January 14, 2025, the Company entered into an amendment to the Securitization Facility to increase the commitment of the lenders to provide available borrowings from up to $600,000 to up to $700,000 and extend the termination date of the Securitization Facility from April 24, 2026 to January 14, 2027. For borrowings that are funded by certain lenders through the issuance of commercial paper, the amendment also reduced the spread to the applicable commercial paper rate from 0.80% to 0.75%. Other borrowings bear interest at a per annum rate equal to the applicable SOFR rate (subject to a SOFR related adjustment of 0.10%), plus a spread of 0.90%.

The amount received under the Securitization Facility is recorded as debt on the Company's consolidated balance sheets. Borrowing availability under the Securitization Facility may be limited by the Company's accounts receivable balances, changes in the credit ratings of the clients comprising the receivables, client concentration

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

levels in the receivables, and certain characteristics of the accounts receivable being transferred (including factors tracking performance of the accounts receivable over time).

The Securitization Facility contains various affirmative and negative covenants, including a consolidated leverage ratio covenant that is consistent with the Restated Credit Agreement and customary events of default, including payment defaults, defaults under certain other indebtedness, a change in control of Concentrix Corporation, and certain events negatively affecting the overall credit quality of the transferred accounts receivable.

The Borrower's sole business consists of the purchase or acceptance through capital contributions of the receivables and related security from the Originators and the subsequent retransfer of or granting of a security interest in such receivables and related security to the administrative agent under the Securitization Facility for the benefit of the lenders. The Borrower is a separate legal entity with its own separate creditors who will be entitled, upon its liquidation, to be satisfied out of the Borrower's assets prior to any assets or value in the Borrower becoming available to the Borrower's equity holders, and the assets of the Borrower are not available to pay creditors of the Company and its subsidiaries.

**Sellers' Note**

On September 25, 2023, as part of the consideration for the Webhelp Combination, Concentrix Corporation issued the Sellers' Note in the aggregate principal amount of €700,000 to certain Sellers. The stated rate of interest associated with the Sellers' Note was two percent (2.00%) per annum, which was below the Company's expected borrowing rate. As a result, the Company discounted the Sellers' Note by €31,500 using an approximate 4.36% imputed annual interest rate. This discounting resulted in an initial value of €668,500 or $711,830. The discounted value was amortized into interest expense over the two-year term.

On September 25, 2025, the Company used the proceeds of the Delayed Draw Term Loans and cash on hand to repay the principal balance and accrued interest on the Sellers' Note. The principal amount outstanding on the Sellers' Note as of November 30, 2024 was classified as long-term debt within the consolidated balance sheet based on the Company's ability and intent to refinance on a long-term basis.

**Covenant compliance**

As of November 30, 2025 and 2024, Concentrix was in compliance with all covenants for the above arrangements.

**Future principal payments**

As of November 30, 2025, future principal payments under the above loans for the subsequent fiscal years are as follows:

---

| | |
|:---|:---|
| | **Amount** |
| **Fiscal Years Ending November 30,** | |
| 2026 <sup>(1)</sup> | $865625 |
| 2027 | 1087000 |
| 2028 | 1718750 |
| 2029 | 25000 |
| 2030 | 406250 |
| Thereafter | 550000 |
| Total | $4652625 |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

<sup>(1)</sup> Includes the 2026 Notes which were classified as long-term debt as of November 30, 2025.

**NOTE 9—REVENUE:**

**Disaggregated revenue** 

The following table presents the Company's revenue disaggregated by primary industry verticals:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| **Industry vertical:** |  |  |  |
| Technology and consumer electronics | $2666072 | $2674040 | $2205834 |
| Retail, travel and e-commerce | 2433885 | 2361866 | 1448666 |
| Communications and media | 1592373 | 1527922 | 1117694 |
| Banking, financial services and insurance | 1536223 | 1455641 | 1091853 |
| Healthcare | 725283 | 727389 | 696266 |
| Other | 871935 | 872042 | 554393 |
| Total | $9825771 | $9618900 | $7114706 |

---

The following table presents the Company's revenue by geographical locations where the Company's services are delivered. Shown below are the countries that account for the Company's revenue for the periods presented:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| **Revenue by geography:** |  |  |  |
| Philippines | $1594559 | $1596578 | $1585878 |
| India | 1126061 | 1054460 | 898250 |
| United States | 1051700 | 1110763 | 1304797 |
| Great Britain | 356490 | 394945 | 205437 |
| Germany | 334293 | 388005 | 232729 |
| Canada | 302085 | 307590 | 317410 |
| Others | 5060583 | 4766559 | 2570205 |
| Total | $9825771 | $9618900 | $7114706 |

---

Deferred revenue contract liabilities and deferred costs to obtain or fulfill a contract are not material.

**NOTE 10—PENSION AND EMPLOYEE BENEFITS PLANS:**

The Company has a 401(k) plan in the United States under which eligible employees may contribute up to the maximum amount as provided by law. Employees become eligible to participate in the 401(k) plan on the first day of the month after their employment date. The Company may make discretionary contributions under the plan. Employees in most of the Company's non-U.S. legal entities are covered by government mandated defined contribution plans. During fiscal years 2025, 2024 and 2023, the Company contributed $127,611, $105,087 and $89,767, respectively, to defined contribution plans.

**Defined Benefit Plans** 

For eligible employees in the United States, the Company maintains a frozen defined benefit pension plan ("the cash balance plan"), which includes both a qualified and non-qualified portion. The pension benefit formula for the cash balance plan is determined by a combination of compensation, age-based credits and annual guaranteed interest credits. The qualified portion of the cash balance plan has been funded through contributions made to a trust fund.

The Company maintains funded or unfunded defined benefit pension or retirement plans for certain eligible employees in the Philippines, Malaysia, India, and France. Benefits under these plans are primarily based on years

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

of service and compensation during the years immediately preceding retirement or termination of participation in the plans.

The Company's measurement date for all defined benefit plans and other post-retirement benefits is November 30. The plan assumptions for both the U.S. and non-U.S. defined benefit pension plans are evaluated annually and are updated as deemed necessary. Net benefit costs related to defined benefit plans were $16,565, $16,097 and $11,328, during fiscal years 2025, 2024 and 2023, respectively.

Components of pension cost for the Company's defined benefit plans are as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| Service costs | $12289 | $9033 | $6937 |
| Interest costs on projected benefit obligation | 10379 | 10893 | 10306 |
| Expected return on plan assets | (6918) | (5295) | (6208) |
| Amortization and deferrals, net | 1696 | 1457 | 98 |
| Settlement charges |  | 9 | 195 |
| Curtailment gain | (881) |  |  |
| Total pension costs | $16565 | $16097 | $11328 |

---

Service costs are recorded in cost of services and selling, general and administrative expenses while the remaining components of total pension costs are recorded within other expense (income), net in the consolidated statements of operations.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

The funded status of the Company's defined benefit plans is summarized below:

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** |
| **Change in Benefit Obligation:** |  |  |
| Benefit obligation at beginning of year | $213865 | $208565 |
| &nbsp;&nbsp;&nbsp;Service costs | 12289 | 9033 |
| &nbsp;&nbsp;&nbsp;Interest costs | 10379 | 10893 |
| &nbsp;&nbsp;&nbsp;Actuarial losses  | 584 | 6017 |
| &nbsp;&nbsp;&nbsp;Benefits paid | (20094) | (17161) |
| &nbsp;&nbsp;&nbsp;Settlements |  | (490) |
| &nbsp;&nbsp;&nbsp;Curtailments | (1784) |  |
| &nbsp;&nbsp;&nbsp;Foreign currency adjustments | (1284) | (2992) |
| Projected obligation at end of year | $213955 | $213865 |
| **Change in Plan Assets:** |  |  |
| Fair value of plan assets at beginning of year | $135923 | $126752 |
| &nbsp;&nbsp;&nbsp;Actual return on assets | 8395 | 17251 |
| &nbsp;&nbsp;&nbsp;Settlements |  | (83) |
| &nbsp;&nbsp;&nbsp;Employer contributions | 4058 | 4442 |
| &nbsp;&nbsp;&nbsp;Benefits paid | (14815) | (12279) |
| &nbsp;&nbsp;&nbsp;Foreign currency adjustments | (670) | (160) |
| Fair value of plan assets at end of year | $132891 | $135923 |
| **Funded Status of Plans:** |  |  |
| Unfunded status | $81064 | $77942 |

---

Amounts recognized in the consolidated balance sheet and recorded within other accrued liabilities and other long-term liabilities as of November 30, 2025 and 2024 consist of the following:

---

| | | |
|:---|:---|:---|
| | **As of November 30,** | **As of November 30,** |
| | **2025** | **2024** |
| Current liability | $16623 | $16694 |
| Non-current liability | 64441 | 61248 |
| Total | $81064 | $77942 |

---

The accumulated benefit obligation for all defined benefit pension plans was $192,950 and $213,461 at November 30, 2025 and 2024, respectively.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

The following weighted-average rates were used in determining the benefit obligations as of November 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **As of November 30,** | **As of November 30,** |
| | **2025** | **2024** |
| Discount rate | 3.6% - 6.1% | 3.2% - 6.7% |
| Interest crediting rate for cash balance plan | 4.0% | 4.0% |
| Expected rate of future compensation growth | 1.5% - 8.0% | 2.5% - 7.0% |

---

The following weighted-average rates were used in determining the pension costs for the fiscal years ended November 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** |
| Discount rate | 3.2% - 6.7% | 4.0% - 7.5% |
| Interest crediting rate for cash balance plan | 4.0% | 4.0% |
| Expected return on plan assets | 1.0% - 7.0% | 3.6% - 7.1% |
| Expected rate of future compensation growth | 2.5% - 7.5% | 1.8% - 8.0% |

---

For the cash balance plan, the discount rate reflects the rate at which benefits could effectively be settled and is based on current investment yields of high-quality corporate bonds. The Company uses an actuarially-developed yield curve approach to match the timing of cash flows of expected future benefit payments by applying specific spot rates along the yield curve to determine the assumed discount rate.

The range of discount rates utilized in determining the pension cost and projected benefit obligation of the Company's defined benefit plans reflects a lower prevalent rate applicable to the frozen cash balance plan for eligible employees in U.S. and a higher applicable rate for the unfunded defined benefit plan for certain eligible employees in the Philippines, France and Malaysia. The plans outside the U.S. represented approximately 42% and 40% of the Company's total projected benefit obligation for all defined benefit plans as of November 30, 2025 and 2024, respectively**.**

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**Plan Assets**

As of November 30, 2025 and 2024, plan assets for the cash balance plan consisted of common/collective trusts (of which approximately 26% are invested in equity backed funds and approximately 74% are invested in funds in fixed income instruments) and a private equity fund. The Company's targeted allocation was 25% equity and 75% fixed income. The investment objectives for the plan assets are to generate returns that will enable the plan to meet its future obligations. The Company's expected long-term rate of return was determined based on the asset mix of the plan, projected returns, past performance and other factors. The following table sets forth by level within the fair value hierarchy, total plan assets at fair value as of November 30, 2025 and 2024, including the cash balance plan and other funded benefit plans:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Investments** | **As of November 30, 2025** | **As of Quoted Prices in Active Markets for Identical Assets<br>(Level 1)** | **As of Significant Other Observable Inputs (Level 2)** | **As of Significant Unobservable Inputs (Level 3)** |
| Cash and cash equivalents | $3682 | $3682 | $— | $— |
| Common/collective trusts: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income | 86623 |  | 86623 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. large cap | 13642 |  | 13642 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. small cap | 3489 |  | 3489 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;International equity | 13825 |  | 13825 |  |
| Governmental bonds | 6873 |  | 6873 |  |
| Corporate bonds | 4757 |  | 4757 |  |
| Total investments | $132891 | $3682 | $129209 | $— |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Investments** | **As of November 30, 2024** | **As of Quoted Prices in Active Markets for Identical Assets<br>(Level 1)** | **As of Significant Other Observable Inputs (Level 2)** | **As of Significant Unobservable Inputs (Level 3)** |
| Cash and cash equivalents | $3606 | $3606 | $— | $— |
| Common/collective trusts: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income | 59928 |  | 59928 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. large cap | 25924 |  | 25924 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. small cap | 7662 |  | 7662 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;International equity | 27168 |  | 27168 |  |
| Governmental bonds | 8501 |  | 8501 |  |
| Corporate bonds | 3134 |  | 3134 |  |
| Total investments | $135923 | $3606 | $132317 | $— |

---

The Company's cash balance plan holds level 2 investments in common/collective trust funds that are public investment vehicles valued using a net asset value ("NAV") provided by the manager of each fund. The NAV is based on the underlying net assets owned by the fund, divided by the number of shares outstanding. The NAV's unit price is quoted on a private market that may not be active. However, the NAV is based on the fair value of the underlying securities within the fund, which are traded on an active market, and valued at the closing price reported on the active market on which those individual securities are traded. The significant investment strategies of the funds are as described in the financial statements provided by each fund. There are no restrictions on redemptions from these funds. Level 3 investments are equity based funds that primarily invest in domestic early stage capital funds.

**Benefit Payments**

The following table details expected benefit payments for the cash balance plan and other defined benefit plans:

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

---

| | |
|:---|:---|
| **Fiscal Years Ending November 30,** | |
| 2026 | $30790 |
| 2027 | 27236 |
| 2028 | 25420 |
| 2029 | 23419 |
| 2030 | 22260 |
| Thereafter | 98213 |
| Total | $227338 |

---

The Company expects to make approximately $3,877 in contributions during fiscal year 2026.

**NOTE 11—LEASES:**

The Company leases certain of its facilities and equipment under operating lease agreements, which expire in various periods through 2036. The Company's finance leases are not material.

The following table presents the various components of operating lease costs:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| Operating lease cost | $323427 | $295111 | $216774 |
| Short-term lease cost | 69823 | 89001 | 21802 |
| Variable lease cost | 53709 | 44237 | 58283 |
| Sublease income | (2959) | (4492) | (5394) |
| Total operating lease cost | $444000 | $423857 | $291465 |

---

The following table presents a maturity analysis of expected undiscounted cash flows for operating leases on an annual basis for the next five fiscal years and thereafter as of November 30, 2025:

---

| | |
|:---|:---|
| **Fiscal Years Ending November 30,** | |
| 2026 | $312965 |
| 2027 | 251660 |
| 2028 | 192770 |
| 2029 | 129777 |
| 2030 | 71067 |
| Thereafter | 86524 |
| Total payments | 1044763 |
| Less: imputed interest\* | 146580 |
| Total present value of lease payments | $898183 |

---

\*Imputed interest represents the difference between undiscounted cash flows and discounted cash flows.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

The following amounts were recorded in the consolidated balance sheets related to the Company's operating leases:

---

| | | | |
|:---|:---|:---|:---|
| | | **As of November 30,** | **As of November 30,** |
|<br>**Description** |<br>**Balance Sheet location** | **2025** | **2024** |
| Operating lease ROU assets | Other assets | $857025 | $816550 |
| Current operating lease liabilities | Other accrued liabilities | 256739 | 235912 |
| Non-current operating lease liabilities | Other long-term liabilities | 641444 | 625888 |

---

The following table presents supplemental cash flow information related to the Company's operating leases. Cash payments related to variable lease costs and short-term leases are not included in the measurement of operating lease liabilities, and, as such, are excluded from the amounts below:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| Cash paid for amounts included in the measurement of lease liabilities | $345027 | $310859 | $225142 |
| Non-cash ROU assets obtained in exchange for lease liabilities | 264095 | 295894 | 152071 |

---

The weighted-average remaining lease term and discount rate as of November 30, 2025 and 2024 were as follows:

---

| | | |
|:---|:---|:---|
| | **As of November 30,** | **As of November 30,** |
| | **2025** | **2024** |
| Weighted-average remaining lease term (years) | 4.20 | 4.50 |
| Weighted-average discount rate | 6.85% | 6.91% |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**NOTE 12—INCOME TAXES:** 

The sources of income (loss) before the provision for income taxes are as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| United States | $(775986) | $4279 | $(51820) |
| Foreign | (406236) | 294995 | 460048 |
| Total income (loss) before income taxes | $(1182222) | $299274 | $408228 |

---

Provision for income taxes consists of the following:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| **Current tax provision:** |  |  |  |
| Federal | $81553 | $89987 | $78961 |
| State | 28394 | 7734 | 11064 |
| Foreign | 141632 | 185584 | 126072 |
|  | $251579 | $283305 | $216097 |
| **Deferred tax benefit:** |  |  |  |
| Federal | $(77575) | $(104236) | $(97371) |
| State | (9809) | (20462) | (12850) |
| Foreign | (67493) | (110550) | (11490) |
|  | (154877) | (235248) | (121711) |
| Total income tax provision | $96702 | $48057 | $94386 |

---

The following presents the breakdown of net deferred tax liabilities after netting by taxing jurisdiction:

---

| | | |
|:---|:---|:---|
| | **As of November 30,** | **As of November 30,** |
| | **2025** | **2024** |
| Deferred tax assets | $317453 | $218396 |
| Deferred tax liabilities | 296519 | 312574 |
| Total net deferred tax asset (liability) | $20934 | $(94178) |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

Net deferred tax liabilities consist of the following:

---

| | | |
|:---|:---|:---|
| | **As of November 30,** | **As of November 30,** |
| | **2025** | **2024** |
| **Assets:** |  |  |
| &nbsp;&nbsp;&nbsp;Net operating losses | $172819 | $172182 |
| &nbsp;&nbsp;&nbsp;Accruals and other reserves | 87492 | 78308 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 120727 | 107095 |
| &nbsp;&nbsp;&nbsp;U.S. interest limitation carry forward | 88219 | 49481 |
| &nbsp;&nbsp;&nbsp;Share-based compensation expense | 24402 | 17714 |
| &nbsp;&nbsp;&nbsp;Deferred revenue | 5764 | 5280 |
| &nbsp;&nbsp;&nbsp;Tax credits | 5516 | 5082 |
| &nbsp;&nbsp;&nbsp;Foreign tax credit | 9610 | 5199 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities | 202480 | 201266 |
| &nbsp;&nbsp;&nbsp;Intercompany loans payable | 119678 | 110708 |
| &nbsp;&nbsp;&nbsp;Other | 13548 | 32048 |
| &nbsp;&nbsp;&nbsp;Gross deferred tax assets | 850255 | 784363 |
| &nbsp;&nbsp;&nbsp;Valuation allowance | (147609) | (125163) |
| &nbsp;&nbsp;&nbsp;Total deferred tax assets | $702646 | $659200 |
| **Liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;Intangible assets | $447819 | $529129 |
| &nbsp;&nbsp;&nbsp;Unremitted non-US earnings | 48952 | 42433 |
| &nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 184941 | 181816 |
| &nbsp;&nbsp;&nbsp;Total deferred tax liabilities | 681712 | 753378 |
| **Net deferred tax asset (liability)** | $20934 | $(94178) |

---

The valuation allowance relates primarily to certain federal, state and foreign net operating loss carry forwards, foreign deferred items and state credits. The Company's assessment is that it is not more likely than not that these deferred tax assets will be realized.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

A reconciliation of the statutory U.S. federal income tax rate to the Company's effective income tax rate is as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| Federal statutory income tax rate | 21.0% | 21.0% | 21.0% |
| State taxes, net of federal income tax benefit | (1.1)% | (1.8)% | (1.0)% |
| International rate difference | (1.7)% | (9.0)% | (2.3)% |
| Withholding taxes | (1.6)% | 3.9% | 2.5% |
| Uncertain tax benefits | 0.4% | 0.7% | 1.3% |
| Changes in valuation allowance | (1.4)% | 6.5% | 1.7% |
| Impact of inclusion of foreign income <sup>(1)</sup> | (0.1)% | 0.3% | (4.7)% |
| Impairment charges | (26.7)% | —% | —% |
| Capital loss | —% | (12.4)% | —% |
| Other <sup>(2)</sup> | 3.0% | 6.9% | 4.6% |
| Effective income tax rate | (8.2)% | 16.1% | 23.1% |

---

(1)&nbsp;&nbsp;&nbsp;&nbsp;Represents Subpart F income, Base Erosion and Anti-Abuse Tax (BEAT), and Global Intangible Low-Taxed Income (GILTI) (less Section 250 deduction), net of associated foreign tax credits.

(2)&nbsp;&nbsp;&nbsp;&nbsp;Includes categories of reconciling items that are not individually equal to or greater than 5% for the fiscal year ended November 30, 2025. Includes the effect of foreign tax rate impact to deferred tax liabilities and costs related to future legal entity restructuring for the fiscal year ended November 30, 2024.

The Company's U.S. business has sufficient cash flow and liquidity to fund its operating requirements and the Company expects and intends that profits earned outside the United States will be fully utilized and reinvested outside of the United States with the exception of earnings of certain acquired non-U.S. entities. The Company has recorded deferred tax liabilities related to non-U.S. withholding taxes on the earnings of its non-U.S. subsidiaries likely to be repatriated in the future.

As of November 30, 2025, the Company had approximately $3,265,961 of undistributed earnings of its non-U.S. subsidiaries for which it has not provided for non-U.S. withholding taxes and state taxes because such earnings are intended to be reinvested indefinitely in international operations. It is not practicable to determine the amount of applicable taxes that would be due if such earnings were distributed. Accordingly, the Company has not provisioned U.S. state taxes and non-U.S. withholding taxes on the non-U.S. legal entities for which the earnings are permanently reinvested.

As of November 30, 2025, the Company had net operating loss carry forwards of approximately $302,482 and $26,824 for federal and state purposes, respectively. The federal net operating loss carry forward and the state net operating loss carry forwards will begin to expire in the fiscal year ending November 30, 2026. The Company also had approximately $234,062 of foreign net operating loss carry forwards that will also begin to expire in fiscal year ending November 30, 2026 if not used. In addition, the Company has approximately $15,126 of various federal and state income tax credit carry forwards that, if not used, will begin to expire in the fiscal year ending November 30, 2026. Utilization of the acquired loss carry forwards may be limited pursuant to Section 382 of the Internal Revenue Code of 1986.

The Company enjoys tax holidays in certain jurisdictions, primarily Algeria, China, Colombia, Costa Rica, Dominican Republic, El Salvador, Estonia, Guatemala, Honduras, India, Jamaica, Jordan, Latvia, Madagascar, Nicaragua, the Philippines, and Türkiye. The tax holidays provide for lower or zero rates of taxation and require various thresholds of investment and business activities in those jurisdictions. The estimated tax benefits from the above tax holidays for fiscal years 2025, 2024, and 2023 were approximately $12,172, $17,332, and $7,961, respectively.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

The aggregate changes in the balances of gross unrecognized tax benefits, excluding accrued interest and penalties, during fiscal years 2025, 2024, and 2023 were as follows:

---

| | |
|:---|:---|
| Balance as of November 30, 2022 | $70963 |
| Additions based on tax positions related to the current year | 5819 |
| Additions based on tax positions related to the prior year / acquisition | 6071 |
| Lapse of statute of limitations | (4938) |
| Changes due to translation of foreign currencies | 1407 |
| Balance as of November 30, 2023 | 79322 |
| Additions based on tax positions related to the current year | 11081 |
| Additions based on tax positions related to the prior year / acquisition | 18576 |
| Lapse of statute of limitations | (8071) |
| Changes due to translation of foreign currencies | (132) |
| Settlements | (428) |
| Balance as of November 30, 2024 | 100348 |
| Additions based on tax positions related to the current year | 23367 |
| Additions based on tax positions related to the prior year | 1197 |
| Lapse of statute of limitations | (42095) |
| Changes due to translation of foreign currencies | (643) |
| Balance as of November 30, 2025 | $82174 |

---

The Company conducts business globally and files income tax returns in various U.S. and non-U.S. jurisdictions. The Company is subject to continuous examination and audits by various tax authorities. Significant audits are underway in the United States and India. The Company is not aware of any material exposures arising from these tax audits or in other jurisdictions not already provided for.

Although timing of the resolution of audits and/or appeals is highly uncertain, the Company believes it is reasonably possible that the total amount of unrecognized tax benefits as of November 30, 2025 could decrease between $10,610 and $14,053 in the next twelve months. The Company is no longer subject to U.S. federal income tax audit for returns covering years through fiscal year 2021. The Company is no longer subject to non-U.S. or U.S. state income tax audits for returns covering years through fiscal year 2008 and fiscal year 2020, respectively.

The liability for unrecognized tax benefits, including interest and penalties, was $95,034 and $112,961 at November 30, 2025 and November 30, 2024, respectively, and is included in other long-term liabilities in the consolidated balance sheets. As of November 30, 2025 and 2024, $88,130 and $60,512 of the total unrecognized tax benefits, net of federal benefit, would affect the effective tax rate, if realized. The Company's policy is to include interest and penalties related to income taxes, including unrecognized tax benefits, within the provision for income taxes. As of November 30, 2025 and 2024, the Company had accrued $12,860 and $12,613, respectively, in income taxes payable related to accrued interest and penalties.

**NOTE 13—COMMITMENTS AND CONTINGENCIES:**

From time to time, the Company receives notices from third parties, including customers and suppliers, seeking indemnification, payment of money, or other actions in connection with claims made against them. Also, from time to time, the Company has been involved in various bankruptcy preference actions where the Company was a supplier to the companies now in bankruptcy. In addition, the Company is subject to various other claims, both asserted and unasserted, that arise in the ordinary course of business. The Company evaluates these claims and records the related liabilities. It is possible that the liabilities ultimately incurred by the Company could differ from the amounts recorded.

The Company does not believe that the above commitments and contingencies will have a material adverse effect on the Company's results of operations, financial position or cash flows.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**NOTE 14—EARNINGS (LOSS) PER SHARE:**

Basic and diluted earnings (loss) per common share ("EPS") are computed using the two-class method, which is an earnings allocation formula that determines EPS for each class of common stock and participating security.

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| Basic earnings (loss) per common share: |  |  |  |
| Net income (loss) | $(1278924) | $251217 | $313842 |
| Less: net income allocated to participating securities<sup>(1)</sup> | (4103) | (9504) | (6001) |
| Net income (loss) attributable to common stockholders | $(1283027) | $241713 | $307841 |
| Weighted-average number of common shares - basic | 63012 | 64977 | 53801 |
| Basic earnings (loss) per common share | $(20.36) | $3.72 | $5.72 |
| Diluted earnings (loss) per common share: |  |  |  |
| Net income (loss) | $(1278924) | $251217 | $313842 |
| Less: net income allocated to participating securities<sup>(1)</sup> | (4103) | (9490) | (5978) |
| Net income (loss) attributable to common stockholders | $(1283027) | $241727 | $307864 |
| Weighted-average number of common shares - basic | 63012 | 64977 | 53801 |
| Effect of dilutive securities: |  |  |  |
| Stock options and certain restricted stock units<sup>(2)</sup> |  | 97 | 209 |
| Weighted-average number of common shares - diluted | 63012 | 65074 | 54010 |
| Diluted earnings (loss) per common share | $(20.36) | $3.71 | $5.70 |

---

(1)&nbsp;&nbsp;&nbsp;&nbsp;Restricted stock awards and certain restricted stock units granted to employees by the Company are considered participating securities. For the fiscal year ended November 30, 2025, participating securities did not participate in net losses prior to dividends. As a result, the allocation in fiscal 2025 represents dividends paid to participating securities.

(2)&nbsp;&nbsp;&nbsp;&nbsp;As a result of the Company's net loss for the fiscal year ended November 30, 2025, the effect of stock options and other certain restricted stock units awards would be antidilutive. As a result, they have been excluded from the diluted EPS calculation for the fiscal year ended November 30, 2025.

**NOTE 15—STOCKHOLDERS' EQUITY:**

**Share repurchase program**

In September 2021, the Company's board of directors authorized the repurchase of up to $500,000 of the outstanding shares of Concentrix common stock from time to time as market and business conditions warrant, including through open market purchases or Rule 10b5-1 trading plans. In January 2025, the Company's board of directors extended the share repurchase program by authorizing an increase of the amount remaining for share repurchases under the existing share repurchase authorization to $600,000. The repurchase program has no termination date and may be suspended or discontinued at any time.

During the fiscal years ended November 30, 2025 and 2024 under the share repurchase program, the Company repurchased 3,557 and 2,201 shares, respectively, of its common stock for an aggregate purchase price of $168,708 and $136,096, respectively. The share repurchases were made on the open market and the shares repurchased by the Company are held in treasury for general corporate purposes. At November 30, 2025, approximately $439,468 remained available for share repurchases under the existing authorization from the Company's board of directors.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

During December 2025, the Company repurchased 256 shares of Concentrix common stock under the repurchase program for an aggregate purchase price of $9,911.

**Dividends**

During fiscal years 2025 and 2024, the Company paid the following dividends per share approved by the Company's board of directors:

---

| | | | |
|:---|:---|:---|:---|
| **Announcement Date** | **Record Date** | **Per Share Dividend Amount** | **Payment Date** |
| January 24, 2024 | February 5, 2024 | $0.3025 | February 15, 2024 |
| March 26, 2024 | April 26, 2024 | $0.3025 | May 7, 2024 |
| June 26, 2024 | July 26, 2024 | $0.3025 | August 6, 2024 |
| September 25, 2024 | October 25, 2024 | $0.33275 | November 5, 2024 |
| January 15, 2025 | January 31, 2025 | $0.33275 | February 11, 2025 |
| March 26, 2025 | April 25, 2025 | $0.33275 | May 6, 2025 |
| June 26, 2025 | July 25, 2025 | $0.33275 | August 5, 2025 |
| September 25, 2025 | October 24, 2025 | $0.36 | November 4, 2025 |

---

On January 13, 2026, the Company announced a cash dividend of $0.36 per share to stockholders of record as of January 30, 2026, payable on February 10, 2026.

**NOTE 16—SEGMENT REPORTING:**

The Company operates as one operating segment. The Company's CODM is its President and Chief Executive Officer, who reviews financial information presented on a consolidated basis. The CODM uses consolidated net income (loss) and operating income (loss) to assess financial performance, allocate resources, and make key operating decisions. The following table presents selected financial information, including significant segment expenses, with respect to the Company's single operating segment for the fiscal years ended November 30, 2025, 2024 and 2023:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** | **Fiscal Years Ended November 30,** |
| | **2025** | **2024** | **2023** |
| Revenue | $9825771 | $9618900 | $7114706 |
| Cost of revenue <sup>(1)</sup> | 6359357 | 6150666 | 4535003 |
| Selling, general and administrative expenses <sup>(2)</sup> | 1997095 | 1913309 | 1397914 |
| Acquisition-related, integration and restructuring expenses | 101468 | 156771 | 69674 |
| Share-based compensation expense | 97875 | 95922 | 62493 |
| Amortization of intangible assets | 434332 | 458925 | 214832 |
| Impairment charges | 1527726 |  |  |
| Depreciation expense | 226101 | 246920 | 173463 |
| Operating income (loss) | (918183) | 596387 | 661327 |
| Interest expense and finance charges, net | 290349 | 321828 | 201004 |
| Other expense (income), net | (26310) | (24715) | 52095 |
| Provision for income taxes | 96702 | 48057 | 94386 |
| Net income (loss) | $(1278924) | $251217 | $313842 |

---

(1) Exclusive of depreciation expense and acquisition-related, integration and restructuring expenses.

(2) Exclusive of depreciation expense, amortization of intangible assets, acquisition-related, integration and restructuring expenses, and share-based compensation expense.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

For fiscal years 2025 and 2024, acquisition-related, integration and restructuring expenses, primarily included integration costs associated with our combination with Webhelp and restructuring expenses. These costs primarily included severance and employee-related costs, costs associated with facilities consolidation, including lease terminations to integrate the businesses, and information technology system consolidation costs. For fiscal year 2023, acquisition-related, integration and restructuring expenses primarily consisted of acquisition-related and integration costs associated with our combination with Webhelp, including legal and professional services.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**ITEM 9. CHANGES AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE**

None.

**ITEM 9A. CONTROL AND PROCEDURES**

**Evaluation of disclosure controls and procedures**

Based on the evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as required by Rules 13a-15(b) or 15d-15(b) under the Exchange Act, our principal executive officer and principal financial officer have concluded that as of the end of the period covered by this report, our disclosure controls and procedures were effective to ensure that information required to be disclosed by Concentrix in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by us in such reports is accumulated and communicated to our management, including the principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

**Report of management on internal control over financial reporting**

Management's Report on Internal Control over Financial Reporting, as of November 30, 2025, appears in Part II, Item 8, of this Annual Report on Form 10-K, and is incorporated herein by reference.

The effectiveness of the Company's internal control over financial reporting, as of November 30, 2025, has been audited by Ernst & Young LLP, an independent registered public accounting firm, as stated in their report, which appears in Part II, Item 8, of this Annual Report on Form 10-K.

**Changes in internal control over financial reporting** 

There were no changes in our internal control over financial reporting that occurred during our fourth fiscal quarter of fiscal year 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**Limitations on controls**

Our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives as specified above. Management does not expect, however, that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all error and fraud. Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected.

**ITEM 9B. OTHER INFORMATION**

**Rule 10b5-1 trading arrangements**

During the three months ended November 30, 2025, none of our directors or officers adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as those terms are defined in Item 408 of Regulation S-K.

**ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS**

Not applicable.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**PART III**

**ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE**

Certain information required by this Item 10 is incorporated by reference to the material under the headings "Board of Directors," "Board Committees," "Proposals Requiring Your Vote—Proposal No. 1: Election of Directors," and "Our Executive Officers" in the Company's definitive Proxy Statement for the 2026 Annual Meeting of Stockholders, which we will file with the SEC not later than April 1, 2026.

Item 405 of Regulation S-K calls for disclosure of any known late filing or failure by an insider to file a report required by Section 16(a) of the Exchange Act. To the extent disclosure for delinquent reports is being made, it can be found under the caption "Delinquent Section 16(a) Reports" in the Company's definitive Proxy Statement for the 2026 Annual Meeting of Stockholders, which we will file with the SEC not later than April 1, 2026, and is incorporated herein by reference.

Our Code of Ethical Business Conduct, with which our directors, officers and staff must comply, establishes legal and ethical standards for conducting our business, including in accordance with applicable Nasdaq listing standards and SEC regulations. Our Code of Ethical Business Conduct is available free of charge on the "Governance**—**Governance Documents" page of the Investors section of our website at www.concentrix.com, and a copy may also be obtained, upon request, from our Corporate Secretary at 39899 Balentine Drive, Suite 235, Newark, California, 94560. Future waivers from, or amendments to, our Code of Ethical Business Conduct that apply to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions will be timely posted on the webpage referenced in this paragraph.

We have an insider trading policy governing the purchase, sale, and other dispositions of our securities that applies to all of our personnel, including directors, officers, game-changers, and other covered persons. We also follow such procedures, as applicable, for the repurchase of our securities. We believe that our insider trading policy and repurchase procedures are reasonably designed to promote compliance with insider trading laws, rules, and regulations, and listing standards applicable to us. A copy of our insider trading policy, the Concentrix Corporation Securities Trading Policy, is filed as Exhibit 19.1 to this Form 10-K.

**ITEM 11. EXECUTIVE COMPENSATION**

The information required by this Item 11 is incorporated by reference to the material under the headings "Board Committees—Compensation Committee," "Director Compensation," "Compensation Discussion and Analysis," "2025 Summary Compensation Table," "Grants of Plan-Based Awards in Fiscal Year 2025," "Outstanding Equity Awards at 2025 Fiscal Year-End," "Option Exercises and Stock Vested in Fiscal Year 2025," "Pension Benefits," "Potential Payments upon Termination or in Connection with a Change of Control," "CEO Pay Ratio," "Pay Versus Performance," and "Corporate Governance**—**Risk Management" in the Company's definitive Proxy Statement for the 2026 Annual Meeting of Stockholders, which we will file with the SEC not later than April 1, 2026.

**ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS**

The information required by this Item 12 is incorporated by reference to the material under the headings "Beneficial Ownership of Securities" and "Equity Compensation Plan Information" in the Company's definitive Proxy Statement for the 2026 Annual Meeting of Stockholders, which we will file with the SEC not later than April 1, 2026.

**ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE**

The information required by this Item 13 is incorporated by reference to the material under the headings "Corporate Governance—Related Party Transactions" and "Board of Directors—Director Independence" in the Company's definitive Proxy Statement for the 2026 Annual Meeting of Stockholders, which we will file with the SEC not later than April 1, 2026.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES**

The information required by this Item 14 is incorporated by reference to the material under the heading "Proposals Requiring Your Vote—Proposal No. 2: Ratification of Appointment of Independent Registered Public Accounting Firm" in the Company's definitive Proxy Statement for the 2026 Annual Meeting of Stockholders, which we will file with the SEC not later than April 1, 2026.

**PART IV**

**ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES**

**(a)(1) Financial Statements**

The consolidated financial statements of the Company filed as part of this Annual Report on Form 10-K are included in Item 8. Financial Statements and Supplementary Data.

**(a)(2) Financial Statement Schedules**

*Schedules Omitted*

Schedules other than Schedule II are omitted because they are not required or applicable under instructions contained in Regulation S-X or because the information called for is shown in the consolidated financial statements.

**CONCENTRIX**

**SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS**

**For the Fiscal Years Ended November 30, 2025, 2024 and 2023**

**(in thousands)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Additions/Deductions** | | | |
| |<br>**Balances at**<br>**Beginning of**<br>**Fiscal Year** | **Charged to Revenue**<br>**and Expense, net** |<br>**Additions**<br>**from**<br>**Acquisitions** |<br>**Reclassifications**<br>**and**<br>**Write-offs** |<br>**Balances at**<br>**End of**<br>**Fiscal Year** |
| **Fiscal Year Ended November 30, 2025** | | | | | |
| Allowance for deferred tax assets | $125163 | $19084 | $— | $3362 | $147609 |
| **Fiscal Year Ended November 30, 2024** |  |  |  |  |  |
| Allowance for deferred tax assets | $117679 | $40340 | $— | $(32856) | $125163 |
| **Fiscal Year Ended November 30, 2023** |  |  |  |  |  |
| Allowance for deferred tax assets | $103169 | $4823 | $11760 | $(2073) | $117679 |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**(a)(3) Exhibits**

---

| | |
|:---|:---|
| Exhibit No. | Exhibit Description |
| 2.1 | <u>[Share Purchase and Contribution Agreement, dated June 12, 2023, by and among Concentrix Corporation, OSYRIS S.à r.l., Marnix Lux SA, the other beneficiaries party thereto, and Sandrine Asseraf as the PoA Seller Representative (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on June 12, 2023).\*](https://www.sec.gov/Archives/edgar/data/1803599/000180359923000135/exhibit101061223.htm)</u> |
| 2.2 | <u>[First Amendment to Share Purchase and Contribution Agreement, dated July 14, 2023, by and among Concentrix Corporation, OSYRIS S.à r.l., Marnix Lux SA, Sandrine Asseraf as the PoA Seller Representative, Priscilla Maters, as the representative of the GBL Sellers and Frédéric Jousset, and Sapiens, as the representative of the Non-PoA Sellers (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on July 17, 2023).\*](https://www.sec.gov/Archives/edgar/data/1803599/000180359923000159/a071423exhibit101.htm)</u> |
| 3.1 | <u>[Composite Amended and Restated Certificate of Incorporation of Concentrix Corporation filed on December 2, 2020, as amended by the Certificate of Amendment of the Certificate of Incorporation of Concentrix Corporation, filed March 25, 2025 (incorporated by reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q filed on April 4, 2025).](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000106/exhibit31-form10qxq12025.htm)</u>  |
| 3.2 | <u>[Amended and Restated Bylaws of Concentrix Corporation, as amended (incorporated by reference to Exhibit 3.2 to the Company's Quarterly Report filed on April 4, 2025).](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000106/exhibit32-form10qxq12025.htm)</u> |
| 4.1 | <u>[Description of Securities.](exhibit41-2025form10k.htm)</u> |
| 4.2 | <u>[Indenture, dated as of August 2, 2023, by and between Concentrix Corporation and U.S. Bank Trust Company, National Association, as trustee (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on August 2, 2023).](https://www.sec.gov/Archives/edgar/data/1803599/000180359923000177/exhibit41indenture.htm)</u> |
| 4.3 | <u>[First Supplemental Indenture, dated as of August 2, 2023, by and between Concentrix Corporation and U.S. Bank Trust Company, National Association, as trustee (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed on August 2, 2023).](https://www.sec.gov/Archives/edgar/data/1803599/000180359923000177/exhibit42firstsupplemental.htm)</u> |
| 4.4 | <u>[Second Supplemental Indenture, dated as of August 2, 2023, by and between Concentrix Corporation and U.S. Bank Trust Company, National Association, as trustee (incorporated by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K filed on August 2, 2023).](https://www.sec.gov/Archives/edgar/data/1803599/000180359923000177/exhibit43secondsupplementa.htm)</u> |
| 4.5 | <u>[Third Supplemental Indenture, dated as of August 2, 2023, by and between Concentrix Corporation and U.S. Bank Trust Company, National Association, as trustee (incorporated by reference to Exhibit 4.4 to the Company's Current Report on Form 8-K filed on August 2, 2023).](https://www.sec.gov/Archives/edgar/data/1803599/000180359923000177/exhibit44thirdsupplemental.htm)</u> |
| 10.1 | <u>[Amendment and Restatement Agreement, dated as of April](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000111/exhibit101041125.htm)[1](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000111/exhibit101041125.htm)[1](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000111/exhibit101041125.htm)[, 202](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000111/exhibit101041125.htm)[5](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000111/exhibit101041125.htm)[, by and among Concentrix Corporation, the lenders party thereto,](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000111/exhibit101041125.htm)[Bank of America, N.A., and JPMorgan Chase Bank, N.A. (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on April 11, 2025)](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000111/exhibit101041125.htm)[.](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000111/exhibit101041125.htm)</u> |
| 10.2 | <u>[Receivables Financing Agreement, dated as of October 30, 2020, by and among Concentrix Receivables, Inc., as borrower, the Company, as initial servicer, the lenders party thereto, and PNC Bank, National Association, as administrative agent (incorporated by reference to Exhibit 10.7 to Amendment No. 2 to the Company's Registration Statement on Form 10 filed on October 30, 2020).](https://www.sec.gov/Archives/edgar/data/1803599/000119312520282763/d880425dex107.htm)</u> |
| 10.3 | <u>[Receivables Purchase Agreement, dated as of October 30, 2020, by and among Concentrix Receivables, Inc., the Company, as servicer, and the subsidiaries of the Company named therein, as originators (incorporated by reference to Exhibit 10.8 to Amendment No. 2 to the Company's Registration Statement on Form 10 filed on October 30, 2020).](https://www.sec.gov/Archives/edgar/data/1803599/000119312520282763/d880425dex108.htm)</u> |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

---

| | |
|:---|:---|
| 10.4 | <u>[First Omnibus Amendment, dated as of May 5, 2021, by and among the Company, as servicer, Concentrix Receivables, Inc., as borrower, the subsidiaries of the Company named therein, as originators, the lenders party thereto, and PNC Bank, National Association, as administrative agent (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on July 9, 2021).](https://www.sec.gov/Archives/edgar/data/1803599/000180359921000128/exhibit101-form10xqxq22021.htm)</u> |
| 10.5 | <u>[Second Amendment to Receivables Financing Agreement, dated as of July 6, 2022, by and among Concentrix Receivables, Inc., as borrower, the Company, as servicer, the lenders party thereto, and PNC Bank, National Association, as administrative agent (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on July 8, 2022).](https://www.sec.gov/Archives/edgar/data/1803599/000180359922000108/q22022form10-qexhibit102.htm)</u> |
| 10.6 | <u>[Third Amendment to Receivables Financing Agreement, dated as of April 25, 2024, by and among Concentrix Receivables, Inc., as borrower, the Company, as servicer, the group agents and the lenders party thereto, and PNC Bank, National Association, as administrative agent (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on April 26, 2024).](https://www.sec.gov/Archives/edgar/data/1803599/000180359924000117/exhibit101-thirdamendmentt.htm)</u> |
| 10.7 | <u>[Fourth Amendment to Receivables Financing Agreement, dated as of January 14, 2025, by and among Concentrix Receivables, Inc., as borrower, the Company, as servicer, the group agents and the lenders party thereto, and PNC Bank, National Association, as administrative agent (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on January 21, 2025).](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000014/exhibit101-fourthamendment.htm)</u> |
| 10.8 | <u>[Fifth Amendment to Receivables Financing Agreement, dated as of April 11, 2025, by and among Concentrix Receivables, Inc., as borrower, the Company, as servicer, the group agents and the lenders party thereto, and PNC Bank, National Association, as administrative agent (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on April 11, 2025).](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000111/exhibit102041125.htm)</u> |
| 10.9 | <u>[Put Option Agreement, dated as of March 29, 2023, by and among Concentrix Corporation, OSYRIS S.à r.l., Marnix Lux SA, the other beneficiaries party thereto, and Sandrine Asseraf as the PoA Seller Representative, including the form of Sellers' Note set forth as Schedule 7 thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on March 31, 2023).\*](https://www.sec.gov/Archives/edgar/data/1803599/000180359923000091/a033123exhibit101.htm)</u> |
| 10.10 | <u>[Investor Rights Agreement, dated as of March 29, 2023, by and among Concentrix Corporation and the initial stockholders party thereto (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on March 31, 2023).\*](https://www.sec.gov/Archives/edgar/data/1803599/000180359923000091/a033123exhibit102.htm)</u> |
| 10.11 | <u>[Commitment Letter, dated as of March 29, 2023, by and between Concentrix Corporation and JPMorgan Chase Bank, N.A (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed on March 31, 2023).](https://www.sec.gov/Archives/edgar/data/1803599/000180359923000091/a033123exhibit103.htm)</u> |
| 10.12 | <u>[Sellers' Note, dated September 25, 2023, by and among Concentrix Corporation and certain holders party thereto (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed on September 25, 2023).](https://www.sec.gov/Archives/edgar/data/1803599/000180359923000187/exhibit103092523.htm)</u> |
| 10.13 | <u>[Form of Stock Restriction Agreement by and between Concentrix Corporation and the shareholders of Marnix Lux SA party thereto (incorporated by reference to Exhibit E to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on July 17, 2023).](https://www.sec.gov/Archives/edgar/data/1803599/000180359923000159/a071423exhibit101.htm)</u> |
| 10.14 | <u>[Offer Letter, dated as of November 24, 2020, by and between the Company and Christopher Caldwell (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on November 25, 2020).†](https://www.sec.gov/Archives/edgar/data/1803599/000180359920000018/exhibit101.htm)</u> |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

---

| | |
|:---|:---|
| 10.15 | <u>[Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on October 29, 2024).†](https://www.sec.gov/Archives/edgar/data/1803599/000180359924000179/amendedandrestated2020plan.htm)</u> |
| 10.16 | <u>[Form of Restricted Stock Unit Award Agreement under the Concentrix Corporation 2020 Stock Incentive Plan (Non-Employee Directors)](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit1016-202410xk.htm)[(incorporated by refere](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit1016-202410xk.htm)[nce to Exhibit 10.16](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit1016-202410xk.htm)[to the Company](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit1016-202410xk.htm)['](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit1016-202410xk.htm)[s Annual R](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit1016-202410xk.htm)[eport on Form 10-K filed on January 28, 2025)](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit1016-202410xk.htm)[.†](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit1016-202410xk.htm)</u> |
| 10.17 | <u>[Form of Stock Option Award Agreement under the Concentrix Corporation 2020 Stock Incentive Plan (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on January 22, 2021).†](https://www.sec.gov/Archives/edgar/data/1803599/000180359921000024/formofstockoptionaward.htm)</u> |
| 10.18 | <u>[Form of Restricted Stock Award Agreement under the Concentrix Corporation 2020 Stock Incentive Plan (2022) (incorporated by reference to Exhibit 10.15 to the Company's Annual Report on Form 10-K filed on January 28, 2022).†](https://www.sec.gov/Archives/edgar/data/1803599/000180359922000025/exhibit1015-2021form10k.htm)</u> |
| 10.19 | <u>[Form of Restricted Stock Unit Award Agreement under the Concentrix Corporation 2020 Stock Incentive Plan (2022) (incorporated by reference to Exhibit 10.16 to the Company's Annual Report on Form 10-K filed on January 28, 2022).†](https://www.sec.gov/Archives/edgar/data/1803599/000180359922000025/exhibit1016-2021form10k.htm)</u> |
| 10.20 | <u>[Form of Performance Restricted Stock Unit Award Agreement under the Concentrix Corporation 2020 Stock Incentive Plan (incorporated by reference to Exhibit 10.17 to the Company's Annual Report on Form 10-K filed on January 28, 2022).†](https://www.sec.gov/Archives/edgar/data/1803599/000180359922000025/exhibit1017-2021form10k.htm)</u> |
| 10.21 | <u>[Form of Restricted Stock Unit Award Agreement under the Concentrix Corporation 2020 Stock Incentive Plan (2023) (incorporated by reference to Exhibit 10.20 to the Company's Annual Report on Form 10-K filed on January 29, 2024).†](https://www.sec.gov/Archives/edgar/data/1803599/000180359924000011/exhibit1020-2023form10k.htm)</u> |
| 10.22 | <u>[Form of Performance Restricted Stock Unit Award Agreement under the Concentrix Corporation 2020 Stock Incentive Plan (TSR 2025).](exhibit1022-2025form10k.htm)[†](exhibit1022-2025form10k.htm)</u> |
| 10.23 | <u>[Form of Performance Restricted Stock Unit Award Agreement under the Concentrix Corporation 2020 Stock Incentive Plan (2025).](exhibit1023-202510xk.htm)[†](exhibit1023-202510xk.htm)</u> |
| 10.24 | <u>[Concentrix Corporation 2020 Employee Stock Purchase Plan, as amended.†](exhibit1024-2025form10xk.htm)</u> |
| 10.25 | <u>[Concentrix Corporation Change of Control Severance Plan (incorporated by reference to Exhibit 10.9 to the Company's Current Report on Form 8-K filed on December 2, 2020).†](https://www.sec.gov/Archives/edgar/data/1803599/000180359920000026/exhibit109.htm)</u> |
| 10.26 | <u>[Form of Indemnification Agreement between the Company and individual directors and officers (incorporated by reference to Exhibit 10.4 to Amendment No. 1 to the Registration Statement on Form 10 filed by Concentrix Corporation on October 13, 2020 (File No. 001-39494)).†](https://www.sec.gov/Archives/edgar/data/1803599/000119312520268602/d880425dex104.htm)</u> |
| 10.27 | <u>[Service Agreement, effective as of January 7, 2019, by and between Concentrix CVG CMG UK Limited and Cormac Twomey (incorporated by reference to Exhibit 10.16 to the Company's Annual Report on Form 10-K filed on February 16, 2021).†](https://www.sec.gov/Archives/edgar/data/1803599/000180359921000045/exhibit1016.htm)</u> |
| 10.28 | <u>[Service Agreement, dated January 30, 2025, by and between Concentrix TSC UK Ltd and Craig Gibson (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on April 4, 2025).†](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000106/exhibit101-form10qxq12025.htm)</u> |
| 16.1 | <u>[Letter from KPMG LLP (incorporated by reference to Exhibit 16.1 to the Company's Current Report on Form 8-K filed on October 30, 2024).](https://www.sec.gov/Archives/edgar/data/1803599/000180359924000187/ex161-letterfromkpmg.htm)</u> |
| 19.1 | <u>[Concentrix Corporation Securities Trading Policy](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit191-2024form10xk.htm)[(](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit191-2024form10xk.htm)[incorporated by reference to Exhibit 19.1 to the Company's Annual Report on Form 10-K filed on January 28, 2025)](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit191-2024form10xk.htm)[.](https://www.sec.gov/Archives/edgar/data/1803599/000180359925000022/exhibit191-2024form10xk.htm)</u> |
| 21.1 | <u>[Subsidiaries of the Company.](exhibit211-2025form10k.htm)</u> |
| 23.1 | <u>[Consent of Ernst](exhibit231-2025form10k.htm)[& Young LLP.](exhibit231-2025form10k.htm)</u> |
| 23.2 | <u>[Consent of KPMG LLP.](exhibit232-2025form10k.htm)</u> |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

---

| | |
|:---|:---|
| 24.1 | <u>[Power of Attorney (included on signature page of this report).](#ic6c7f84d93cf4ade8f96643eb3cd05dd_196)</u> |
| 31.1 | <u>[Certification of Chief Executive Officer pursuant to Rule 13a- 14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.](exhibit311-2025form10k.htm)</u> |
| 31.2 | <u>[Certification of Chief Financial Officer pursuant to Rule 13a- 14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.](exhibit312-2025form10k.htm)</u> |
| 32.1 | <u>[Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit321-2025form10k.htm)</u> |
| 97.1 | <u>[Concentrix Corporation Compensation Clawback Policy (incorporated by reference to Exhibit 97.1 to the Company's Annual Report on Form 10-K filed on January 29, 2024).](https://www.sec.gov/Archives/edgar/data/1803599/000180359924000011/exhibit971-2023form10k.htm)</u> |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 104 | Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit 101). |

---

\* &nbsp;&nbsp;&nbsp;&nbsp;Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Concentrix Corporation hereby undertakes to furnish copies of any of the omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission.

†&nbsp;&nbsp;&nbsp;&nbsp;Management contract or compensatory plan or arrangement required to be filed as an exhibit pursuant to Item 15(b) of Form 10-K.

**ITEM 16. FORM 10-K SUMMARY**

None.

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: January 28, 2026

---

| | |
|:---|:---|
| CONCENTRIX CORPORATION | CONCENTRIX CORPORATION |
| By: | /s/ Christopher Caldwell |
|  | Christopher Caldwell |
|  | President and Chief Executive Officer |

---

**POWER OF ATTORNEY**

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Christopher Caldwell and Andre Valentine, and each of them, his true and lawful attorneys-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **<u>Name</u>** | **<u>Title</u>** | **<u>Date</u>** |
| /s/ Christopher Caldwell | President and Chief Executive Officer (Principal Executive Officer) and Director | January 28, 2026 |
| Christopher Caldwell |  |  |
| /s/ Andre Valentine | Chief Financial Officer (Principal Financial and Principal Accounting Officer) | January 28, 2026 |
| Andre Valentine |  |  |
| /s/ Teh-Chien Chou | Director | January 28, 2026 |
| Teh-Chien Chou |  |  |
| /s/ LaVerne Council | Director | January 28, 2026 |
| LaVerne Council |  |  |

---

------

<u>[**Table of Contents**](#ic6c7f84d93cf4ade8f96643eb3cd05dd_7)</u> 

---

| | | |
|:---|:---|:---|
| /s/ Jennifer Deason | Director | January 28, 2026 |
| Jennifer Deason |  |  |
| /s/ Nicolas Gheysens | Director | January 28, 2026 |
| Nicolas Gheysens |  |  |
| /s/ Kathryn Hayley | Director | January 28, 2026 |
| Kathryn Hayley |  |  |
| /s/ Kathryn Marinello | Director | January 28, 2026 |
| Kathryn Marinello |  |  |
| /s/ Dennis Polk | Director | January 28, 2026 |
| Dennis Polk |  |  |
| /s/ Ann Vezina | Director | January 28, 2026 |
| Ann Vezina |  |  |

---

## Exhibit 4.1

**Exhibit 4.1**

**DESCRIPTION OF THE REGISTRANT'S SECURITIES**

**REGISTERED PURSUANT TO SECTION 12 OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

*As of the date of the Annual Report on Form 10-K of which this exhibit forms a part, the only class of securities of Concentrix Corporation ("Concentrix", "we", "us", and "our") registered under Section 12 of the Securities Exchange Act of 1934, as amended, is our common stock, par value $0.0001 per share.*

**General**

The following description of our common stock summarizes provisions of our amended and restated certificate of incorporation, as amended ("Charter), amended and restated bylaws, as amended ("Bylaws"), and the Delaware General Corporation Law ("DGCL"). You should refer to the copies of our Charter and our Bylaws, which are incorporated by reference as exhibits to the Annual Report on Form 10-K of which this exhibit is a part, and to the applicable provisions of Delaware law.

**Authorized Common Stock**

Under our Charter, the total number of shares of all classes of shares that Concentrix has authority to issue is 260,000,000, including 250,000,000 shares of common stock, $0.0001 par value per share. Except as otherwise provided in our Charter or in a board resolution, shares purchased, redeemed by, surrendered to, or otherwise acquired by us assume the status of authorized but unissued shares, undesignated as to class or series, and may thereafter be reissued in the same manner as other authorized but unissued shares.

**Rights of Common Stock**

*Dividends; Voting Rights; Liquidation*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The holders of shares of Concentrix common stock are entitled to dividends as our board of directors may lawfully declare from time to time from legally available funds subject to the preferential rights of the holders of any shares of Concentrix preferred stock that may be issued in the future.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The holders of shares of Concentrix common stock are entitled to one vote per share on any matter to be voted upon by Concentrix stockholders and our Charter does not provide for cumulative voting in connection with the election of directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Upon any voluntary or involuntary liquidation, dissolution, or winding up of Concentrix' affairs, the holders of shares of Concentrix common stock are entitled to share, on a pro rata basis, all assets remaining after payment to creditors and subject to prior distribution rights of any shares of Concentrix preferred stock that may be issued in the future. After the distribution, all of the outstanding shares of common stock will be fully paid and non-assessable.

*Other Rights and Restrictions*. No holder of shares of Concentrix common stock will have any preemptive right to subscribe for any shares of Concentrix capital stock issued in the future, and there are no redemption or sinking fund provisions applicable to the common stock.

*Preferred Stock*. Under our Charter, our board of directors, without further action by the Concentrix stockholders, is authorized to issue 10,000,000 shares of preferred stock in one or more classes or series. Concentrix' board of directors may fix the rights, preferences and privileges of the preferred stock, along with any limitations or restrictions, including voting rights, dividend rights, conversion rights, redemption privileges, and liquidation preferences of each class or series of preferred stock. The shares of Concentrix preferred stock could have voting or conversion rights that could adversely affect the voting power or other rights of holders of shares of Concentrix common stock. The issuance of shares of Concentrix preferred stock could also have the effect, under certain circumstances, of delaying, deferring, or preventing a takeover or other transaction that holders of some or a majority of shares of Concentrix common stock might believe to be in their best interests or in which holders might receive a premium for their shares over the then-market price of the shares.

**Certain Anti-Takeover, Limited Liability, and Indemnification Provisions**

------

Our Charter and Bylaws described below may have the effect of discouraging, delaying, or preventing a change in control or another person from acquiring control of Concentrix.

*Concentrix Certificate of Incorporation and Bylaw Provisions*

Our Charter and Bylaws include provisions that may have the effect of discouraging, delaying, or preventing a change in control or an unsolicited acquisition proposal that a Concentrix stockholder might consider favorable, including a proposal that might result in the payment of a premium over the market price for the shares held by Concentrix' stockholders. These provisions are summarized in the following paragraphs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Authorized but Unissued or Undesignated Capital Stock.* The Concentrix' authorized capital stock consists of 250 million shares of common stock and 10 million shares of preferred stock. The authorized but unissued (and in the case of preferred stock, undesignated) shares of Concentrix stock may be issued by our board of directors in one or more transactions without our stockholders' approval. We may use additional shares for a variety of purposes, including future public offerings to raise additional capital, to fund acquisitions and as employee compensation. Moreover, our Charter grants Concentrix' board of directors broad power to establish the rights and preferences of authorized and unissued preferred stock. The issuance of shares of Concentrix preferred stock pursuant to our board of directors' authority described above could decrease the amount of earnings and assets available for distribution to holders of shares of Concentrix common stock and adversely affect the rights and powers, including voting rights, of such holders and may have the effect of delaying, deferring, or preventing a change in control. Our board of directors does not currently intend to seek Concentrix' stockholder approval prior to any issuance of preferred stock, unless otherwise required by law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• No Stockholder Action by Written Consent.* Our Charter and Bylaws provide that an action required or permitted to be taken at any annual or special meeting of our stockholders may only be taken at a duly called annual or special meeting of our stockholders. This provision prevents our stockholders from initiating or effecting any action by written consent, and thereby taking actions opposed by our board of directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Notice Procedures.* Our Bylaws establish advance notice procedures with regard to all Concentrix stockholder proposals to be brought before meetings of our stockholders, including proposals relating to the nomination of candidates for election as directors, the removal of directors, and amendments to our Charter or Bylaws. These procedures provide that notice of such Concentrix stockholder proposals must be timely given in writing to the Concentrix Secretary prior to the meeting. The notice must contain certain information specified in our Bylaws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• No Cumulative Voting*. The DGCL provides that stockholders are denied the right to cumulate votes in the election of directors unless the company's certificate of incorporation provides otherwise. Our Charter does not provide for cumulative voting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Concentrix Board and Vacancies.* Our Bylaws provide that the number of directors on its board of directors is fixed exclusively by its board of directors. Any vacancies created in its board of directors resulting from any increase in the authorized number of directors or the death, resignation, retirement, disqualification, removal from office, or other cause may only be filled by a majority of the board of directors then in office, even if less than a quorum is present, or by a sole remaining director. Any director appointed to fill a vacancy on our board of directors will be appointed for a term expiring at the next annual meeting, and such director's successor has been elected and qualified. Any director or the entire board of directors may be removed, with or without cause, by the holders of not less than a majority of the voting power of the capital stock entitled to vote at an election of directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Special Meetings of Stockholders*. Our Charter and Bylaws provide that special meetings of our stockholders may be called only by the Secretary only at the request of (i) the chair of our board of directors, our chief executive officer or president, (ii) a majority of our board of directors, or (iii) stockholders holding at least 25% of the then outstanding shares of our common stock. .

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Exclusive Forum*. Our Bylaws contain a forum selection provision for the adjudication of certain disputes. Unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (a) any derivative action or proceeding brought on our behalf; (b) any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, employees, or agents to us or our stockholders; (c) any action asserting a claim arising pursuant to any provision of the DGCL, our Charter and our Bylaws; or (d) any action asserting a claim governed by the internal affairs doctrine will be the Court of Chancery of the State of Delaware, or, if the Court of Chancery of the State of Delaware does not have jurisdiction, the United States District Court for the District of Delaware, in each case, subject to said court having personal jurisdiction over the indispensable parties named as defendants. Unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended against us or any of our directors, officers, other employees or agents will be the U.S. federal district courts.

*Limitations on Liability*

Our Charter limits the liability of our directors (in their capacity as directors but not in their capacity as officers) to us or our stockholders to the fullest extent permitted by Delaware law. Specifically, our directors will not be personally liable for monetary damages for breach of a director's fiduciary duty as a director, except for liability:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• For any breach of the director's duty of loyalty to us or our stockholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• For acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Under Section 174 of the DGCL, which relates to unlawful payments of dividends or unlawful stock repurchases or redemption; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• For any transaction from which the director derived an improper personal benefit.

***Indemnification Arrangements***

The DGCL authorizes corporations to limit or eliminate the personal liability of directors to corporations and their stockholders for monetary damages for certain breaches of directors' fiduciary duties as directors, and our Charter includes such an exculpation provision. Our Charter includes provisions that indemnify, to the fullest extent allowable under the DGCL, the personal liability of directors or officers for monetary damages for actions taken as a director or officer of Concentrix, or for serving at our request as a director or officer or another position at another corporation or enterprise, as the case may be. Our Charter and Bylaws also provide that we must advance reasonable expenses to our directors and officers, subject to the receipt of an undertaking by or on behalf of the indemnified party. Our Bylaws expressly authorize us to carry directors' and officers' insurance to protect us, our directors, officers, and certain employees from certain liabilities.

We have entered into indemnification agreements with each of our directors and executive officers that provide them with rights to indemnification and expense advancement to the fullest extent permitted under the DGCL.

The limitation of liability and indemnification provisions in our Charter may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duty. These provisions may also have the effect of reducing the likelihood of derivative litigation against our directors and officers, even though such an action, if successful, might otherwise benefit us and our stockholders. However, these provisions do not limit or eliminate our rights, or those of any stockholder, to seek non-monetary relief such as injunction or rescission in the event of a breach of a director's duty of care. The provisions do not alter the liability of directors under the federal securities laws. In addition, our stockholders' investment may be adversely affected to the extent that, in a class action or direct suit, we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions. There is currently no pending material litigation or proceeding against any Concentrix directors, officers, or employees for which indemnification is sought.

**Section 203 of the Delaware General Corporation Law**

------

We are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers, which, with specified exceptions, prohibits a publicly-held Delaware corporation from engaging in a business combination with an interested stockholder for a period of three years following the date that such stockholder became an interested stockholder unless:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (1) shares owned by persons who are directors and also officers and (2) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• at or subsequent to the date of the transaction, the business combination is approved by the board of directors of the corporation and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66-2/3% of the outstanding voting stock which is not owned by the interested stockholder.

Generally, a "business combination" includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the "interested stockholder," and an "interested stockholder" is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own 15% or more of a corporation's outstanding voting stock. A Delaware corporation may opt out of these provisions either with an express provision in its original certificate of incorporation or in an amendment to its certificate of incorporation or bylaws approved by its stockholders. However, we have not opted out, and do not currently intend to opt out of, these provisions.

We expect the application of this provision to have an anti-takeover effect with respect to transactions our board of directors does not approve in advance. We also anticipate that Section 203 may discourage business combinations or other attempts that might result in a premium over the market price for the shares of common stock held by our stockholders. Certain provisions of the DGCL, our restated certificate of incorporation and our Bylaws could have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These provisions may also have the effect of preventing changes in our management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests.

**Listing**

Our shares of common stock are listed on the Nasdaq Stock Market under the symbol "CNXC."

**Transfer Agent and Registrar**

The transfer agent and registrar for our common stock is Computershare Trust Company, N.A.

## Exhibit 10.22

**Exhibit 10.22**

***Performance Restricted Stock Unit***

**CONCENTRIX CORPORATION**

**2020 STOCK INCENTIVE PLAN**

**NOTICE OF PERFORMANCE RESTRICTED STOCK UNIT AWARD**

You have been granted performance-based Restricted Stock Units (the "RSUs") representing Common Stock of Concentrix Corporation (the "Company") under the Company's 2020 Stock Incentive Plan (the "Plan") on the following terms:

*Date of Grant:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*[Date of Grant]

*Name of Recipient:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;* [Name of Recipient]

*Target Number of RSUs:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*[Total Number of RSUs]

*Vesting Commencement Date: &nbsp;&nbsp;&nbsp;&nbsp;*[Date Vesting Begins]

*Vesting Schedule:*&nbsp;&nbsp;&nbsp;&nbsp;[Vesting Schedule]

**By signing this document, you and the Company agree that these RSUs are granted under and governed by the terms and conditions of the Plan and the Restricted Stock Unit Agreement (the "Agreement"), both of which are attached to and made a part of this document. Without limiting any condition of this Agreement, your RSUs are subject to forfeiture if you do not confirm acceptance within 90 days of the Date of Grant.** 

**By signing this document you further agree that the Company may deliver by e-mail all documents relating to the Plan or this Award (including without limitation, prospectuses required by the Securities and Exchange Commission) and all other documents that the Company is required to deliver to its security holders (including without limitation, annual reports and proxy statements). You also agree that the Company may deliver these documents by posting them on a website maintained by the Company or by a third party under contract with the Company. If the Company posts these documents on a website, it will notify you by e-mail.**

---

| | |
|:---|:---|
| **[NAME OF RECIPIENT]**<br><u>&nbsp;&nbsp;&nbsp;&nbsp;</u> | **CONCENTRIX CORPORATION**<br>By:<u>&nbsp;&nbsp;&nbsp;&nbsp;</u><br>Its:<u>&nbsp;&nbsp;&nbsp;&nbsp;</u> |

---

CONCENTRIX CORPORATION

NOTICE OF PERFORMANCE RESTRICTED STOCK UNIT AWARD

------

**CONCENTRIX CORPORATION**

**2020 STOCK INCENTIVE PLAN**

**RESTRICTED STOCK UNIT AGREEMENT**

**<u>SECTION 1.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>PAYMENT FOR RSUS.</u>**

No cash payment is required for the RSUs that you are receiving. You are receiving the RSUs as consideration for Services rendered by you.

**<u>SECTION 2.</u> <u>GOVERNING PLAN.</u>**

&nbsp;&nbsp;&nbsp;&nbsp;The RSUs that you are receiving are granted pursuant and subject in all respects to the applicable provisions of the Concentrix Corporation 2020 Stock Incentive Plan (the "Plan"), which are incorporated herein by reference. Terms not otherwise defined in this Agreement have meanings ascribed to them in the Plan.

**<u>SECTION 3.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>VESTING.</u>**

A percentage of the Target Number of RSUs indicated on your Notice of Restricted Stock Unit Award shall vest in accordance with the Vesting Schedule set forth on your Notice of Restricted Stock Unit Award and based on the performance factors set forth in <u>Exhibit A</u> hereto.

For the period from [___________, 20__] through [___________, 20__] (the "Performance Period"), the Committee has approved the performance objectives set forth in <u>Exhibit A</u> hereto based on the Company's achievement of specified levels of total shareholder return ("TSR"), as determined by the Committee in its sole and absolute discretion.

Subject to Section 7, the Committee will determine the number of RSUs, if any, that vest under this Agreement based upon the extent to which the Company achieves the objectives during the Performance Period, as determined in accordance with the performance matrix set forth in <u>Exhibit A</u> hereto.

The Committee may, in its sole and absolute discretion, modify the performance objectives established hereunder, or the related achievement levels, in whole or in part, as the Committee deems appropriate and equitable to reflect a business combination or material change in the Company's business or operations, the result of which would make fair and equitable measurement of the Company's TSR for any remaining portion of the Performance Period impractical.

Except as set forth in Section 7, no RSUs shall vest after your Service has terminated for any reason.

**<u>SECTION 4.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>NATURE OF RSUS.</u>**

Your RSUs are mere bookkeeping entries. They represent only the Company's unfunded and unsecured promise to issue shares of common stock of the Company ("Shares") on a future date. As a holder of RSUs, you have no rights other than the rights of a general creditor of the Company.

CONCENTRIX CORPORATION

PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT

&nbsp;&nbsp;&nbsp;&nbsp;- 1 -

------

Your RSUs carry neither voting rights nor rights to dividends. You, or your estate or heirs, have no rights as a stockholder of the Company unless and until your RSUs are settled by issuing Shares. No adjustments will be made for dividends or other rights if the applicable record date occurs before your Shares are issued, except as described in the Plan.

You may not sell, transfer, assign, pledge or otherwise dispose of any RSUs. For instance, you may not use your RSUs as security for a loan. If you attempt to do any of these things, your RSUs will immediately become invalid.

**<u>SECTION 5.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>DIVIDEND EQUIVALENTS.</u>**

Notwithstanding Section 4 hereof and unless otherwise determined by the Committee, the RSUs include a right to dividend equivalents equal to the value of any dividends paid on the Shares for which the dividend record date occurs between the Date of Grant and the date the RSUs are settled. Each dividend equivalent entitles you to receive the equivalent cash value of any such dividends paid on the number of Shares that vest hereunder. Dividend equivalents will be accrued and paid promptly following vesting.

**<u>SECTION 6.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>FORFEITURE.</u>**

&nbsp;&nbsp;&nbsp;&nbsp;Without limiting any condition of this Agreement, your RSUs are subject to forfeiture if you do not confirm acceptance within 90 days of the Date of Grant.

If your Service terminates prior to [___________, 20__]for any reason other than as set forth in Section 7, then your Award expires immediately as to the number of RSUs that have not vested before the termination date and do not vest as a result of termination. This means that the unvested RSUs will immediately be cancelled. You receive no payment for RSUs that are forfeited. The Company determines when your Service terminates for this purpose and all purposes under the Plan and its determinations are conclusive and binding on all persons.

**<u>SECTION 7.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>CHANGE IN CONTROL.</u>**

If a Change in Control (as defined in the Plan) occurs on or prior to [__________, 20__], performance with respect to the performance objectives set forth in <u>Exhibit A</u> hereto will be measured based on the valuation of the Shares in the Change in Control as determined by the Committee upon the Change in Control. The number of RSUs determined by such performance will remain outstanding thereafter and will vest at the end of the original Performance Period, subject to the other terms and conditions of this Agreement (including, but not limited to, Section 6).

If your employment with the Company terminates as a result of an Involuntary Termination at any time within twenty-four (24) months after a Change in Control, then the number of your unvested RSUs determined in accordance with the foregoing paragraph will immediately vest.

&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Section 7:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;"Involuntary Termination" means, without your express written consent, (i) a reduction by the Company of your base salary or target cash incentive opportunity as in effect immediately prior to such reduction, (ii) the relocation of your principal place of employment to a facility or a location more than fifty (50) miles from your

CONCENTRIX CORPORATION

PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT

&nbsp;&nbsp;&nbsp;&nbsp;- 2 -

------

current location, (iii) any purported termination of your employment by the Company that is not for Cause or by reason of death or disability or (iv) the failure of the Company to obtain the assumption of the RSUs by any successor to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) &nbsp;&nbsp;&nbsp;&nbsp;"Cause" means (i) commission of a felony, an act involving moral turpitude, or an act constituting common law fraud, and that has a material adverse effect on the business or affairs of the Company or its affiliates or stockholders, (ii) intentional or willful misconduct or refusal to follow the lawful instructions of the Board of Directors or the Chief Executive Officer of the Company or (iii) intentional breach of Company confidential information obligations that has an adverse effect on the Company or its affiliates or stockholders. No act or failure to act shall be considered "intentional or willful" unless it is done, or omitted to be done, in bad faith without a reasonable belief that the action or omission is in the best interests of the Company.

**<u>SECTION 8.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>LEAVES OF ABSENCE AND PART-TIME WORK.</u>**

For purposes of this Award, your Service does not terminate and your vesting will continue when you go on a military leave, a sick leave or another *bona fide* leave of absence, if the leave of absence was approved by the Company in writing and if continued crediting of Service is required by the terms of the leave or by applicable law. But your Service terminates when the approved leave ends, unless you immediately return to active work.

If you go on a leave of absence of more than eight (8) weeks or commence working on a part-time basis, then the number of RSUs that vest hereunder may be adjusted on a pro rata basis in the Committee's sole and absolute discretion.

**<u>SECTION 9.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>SETTLEMENT OF RSUS.</u>**

Each of your vested RSUs will be settled when it vests, unless a valid Deferral Election (as defined below) applies to some or all of your RSUs.

At the time of settlement, you will receive one Share for each vested RSU; provided, however, that no fractional Shares will be issued or delivered pursuant to the Plan or this Agreement, and the Committee will determine whether cash will be paid in lieu of any fractional Share or whether such fractional Share and any rights thereto will be canceled, terminated or otherwise eliminated. In addition, the Shares are issued to you subject to the condition that the issuance of the Shares not violate any law or regulation.

**<u>SECTION 10.</u> <u>DEFERRAL ELECTIONS.</u>**

You may elect to defer the settlement of any RSUs that vest pursuant to this Award in accordance with the rules set forth below and any rules and procedures that may hereafter be adopted by the Committee. Such election ("Deferral Election") may not extend the settlement of the RSUs beyond the earlier of (a) 30 days after your separation from service, as defined for purposes of Section 409A of the Code (provided, however, that if you are a "specified employee" as defined under Section 409A of the Code upon your separation from service, your RSUs may not be settled prior to the six-month anniversary of your separation from service, to the extent required to avoid taxation under Section 409A), or (b) the tenth anniversary of the Date of

CONCENTRIX CORPORATION

PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT

&nbsp;&nbsp;&nbsp;&nbsp;- 3 -

------

Grant. Unless otherwise provided by the Committee in accordance with the requirements of Section 409A, Deferral Elections must be in writing, must be received by the Company at its headquarters no later than 30 days following the Date of Grant, must be irrevocable no later than 30 days following the Date of Grant, and will only be effective with respect to RSUs that vest at least 12 months following the date that the Deferral Election is made and becomes irrevocable.

**<u>SECTION 11.</u> <u>WITHHOLDING TAXES.</u>**

Regardless of any action the Company and/or the Subsidiary or Affiliate employing you (the "Employer") takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding ("Tax-Related Items"), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the settlement of the RSUs, the subsequent sale of Shares acquired pursuant to such settlement and the receipt of any dividends; and (2) do not commit to structure the terms of the Award or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items.

Prior to the settlement of your RSUs, you shall pay or make arrangements acceptable to the Company and/or your Employer to satisfy all withholding and payment on account obligations of the Company and/or the Employer. In this regard, you authorize the Company and/or your Employer to withhold all applicable Tax-Related Items legally payable by you from your wages or other cash compensation paid to you by the Company and/or your Employer. With the Company's consent, these arrangements may also include, if permissible under local law, (a) withholding Shares that otherwise would be issued to you when your RSUs are settled, provided that the Company only withholds the amount of Shares necessary to satisfy the maximum legally required withholding amount, (b) having the Company withhold taxes from the proceeds of the sale of the Shares, or (c) any other arrangement approved by the Company. The fair market value of the Shares you surrender, determined as of the date when taxes otherwise would have been withheld in cash, will be applied as a credit against the withholding taxes. Finally, you will pay to the Company or your Employer any amount of Tax-Related Items that the Company or your Employer may be required to withhold as a result of your participation in the Plan or your acquisition of Shares that cannot be satisfied by the means previously described. The Company may refuse to deliver the Shares if you fail to comply with your obligations in connection with the Tax-Related Items as described in this section, and your rights to the Shares shall be forfeited if you do not comply with such obligations on or before December 31 of the calendar year in which the applicable vesting date for the RSUs occurs.

CONCENTRIX CORPORATION

PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT

&nbsp;&nbsp;&nbsp;&nbsp;- 4 -

------

**<u>SECTION 12.</u> <u>RESTRICTIONS ON RESALE.</u>**

You agree not to sell any Shares at a time when applicable laws, Company policies or an agreement between the Company and its underwriters prohibit a sale. This restriction will apply as long as your Service continues and for such period of time after the termination of your Service as the Company may specify.

**<u>SECTION 13.</u> <u>NO RETENTION RIGHTS.</u>**

Neither your Award nor this Agreement gives you the right to be employed or retained by the Company or a subsidiary of the Company in any capacity. The Company and its subsidiaries reserve the right to terminate your Service at any time, with or without cause.

**<u>SECTION 14.</u> <u>ADJUSTMENTS.</u>**

The number of RSUs covered by this Award shall be subject to adjustment in the event of a stock split, a stock dividend or a similar change in Company Shares, and in other circumstances, as set forth in the Plan.

**<u>SECTION 15.</u> CLAWBACK POLICY<u>.</u>**

By accepting the RSUs, you understand and acknowledge that the RSUs and any Shares issued in settlement of the RSUs are subject to the terms and conditions of the Company's Compensation Clawback Policy, as such policy may be amended, modified or supplemented by the Company's Board of Directors.

**<u>SECTION 16.</u> <u>NOTICE.</u>**

Any notice required or permitted under this Agreement shall be given in writing and shall be deemed effectively given upon the earliest of personal delivery, receipt or the third (3<sup>rd</sup>) full day following mailing with postage and fees prepaid, addressed to the other party hereto at the address last known in the Company's records or at such other address as such party may designate by ten (10) days' advance written notice to the other party hereto.

**<u>SECTION 17.</u> <u>APPLICABLE LAW AND CHOICE OF VENUE.</u>**

This Agreement will be interpreted and enforced under the laws of the State of Delaware (without regard to their choice-of-law provisions).

For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this Award or this Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California and agree that such litigation will be conducted only in the courts of Alameda County, California, or the federal courts of the United States for the Northern District of California, and no other courts, where this grant is made and/or to be performed.

**<u>SECTION 18.</u> <u>THE PLAN AND OTHER AGREEMENTS.</u>**

The text of the Plan is incorporated in this Agreement by reference. All capitalized terms used in this Agreement but not defined herein shall have the meanings assigned to them in the Plan. This Agreement and the Plan constitute the entire understanding between you and the Company regarding this Award. Any prior agreements, commitments or negotiations concerning this Award are superseded. This Agreement may be amended by the Committee without your

CONCENTRIX CORPORATION

PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT

&nbsp;&nbsp;&nbsp;&nbsp;- 5 -

------

consent; however, if any such amendment would materially impair your rights or obligations under this Agreement, this Agreement may be amended only by another written agreement, signed by you and the Company.

**<u>SECTION 19.</u> <u>SUCCESSORS AND ASSIGNS.</u>**

&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided in the Plan or this Agreement, every term of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, legatees, legal representatives, successors, transferees and assigns.

**<u>SECTION 20.</u> <u>MISCELLANEOUS.</u>**

You understand and acknowledge that (i) the Plan is entirely discretionary, (ii) the Company and your Employer have reserved the right to amend, suspend or terminate the Plan at any time, (iii) the grant of your Award does not in any way create any contractual or other right to receive additional grants of awards (or benefits in lieu of awards) at any time or in any amount and (iv) all determinations with respect to any additional grants, including (without limitation) the times when awards will be granted, the number of Shares subject to the awards, and the vesting schedule, will be at the sole discretion of the Company.

The value of this Award shall be an extraordinary item of compensation outside the scope of your employment contract, if any, and shall not be considered a part of your normal or expected compensation for purposes of calculating severance, resignation, redundancy or end-of-service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.

You understand and acknowledge that participation in the Plan ceases upon termination of your Service for any reason, except as may explicitly be provided otherwise in the Plan or this Agreement.

You hereby authorize and direct your Employer to disclose to the Company or any Subsidiary any information regarding your employment, the nature and amount of your compensation and the fact and conditions of your participation in the Plan, as your Employer deems necessary or appropriate to facilitate the administration of the Plan.

You consent to the collection, use and transfer of personal data as described in this subsection. You understand and acknowledge that the Company, your Employer and the Company's other Subsidiaries hold certain personal information regarding you for the purpose of managing and administering the Plan, including (without limitation) your name, home address, telephone number, date of birth, social insurance number, salary, nationality, job title, any Shares or directorships held in the Company and details of all awards or any other entitlements to Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor (the "Data"). You further understand and acknowledge that the Company and/or its Subsidiaries will transfer Data among themselves as necessary for the purpose of implementation, administration and management of your participation in the Plan and that the Company and/or any Subsidiary may each further transfer Data to any third party assisting the Company in the implementation, administration and management of the Plan. You understand and acknowledge that the recipients of Data may be located in the United States or elsewhere. You authorize such recipients to receive, possess, use, retain and transfer Data, in electronic or other form, for the

CONCENTRIX CORPORATION

PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT

&nbsp;&nbsp;&nbsp;&nbsp;- 6 -

------

purpose of administering your participation in the Plan, including a transfer to any broker or other third party with whom you elect to deposit Shares acquired under the Plan of such Data as may be required for the administration of the Plan and/or the subsequent holding of Shares on your behalf. You may, at any time, view the Data, require any necessary modifications of Data or withdraw the consents set forth in this subsection by contacting the People Solutions Department of the Company in writing.

**<u>SECTION 21.</u> <u>SECTION 409A OF THE CODE.</u>**

To the extent this Agreement is subject to, and not exempt from, Section 409A of the Code, this Agreement is intended to comply with Section 409A of the Code, and its provisions shall be interpreted in a manner consistent with such intent. You acknowledge and agree that changes may be made to this Agreement to avoid adverse tax consequences to you under Section 409A.

**BY SIGNING THE COVER SHEET OF THIS AGREEMENT, YOU AGREE TO ALL OF THE TERMS AND CONDITIONS DESCRIBED ABOVE AND IN THE PLAN.**

CONCENTRIX CORPORATION

PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT

&nbsp;&nbsp;&nbsp;&nbsp;- 7 -

## Exhibit 10.23

**Exhibit 10.23**

*Performance Restricted Stock Unit Award*

**CONCENTRIX CORPORATION**

**2020 STOCK INCENTIVE PLAN**

**NOTICE OF PERFORMANCE RESTRICTED STOCK UNIT AWARD**

You have been granted performance-based Restricted Stock Units ("RSUs") representing Common Stock of Concentrix Corporation (the "Company") under the Company's 2020 Stock Incentive Plan (the "Plan") on the following terms:

*Date of Grant:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*[Date of Grant]

*Name of Recipient: &nbsp;&nbsp;&nbsp;&nbsp;*[Name of Recipient]

*Total Number of RSUs: &nbsp;&nbsp;&nbsp;&nbsp;*[Total Number of RSUs]

*Fair Market Value per RSU: &nbsp;&nbsp;&nbsp;&nbsp;*$[Value per RSU]

*Total Fair Market Value Of Award: &nbsp;&nbsp;&nbsp;&nbsp;*$[Total Value]

*Vesting Commencement Date:* &nbsp;&nbsp;&nbsp;&nbsp;[Date vesting begins]

*Vesting Schedule:* &nbsp;&nbsp;&nbsp;&nbsp;[Vesting Schedule]

**By signing this document, you and the Company agree that these RSUs are granted under and governed by the terms and conditions of the Plan and the Restricted Stock Unit Agreement (the "Agreement"), both of which are attached to and made a part of this document. Without limiting any condition of this Agreement, your RSUs are subject to forfeiture if you do not confirm acceptance within 90 days of the Date of Grant.** 

**By signing this document you further agree that the Company may deliver by e-mail all documents relating to the Plan or this Award (including without limitation, prospectuses required by the Securities and Exchange Commission) and all other documents that the Company is required to deliver to its security holders (including without limitation, annual reports and proxy statements). You also agree that the Company may deliver these documents by posting them on a website maintained by the Company or by a third party under contract with the Company. If the Company posts these documents on a website, it will notify you by e-mail.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CONCENTRIX CORPORATION**

**____________________________ By:__________________________________**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Title:_________________________________**

**CONCENTRIX CORPORATION**

**2020 STOCK INCENTIVE PLAN**

CONCENTRIX CORPORATION

NOTICE OF PERFORMANCE RESTRICTED STOCK UNIT AWARD

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- 1 -

------

**RESTRICTED STOCK UNIT AGREEMENT**

**<u>SECTION 1.</u> <u>PAYMENT FOR SHARES.</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No cash payment is required for the RSUs that you are receiving. You are receiving the RSUs as consideration for Services rendered by you.

**<u>SECTION 2.</u> <u>GOVERNING PLAN.</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The RSUs that you are receiving are granted pursuant and subject in all respects to the applicable provisions of the Concentrix Corporation 2020 Stock Incentive Plan (the "Plan"), which is incorporated herein by reference. Terms not otherwise defined in this Agreement have meanings ascribed to them in the Plan.

**<u>SECTION 3.</u> <u>VESTING.</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A percentage of the Target Number of RSUs indicated on your Notice of Restricted Stock Unit Award shall vest in accordance with the Vesting Schedule set forth on your Notice of Restricted Stock Unit Award and based on the performance factors set forth in <u>Exhibit A</u> hereto.

For the fiscal years during the three-year period ending November 30, 20__ (the "Performance Period"), the Committee has approved the performance objectives set forth in <u>Exhibit A</u> hereto based on the Company's achievement of [________________], as determined by the Committee in its sole and absolute discretion.

Subject to Section 6, the Committee will determine the number of RSUs, if any, that vest under this Agreement based upon the extent to which the Company achieves the objectives during the Performance Period, as determined in accordance with the performance matrix set forth in <u>Exhibit A</u> hereto.

The Committee may, in its sole and absolute discretion, modify the performance objectives established hereunder, or the related achievement levels, in whole or in part, as the Committee deems appropriate and equitable to reflect a business combination or material change in the Company's business or operations, the result of which would make fair and equitable measurement of [________________] for any remaining portion of the Performance Period impractical.

Except as set forth in Section 6, no RSUs shall vest after your Service as an Employee or a Consultant has terminated for any reason.

**<u>SECTION 4.</u> <u>NATURE OF RSUS.</u>**

Your RSUs are mere bookkeeping entries. They represent only the Company's unfunded and unsecured promise to issue shares of common stock of the Company ("Shares") on a future date. As a holder of RSUs, you have no rights other than the rights of a general creditor of the Company.

Your RSUs carry neither voting rights nor rights to dividends. You, or your estate or heirs, have no rights as a stockholder of the Company unless and until your RSUs are settled by issuing Shares. No adjustments will be made for dividends or other rights if the applicable record date occurs before your Shares are issued, except as described in the Plan.

CONCENTRIX CORPORATION

NOTICE OF PERFORMANCE RESTRICTED STOCK UNIT AWARD

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- 1 -

------

You may not sell, transfer, assign, pledge or otherwise dispose of any RSUs. For instance, you may not use your RSUs as security for a loan. If you attempt to do any of these things, your RSUs will immediately become invalid.

**<u>SECTION 5.</u> <u>FORFEITURE.</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without limiting any condition of this Agreement, your RSUs are subject to forfeiture if you do not confirm acceptance within 90 days of the Date of Grant.

If your Service terminates for any reason other than as set forth in Section 6, then your Award expires immediately as to the number of RSUs that have not vested before the termination date and do not vest as a result of termination. This means that the unvested RSUs will immediately be cancelled. You receive no payment for RSUs that are forfeited. The Company determines when your Service terminates for this purpose and all purposes under the Plan and its determinations are conclusive and binding on all persons.

**<u>SECTION 6.</u> <u>CHANGE IN CONTROL.</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If a Change in Control (as defined in the Plan) occurs on or prior to November 30, 20__, performance with respect to the performance objectives set forth in <u>Exhibit A</u> hereto will be measured based on actual performance through the date of the Change in Control and target performance for the remainder of the Performance Period, in each case as determined by the Committee upon the Change in Control. The number of RSUs determined by such performance will remain outstanding thereafter and will vest at the end of the original Performance Period, subject to the other terms and conditions of this Agreement (including, but not limited to, Section 5).

If your employment with the Company terminates as a result of an Involuntary Termination at any time within twenty-four (24) months after a Change in Control, then the number of your unvested RSUs determined in accordance with the foregoing paragraph will immediately vest.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Section 6:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) "Involuntary Termination" means, without your express written consent, (i) a reduction by the Company of your base salary or target cash incentive opportunity as in effect immediately prior to such reduction, (ii) the relocation of your principal place of employment to a facility or a location more than fifty (50) miles from your current location, (iii) any purported termination of your employment by the Company that is not for Cause or by reason of death or disability or (iv) the failure of the Company to obtain the assumption of the RSUs by any successor to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) "Cause" means (i) commission of a felony, an act involving moral turpitude, or an act constituting common law fraud, and that has a material adverse effect on the business or affairs of the Company or its affiliates or stockholders, (ii) intentional or willful misconduct or refusal to follow the lawful instructions of the Board of Directors or the Chief Executive Officer of the Company or (iii) intentional breach of Company confidential information obligations that has an adverse effect on the Company or its affiliates or stockholders. No act or failure to act shall be considered

CONCENTRIX CORPORATION

NOTICE OF PERFORMANCE RESTRICTED STOCK UNIT AWARD

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- 2 -

------

"intentional or willful" unless it is done, or omitted to be done, in bad faith without a reasonable belief that the action or omission is in the best interests of the Company.

**<u>SECTION 7.</u> <u>LEAVES OF ABSENCE AND PART-TIME WORK.</u>**

For purposes of this Award, your Service does not terminate and your vesting will continue when you go on a military leave, a sick leave or another *bona fide* leave of absence, if the leave of absence was approved by the Company in writing and if continued crediting of Service is required by the terms of the leave or by applicable law. But your Service terminates when the approved leave ends, unless you immediately return to active work.

If you go on a leave of absence of more than eight (8) weeks or commence working on a part-time basis, then the number of RSUs that vest hereunder may be adjusted on a pro rata basis in the Committee's sole and absolute discretion.

**<u>SECTION 8.</u> <u>SETTLEMENT OF RSUS.</u>**

Each of your vested RSUs will be settled when it vests, unless a valid Deferral Election (as defined below) applies to some or all of your RSUs.

At the time of settlement, you will receive one Share for each vested RSU; provided, however, that no fractional Shares will be issued or delivered pursuant to the Plan or this Agreement, and the Committee will determine whether cash will be paid in lieu of any fractional Share or whether such fractional Share and any rights thereto will be canceled, terminated or otherwise eliminated. In addition, the Shares are issued to you subject to the condition that the issuance of the Shares not violate any law or regulation.

**<u>SECTION 9.</u> <u>DEFERRAL ELECTIONS.</u>**

You may elect to defer the settlement of any RSUs that vest pursuant to this Award in accordance with the rules set forth below and any rules and procedures that may hereafter be adopted by the Committee. Such election ("Deferral Election") may not extend the settlement of the RSUs beyond the earlier of (a) 30 days after your separation from service, as defined for purposes of Section 409A of the Code (provided, however, that if you are a "specified employee" as defined under Section 409A of the Code upon your separation from service, your RSUs may not be settled prior to the six-month anniversary of your separation from service, to the extent required to avoid taxation under Section 409A), or (b) the tenth anniversary of the Date of Grant. Unless otherwise provided by the Committee in accordance with the requirements of Section 409A, Deferral Elections must be in writing, must be received by the Company at its headquarters no later than 30 days following the Date of Grant, must be irrevocable no later than 30 days following the Date of Grant, and will only be effective with respect to RSUs that vest at least 12 months following the date that the Deferral Election is made and becomes irrevocable.

**<u>SECTION 10.</u> <u>WITHHOLDING TAXES.</u>**

Regardless of any action the Company and/or the Subsidiary or Affiliate employing you (the "Employer") takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding ("Tax-Related Items"), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and/or the Employer (1) make no representations or

CONCENTRIX CORPORATION

NOTICE OF PERFORMANCE RESTRICTED STOCK UNIT AWARD

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- 3 -

------

undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the settlement of the RSUs, the subsequent sale of Shares acquired pursuant to such settlement and the receipt of any dividends; and (2) do not commit to structure the terms of the Award or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items.

Prior to the settlement of your RSUs, you shall pay or make arrangements acceptable to the Company and/or your Employer to satisfy all withholding and payment on account obligations of the Company and/or the Employer. In this regard, you authorize the Company and/or your Employer to withhold all applicable Tax-Related Items legally payable by you from your wages or other cash compensation paid to you by the Company and/or your Employer. With the Company's consent, these arrangements may also include, if permissible under local law, (a) withholding Shares that otherwise would be issued to you when your RSUs are settled, provided that the Company only withholds the amount of Shares necessary to satisfy the maximum legally required withholding amount, (b) having the Company withhold taxes from the proceeds of the sale of the Shares, or (c) any other arrangement approved by the Company. The fair market value of the Shares you surrender, determined as of the date when taxes otherwise would have been withheld in cash, will be applied as a credit against the withholding taxes. Finally, you will pay to the Company or your Employer any amount of Tax-Related Items that the Company or your Employer may be required to withhold as a result of your participation in the Plan or your acquisition of Shares that cannot be satisfied by the means previously described. The Company may refuse to deliver the Shares if you fail to comply with your obligations in connection with the Tax-Related Items as described in this section, and your rights to the Shares shall be forfeited if you do not comply with such obligations on or before December 31 of the calendar year in which the applicable vesting date for the RSUs occurs.

**<u>SECTION 11.</u> <u>RESTRICTIONS ON RESALE.</u>**

You agree not to sell any Shares at a time when applicable laws, Company policies or an agreement between the Company and its underwriters prohibit a sale. This restriction will apply as long as your Service continues and for such period of time after the termination of your Service as the Company may specify.

CONCENTRIX CORPORATION

NOTICE OF PERFORMANCE RESTRICTED STOCK UNIT AWARD

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- 4 -

------

**<u>SECTION 12.</u> <u>NO RETENTION RIGHTS.</u>**

Neither your Award nor this Agreement gives you the right to be employed or retained by the Company or a subsidiary of the Company in any capacity. The Company and its subsidiaries reserve the right to terminate your Service at any time, with or without cause.

**<u>SECTION 13.</u> <u>ADJUSTMENTS.</u>**

The number of RSUs covered by this Award shall be subject to adjustment in the event of a stock split, a stock dividend or a similar change in Company Shares, and in other circumstances, as set forth in the Plan.

**<u>SECTION 14.</u> <u>CLAWBACK POLICY</u>**

By accepting the RSUs, you understand and acknowledge that the RSUs and any Shares issued in settlement of the RSUs are subject to the terms and conditions of the Company's Compensation Clawback Policy, as such policy may be amended, modified or supplemented by the Company's Board of Directors.

**<u>SECTION 15.</u> <u>NOTICE.</u>**

Any notice required or permitted under this Agreement shall be given in writing and shall be deemed effectively given upon the earliest of personal delivery, receipt or the third (3<sup>rd</sup>) full day following mailing with postage and fees prepaid, addressed to the other party hereto at the address last known in the Company's records or at such other address as such party may designate by ten (10) days' advance written notice to the other party hereto.

**<u>SECTION 16.</u> <u>APPLICABLE LAW AND CHOICE OF VENUE.</u>**

This Agreement will be interpreted and enforced under the laws of the State of Delaware (without regard to their choice-of-law provisions).

For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this Award or this Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California and agree that such litigation will be conducted only in the courts of Alameda County, California, or the federal courts of the United States for the Northern District of California, and no other courts, where this grant is made and/or to be performed.

**<u>SECTION 17.</u> <u>THE PLAN AND OTHER AGREEMENTS.</u>**

The text of the Plan is incorporated in this Agreement by reference. All capitalized terms used in this Agreement but not defined herein shall have the meanings assigned to them in the Plan. This Agreement and the Plan constitute the entire understanding between you and the Company regarding this Award. Any prior agreements, commitments or negotiations concerning this Award are superseded. This Agreement may be amended by the Committee without your consent; however, if any such amendment would materially impair your rights or obligations under this Agreement, this Agreement may be amended only by another written agreement, signed by you and the Company.

CONCENTRIX CORPORATION

NOTICE OF PERFORMANCE RESTRICTED STOCK UNIT AWARD

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- 5 -

------

**<u>SECTION 18.</u> <u>SUCCESSORS AND ASSIGNS.</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided in the Plan or this Agreement, every term of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, legatees, legal representatives, successors, transferees and assigns.

**<u>SECTION 19.</u> <u>MISCELLANEOUS.</u>**

You understand and acknowledge that (i) the Plan is entirely discretionary, (ii) the Company and your Employer have reserved the right to amend, suspend or terminate the Plan at any time, (iii) the grant of your Award does not in any way create any contractual or other right to receive additional grants of awards (or benefits in lieu of awards) at any time or in any amount and (iv) all determinations with respect to any additional grants, including (without limitation) the times when awards will be granted, the number of Shares subject to the awards, and the vesting schedule, will be at the sole discretion of the Company.

The value of this Award shall be an extraordinary item of compensation outside the scope of your employment contract, if any, and shall not be considered a part of your normal or expected compensation for purposes of calculating severance, resignation, redundancy or end-of-service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.

You understand and acknowledge that participation in the Plan ceases upon termination of your Service for any reason, except as may explicitly be provided otherwise in the Plan or this Agreement.

You hereby authorize and direct your Employer to disclose to the Company or any Subsidiary any information regarding your employment, the nature and amount of your compensation and the fact and conditions of your participation in the Plan, as your Employer deems necessary or appropriate to facilitate the administration of the Plan.

You consent to the collection, use and transfer of personal data as described in this subsection. You understand and acknowledge that the Company, your Employer and the Company's other Subsidiaries hold certain personal information regarding you for the purpose of managing and administering the Plan, including (without limitation) your name, home address, telephone number, date of birth, social insurance number, salary, nationality, job title, any Shares or directorships held in the Company and details of all awards or any other entitlements to Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor (the "Data"). You further understand and acknowledge that the Company and/or its Subsidiaries will transfer Data among themselves as necessary for the purpose of implementation, administration and management of your participation in the Plan and that the Company and/or any Subsidiary may each further transfer Data to any third party assisting the Company in the implementation, administration and management of the Plan. You understand and acknowledge that the recipients of Data may be located in the United States or elsewhere. You authorize such recipients to receive, possess, use, retain and transfer Data, in electronic or other form, for the purpose of administering your participation in the Plan, including a transfer to any broker or other third party with whom you elect to deposit Shares acquired under the Plan of such Data as may be required for the administration of the Plan and/or the subsequent holding of Shares on your behalf. You may, at any time, view the Data, require any necessary modifications of Data

CONCENTRIX CORPORATION

NOTICE OF PERFORMANCE RESTRICTED STOCK UNIT AWARD

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- 6 -

------

or withdraw the consents set forth in this subsection by contacting the People Solutions Department of the Company in writing.

**<u>SECTION 20.</u> <u>SECTION 409A OF THE CODE.</u>**

To the extent this Agreement is subject to, and not exempt from, Section 409A of the Code, this Agreement is intended to comply with Section 409A of the Code, and its provisions shall be interpreted in a manner consistent with such intent. You acknowledge and agree that changes may be made to this Agreement to avoid adverse tax consequences to you under Section 409A.

**BY SIGNING THE COVER SHEET OF THIS AGREEMENT, YOU AGREE TO ALL OF THE TERMS AND CONDITIONS DESCRIBED ABOVE AND IN THE PLAN.**

CONCENTRIX CORPORATION

NOTICE OF PERFORMANCE RESTRICTED STOCK UNIT AWARD

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- 7 -

## Exhibit 10.24

**Exhibit 10.24**

CONCENTRIX CORPORATION

2020 EMPLOYEE STOCK PURCHASE PLAN

(as adopted by the Board of Directors on November 12, 2020)

(Effective on December 1, 2020)

(Amended on March 22, 2022, September 19, 2024, and September 23, 2025)

------

<u>**Table of Contents**</u>

---

| | |
|:---|:---|
| 2020 EMPLOYEE STOCK PURCHASE PLAN | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 1&nbsp;&nbsp;&nbsp;&nbsp;Purpose of the Plan. | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 2&nbsp;&nbsp;&nbsp;&nbsp;Definitions. | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;"Board" | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;"Code" | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;"Committee" | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;"Common Stock" | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;"Company" | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;"Compensation" | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;&nbsp;&nbsp;"Corporate Reorganization" | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;&nbsp;&nbsp;"Eligible Employee" | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;"Exchange Act" | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;&nbsp;&nbsp;&nbsp;"Fair Market Value" | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;&nbsp;&nbsp;&nbsp;"Offering" | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;&nbsp;&nbsp;&nbsp;"Offering Date" | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;&nbsp;&nbsp;&nbsp;"Offering Period" | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;&nbsp;&nbsp;&nbsp;"Participant" | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o)&nbsp;&nbsp;&nbsp;&nbsp;"Participating Company" | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p)&nbsp;&nbsp;&nbsp;&nbsp;"Plan" | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q)&nbsp;&nbsp;&nbsp;&nbsp;"Plan Account" | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r)&nbsp;&nbsp;&nbsp;&nbsp;"Purchase Date" | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(s)&nbsp;&nbsp;&nbsp;&nbsp;"Purchase Period" | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(t)&nbsp;&nbsp;&nbsp;&nbsp;"Purchase Price" | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(u)&nbsp;&nbsp;&nbsp;&nbsp;"Subsidiary" | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;&nbsp;&nbsp;&nbsp;"Trading Day" | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 3&nbsp;&nbsp;&nbsp;&nbsp;Administration of the Plan. | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Administrative Powers and Responsibilities | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;International Administration | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 4&nbsp;&nbsp;&nbsp;&nbsp;Enrollment and Participation. | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Offering Periods | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Enrollment | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Duration of Participation | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 5&nbsp;&nbsp;&nbsp;&nbsp;Employee Contributions. | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Frequency of Payroll Deductions | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Amount of Payroll Deductions | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Changing Withholding Rate | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Discontinuing Payroll Deductions | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 6&nbsp;&nbsp;&nbsp;&nbsp;Withdrawal from the Plan. | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Withdrawal | 6 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Re-enrollment After Withdrawal | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 7&nbsp;&nbsp;&nbsp;&nbsp;Change in Employment Status. | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Termination of Employment | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Leave of Absence | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Death | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 8&nbsp;&nbsp;&nbsp;&nbsp;Plan Accounts and Purchase of Shares. | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Plan Accounts | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Purchase Price | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Number of Shares Purchased | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Available Shares Insufficient | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;Issuance of Common Stock | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;Unused Cash Balances | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;&nbsp;&nbsp;Stockholder Approval | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 9&nbsp;&nbsp;&nbsp;&nbsp;Limitations on Stock Ownership. | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Five Percent Limit | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Dollar Limit | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 10&nbsp;&nbsp;&nbsp;&nbsp;Rights Not Transferable. | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 11&nbsp;&nbsp;&nbsp;&nbsp;No Rights as an Employee | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 12&nbsp;&nbsp;&nbsp;&nbsp;No Rights as a Stockholder. | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 13&nbsp;&nbsp;&nbsp;&nbsp;Securities Law Requirements. | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 14&nbsp;&nbsp;&nbsp;&nbsp;Stock Offered under the Plan. | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Authorized Shares | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Anti-dilution Adjustments | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Reorganizations | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 15&nbsp;&nbsp;&nbsp;&nbsp;Amendment or Discontinuance. | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 16&nbsp;&nbsp;&nbsp;&nbsp;Execution. | 10 |
| INTERNATIONAL EMPLOYEE STOCK PURCHASE PLAN | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 1&nbsp;&nbsp;&nbsp;&nbsp;Purpose of the Sub-Plan. | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 2&nbsp;&nbsp;&nbsp;&nbsp;Definitions. | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;"Eligible Employee" | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;"Invitation" | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;"Participant" | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;"Section" | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 3&nbsp;&nbsp;&nbsp;&nbsp;Enrollment and Participation. | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Offering Periods | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Enrollment | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Duration of Participation | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Dollar Limit | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 4&nbsp;&nbsp;&nbsp;&nbsp;Employee Contributions. | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Frequency of Payroll Deductions | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Amount of Payroll Deductions | 3 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Changing Withholding Rate | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Discontinuing Payroll Deductions | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;Plan Account | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 5&nbsp;&nbsp;&nbsp;&nbsp;Conversion of Plan Account into U.S. Currency. | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Conversion to U.S. Dollars | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Conversion to Local Currency | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 6&nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Effect of Addenda | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Effect of Certain Plan Terms | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;No Retention Rights | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;No Guaranty of Gain | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;Waiver | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;Severability | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;SECTION 7&nbsp;&nbsp;&nbsp;&nbsp;Execution. | 5 |

---

------

CONCENTRIX CORPORATION

2020 EMPLOYEE STOCK PURCHASE PLAN

<u>SECTION 1</u><u>Purpose of the Plan.</u>

The Plan was adopted by the Board on November 12, 2020 and subsequently approved by the Company's stockholders on November 24, 2020. The purpose of the Plan is to provide Eligible Employees with an opportunity to increase their proprietary interest in the success of the Company by purchasing Common Stock from the Company on favorable terms and to pay for such purchases through payroll deductions. The Plan is intended to qualify under Section 423 of the Code.

<u>SECTION 2</u><u>Definitions.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)"<u>Board</u>" means the Board of Directors of the Company, as constituted from time to time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)"<u>Code</u>" means the Internal Revenue Code of 1986, as amended.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)"<u>Committee</u>" means the Compensation Committee of the Board or such other committee, comprised exclusively of one or more directors of the Company, as may be appointed by the Board from time to time to administer the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)"<u>Common Stock</u>" means the Company's common stock, par value $0.0001 per share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)"<u>Company</u>" means Concentrix Corporation, a Delaware corporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)"<u>Compensation</u>" means, unless provided otherwise by the Committee in the terms and conditions of an Offering, base salary and wages paid in cash to a Participant by a Participating Company, without reduction for any pre-tax contributions made by the Participant under Sections 401(k) or 125 of the Code. Compensation shall, unless provided otherwise by the Committee in the terms and conditions of an Offering, exclude variable compensation (including commissions, bonuses, incentive compensation, overtime pay and shift premiums), all non-cash items, moving or relocation allowances, cost-of-living equalization payments, car allowances, tuition reimbursements, imputed income attributable to cars or life insurance, severance pay, fringe benefits, contributions or benefits received under employee benefit plans, income attributable to the exercise of stock options, and similar items. The Committee shall determine whether a particular item is included in Compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)"<u>Corporate Reorganization</u>" means:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)The consummation of a merger or consolidation of the Company with or into another entity, or any other corporate reorganization in which the Company's stockholders immediately prior thereto own less than 50% of the voting securities of the Company (or its successor or parent) immediately thereafter; or

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)The sale, transfer or other disposition of all or substantially all of the Company's assets or the complete liquidation or dissolution of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)"<u>Eligible Employee</u>" means any employee of a Participating Company who has rendered services as an employee for at least six (6) months after the employee's date of hire with the Company or a Participating Company and whose customary employment is for more than five (5) months per calendar year and for more than twenty (20) hours per week. The foregoing notwithstanding, an individual shall not be considered an Eligible Employee if his or her participation in the Plan is prohibited by the law of any country which has jurisdiction over him or her.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)"<u>Exchange Act</u>" means the Securities Exchange Act of 1934, as amended.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)"<u>Fair Market Value</u>" means the fair market value of a share of Common Stock, determined as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)If the Common Stock was traded on any established national securities exchange, including the New York Stock Exchange or The NASDAQ Stock Market, on the date in question, then the Fair Market Value shall be equal to the closing price as quoted on such exchange (or the exchange with the greatest volume of trading in the Common Stock) on such date as reported in *The Wall Street Journal* or such other source as the Committee deems reliable; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)If the foregoing provision is not applicable, then the Fair Market Value shall be determined by the Committee in good faith on such basis as it deems appropriate.

For any date that is not a Trading Day, the Fair Market Value of a share of Common Stock for such date shall be determined by using the closing sale price for the immediately preceding Trading Day. The determination of the Fair Market Value pursuant to the foregoing provisions shall be conclusive and binding on all persons.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)"<u>Offering</u>" means the grant of options to purchase shares of Common Stock to Eligible Employees under the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)"<u>Offering Date</u>" means the first day of an Offering; provided, however, that if any Offering Date falls on a day that is not a Trading Day, then such Offering Date shall instead fall on the next Trading Day.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)"<u>Offering Period</u>" means a period with respect to which the right to purchase Common Stock may be granted to Eligible Employees under the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)"<u>Participant</u>" means an Eligible Employee who elects to participate in the Plan in accordance with the terms hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o)"<u>Participating Company</u>" means (i) the Company and (ii) each present or future Subsidiary designated by the Committee as a Participating Company.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p)"<u>Plan</u>" means this Concentrix Corporation 2020 Employee Stock Purchase Plan, as it may be amended from time to time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q)"<u>Plan Account</u>" means the account established for each Participant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r)"<u>Purchase Date</u>" means one or more dates during an Offering on which shares of Common Stock may be purchased pursuant to the terms of the Offering; provided, however, that if any Purchase Date falls on a day that is not a Trading Day, then such Purchase Date shall instead fall on the immediately preceding Trading Day.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(s)"<u>Purchase Period</u>" means one or more successive periods during an Offering, beginning on the Offering Date or on the day after a Purchase Date, and ending on the next succeeding Purchase Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(t)"<u>Purchase Price</u>" means the price at which Participants may purchase shares of Common Stock under the Plan, as determined pursuant to Section 8(b).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(u)"<u>Subsidiary</u>" means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns common stock, limited liability company interests, partnership interests or other equity possessing 50% or more of the total combined equity voting power in one of the other corporations in such chain.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)"<u>Trading Day</u>" means a day on which the national securities exchange on which the Common Stock is traded is open for trading.

<u>SECTION 3</u><u>Administration of the Plan.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Administrative Powers and Responsibilities</u>. The Plan shall be administered by the Committee. The Committee shall have full power and authority, subject to the provisions of the Plan, to promulgate such rules and regulations as it deems necessary for the proper administration of the Plan, to interpret the provisions and supervise the administration of the Plan, and to take all action in connection therewith or in relation thereto as it deems necessary or advisable. Any decision reduced to writing and signed by all of the members of the Committee shall be fully effective as if it had been made at a meeting duly held. The Committee's determinations under the Plan, unless otherwise determined by the Board, shall be final and binding on all persons. The Company shall pay all expenses incurred in the administration of the Plan. No member of the Committee shall be personally liable for any action, determination, or interpretation made in good faith with respect to the Plan, and all members of the Committee shall be fully indemnified by the Company with respect to any such action, determination or interpretation. The Committee may adopt such rules, guidelines and forms as it deems appropriate to implement the Plan. Subject to the requirements of applicable law, the Committee may designate persons other than members of the Committee to carry out its responsibilities and may prescribe such conditions and limitations as it may deem appropriate. All decisions, interpretations and other actions of the Committee shall be final and binding on all Participants and all persons deriving their rights from a Participant. No member of the Committee shall be liable for any action that he has taken or has failed to take in good faith with respect to the Plan. Notwithstanding anything to the contrary in the Plan, the Board may, in its sole discretion, at any

------

time and from time to time, resolve to administer the Plan. In such event, the Board shall have all of the authority and responsibility granted to the Committee herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>International Administration</u>. The Committee shall establish sub-plans (which need not qualify under Section 423 of the Code) and initiate separate Offerings through such sub-plans for the purpose of (i) facilitating participation in the Plan by non-U.S. employees in compliance with foreign laws and regulations without affecting the qualification of the remainder of the Plan under Section 423 of the Code or (ii) qualifying the Plan for preferred tax treatment under foreign tax laws (which sub-plans, at the Committee's discretion, may provide for allocations of the authorized shares reserved for issue under the Plan as set forth in Section 14(a)). The rules, guidelines and forms of such sub-plans (or the Offerings thereunder) may take precedence over other provisions of the Plan, with the exception of Section 4(a)(i), Section 5(b), Section 8(b) and Section 14(a), but unless otherwise superseded by the terms of such sub-plan, the provisions of the Plan shall govern the operation of such sub-plan.

<u>SECTION 4</u><u>Enrollment and Participation.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Offering Periods</u>. While the Plan is in effect, the Committee may from time to time grant options to purchase shares of Common Stock pursuant to the Plan to Eligible Employees during a specified Offering Period. Each such Offering shall be in such form and shall contain such terms and conditions as the Committee shall determine, subject to compliance with the terms and conditions of the Plan (which may be incorporated by reference) and the requirements of Section 423 of the Code, including the requirement that all Eligible Employees have the same rights and privileges (except with respect to sub-plans established for the purpose of facilitating participation by non-U.S. employees). The Committee shall specify prior to the commencement of each Offering (i) the period during which the Offering shall be effective, which may not exceed 27 months from the Offering Date and may include one or more successive Purchase Periods within the Offering, (ii) the Purchase Dates and Purchase Price for shares of Common Stock which may be purchased pursuant to the Offering, and (iii) if applicable, any limits on the number of shares of Common Stock purchasable by a Participant, or by all Participants in the aggregate, during any Offering Period or, if applicable, Purchase Period, in each case consistent with the limitations of the Plan. The Committee shall have the discretion to provide for the automatic termination of an Offering following any Purchase Date on which the Fair Market Value of a share of Common Stock is equal to or less than the Fair Market Value of a share of Common Stock on the Offering Date, and for the Participants in the terminated Offering to be automatically re-enrolled in a new Offering that commences immediately after such Purchase Date. The terms and conditions of each Offering need not be identical, and shall be deemed incorporated by reference and made a part of the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Enrollment</u>. Any individual who, on the day preceding the first day of an Offering Period, qualifies as an Eligible Employee may elect to become a Participant in the Plan for such Offering Period by completing the enrollment process prescribed and communicated for this purpose from time to time by the Company to Eligible Employees. By completing the enrollment process, an Eligible Employee: (i) authorizes the applicable Participating Company to make the relevant payroll deductions from the Eligible Employee's Compensation on each applicable payday and to pay or apply such amounts to the purchase of Common Stock under the Plan; (ii) agrees to be bound by the terms of any enrollment form and the Plan; and (iii) accepts

------

and consents to any action taken under the Plan by the Committee, the Company or the applicable Participating Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Duration of Participation</u>. Once enrolled in the Plan, a Participant shall continue to participate in the Plan until he or she ceases to be an Eligible Employee or withdraws from the Plan under Section 6(a). A Participant who withdrew from the Plan under Section 6(a) may again become a Participant, if he or she then is an Eligible Employee, by following the procedure described in Section 4(b). A Participant whose employee contributions were discontinued automatically shall automatically resume participation at the beginning of the earliest Offering Period ending in the next calendar year, if he or she is then an Eligible Employee. When a Participant reaches the end of an Offering Period but his or her participation is to continue, then such Participant shall automatically be re-enrolled for the Offering Period that commences immediately after the end of the prior Offering Period.

<u>SECTION 5</u><u>Employee Contributions.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Frequency of Payroll Deductions</u>. A Participant may purchase shares of Common Stock under the Plan solely by means of payroll deductions; provided, however, that to the extent provided in the terms and conditions of an Offering, a Participant may also make contributions through payment by cash or check prior to one or more Purchase Dates during the Offering. Payroll deductions, subject to the provisions of Section 5(b) or as otherwise provided under the terms and conditions of an Offering, shall occur on each payday during participation in the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Amount of Payroll Deductions</u>. An Eligible Employee shall designate during the enrollment process the portion of his or her Compensation that he or she elects to have withheld for the purchase of Common Stock. Such portion shall be a whole percentage of the Eligible Employee's Compensation, but not less than 1% nor more than 15% (or such lower rate of Compensation specified as the limit in the terms and conditions of the applicable Offering). Unless otherwise determined by the Committee, the amount of an Eligible Employee's Compensation that may be withheld for the purchase of Common Stock shall not exceed an amount per calendar year that is equal to the product of (x) $25,000 multiplied by (y) the percentage of Fair Market Value utilized for the Purchase Price, as set forth in Section 8(b).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Changing Withholding Rate</u>. Unless otherwise provided under the terms and conditions of an Offering, a Participant may not increase the rate of payroll withholding during the Offering Period, but may decrease the rate of payroll withholding during the Offering Period to a whole percentage of his or her Compensation in accordance with such procedures and subject to such limitations as the Company may establish for all Participants. A Participant may also increase or decrease the rate of payroll withholding effective for a new Offering Period by submitting an authorization to change the payroll deduction rate pursuant to the process prescribed by the Company from time to time. The new withholding rate shall be a whole percentage of the Eligible Employee's Compensation consistent with Section 5(b).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Discontinuing Payroll Deductions</u>. If a Participant wishes to discontinue employee contributions entirely, he or she may do so by withdrawing from the Plan pursuant to Section 6(a). In addition, employee contributions may be discontinued automatically pursuant to Section 9(b).

------

<u>SECTION 6</u><u>Withdrawal from the Plan.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Withdrawal</u>. A Participant may elect to withdraw from the Plan by giving notice pursuant to the process prescribed and communicated by the Company from time to time. Such withdrawal may be elected at any time before the last day of an Offering Period, except as otherwise provided in the Offering. In addition, if payment by cash or check is permitted under the terms and conditions of an Offering, Participants may be deemed to withdraw from the Plan by declining or failing to remit timely payment to the Company for the shares of Common Stock. As soon as reasonably practicable thereafter, payroll deductions shall cease and the entire amount credited to the Participant's Plan Account shall be refunded to him or her in cash, without interest. No partial withdrawals shall be permitted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Re-enrollment After Withdrawal</u>. A former Participant who has withdrawn from the Plan shall not be a Participant until he or she re-enrolls in the Plan in accordance with the terms hereof. Re-enrollment may be effective only at the commencement of an Offering Period.

<u>SECTION 7</u><u>Change in Employment Status.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Termination of Employment</u>. Termination of employment as an Eligible Employee for any reason, including death, shall be treated as an automatic withdrawal from the Plan under Section 6(a). A transfer from one Participating Company to another shall not be treated as a termination of employment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Leave of Absence</u>. For purposes of the Plan, employment shall not be deemed to terminate when the Participant goes on a military leave, a sick leave or another bona fide leave of absence, if the leave was approved by the Company in writing. For purposes of the Plan, employment, however, shall be deemed to terminate three (3) months after the Participant goes on a leave, unless a contract or statute guarantees his or her right to return to work. Employment shall be deemed to terminate in any event when the approved leave ends, unless the Participant immediately returns to work.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Death</u>. In the event of the Participant's death, the amount credited to his or her Plan Account shall be paid to the Participant's estate.

<u>SECTION 8</u><u>Plan Accounts and Purchase of Shares.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Plan Accounts</u>. The Company shall maintain a Plan Account on its books in the name of each Participant. Whenever an amount is deducted from the Participant's Compensation under the Plan, such amount shall be credited to the Participant's Plan Account. Amounts credited to Plan Accounts shall not be trust funds and may be commingled with the Company's general assets and applied to general corporate purposes. No interest will accrue, be credited or be paid to Participants in respect of any amounts credited to the Participant's Plan Account.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Purchase Price</u>. The Purchase Price for each share of Common Stock purchased during an Offering Period shall be the lesser of:

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) 95% of the Fair Market Value of such share on the Purchase Date; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) 95% of the Fair Market Value of such share on the Offering Date.

The Committee may specify an alternative Purchase Price amount or formula in the terms and conditions of an Offering, but in no event may such amount or formula result in a Purchase Price less than that calculated pursuant to the immediately preceding formula.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Number of Shares Purchased</u>. As of each Purchase Date, each Participant shall be deemed to have elected to purchase the number of whole or fractional shares of Common Stock calculated in accordance with this Section 8(c), unless the Participant has previously elected to withdraw from the Plan in accordance with Section 6(a). The amount then in the Participant's Plan Account shall be divided by the Purchase Price and the number of whole or fractional shares that results shall be purchased from the Company with the funds in the Participant's Plan Account. Unless provided otherwise by the Committee prior to commencement of an Offering, the maximum number of shares of Common Stock which may be purchased by an individual Participant during an Offering is 500 shares. The foregoing notwithstanding, no Participant shall purchase more than such number of shares of Common Stock as may be determined by the Committee with respect to the Offering Period, or Purchase Period, if applicable, nor more than the amounts of Common Stock set forth in Sections 9(b) and 14(a). For each Offering Period and, if applicable, Purchase Period, the Committee shall have the authority to establish additional limits on the number of shares purchasable by all Participants in the aggregate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Available Shares Insufficient</u>. In the event that the aggregate number of shares of Common Stock that all Participants elect to purchase during an Offering Period exceeds the maximum number of shares remaining available for issuance under Section 14(a), or which may be purchased pursuant to any additional aggregate limits imposed by the Committee, then the number of shares to which each Participant is entitled shall be determined by multiplying the number of shares available for issuance by a fraction, the numerator of which is the number of shares that such Participant has elected to purchase and the denominator of which is the number of shares that all Participants have elected to purchase.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Issuance of Common Stock</u>. Shares may be registered in the name of the Participant or jointly in the name of the Participant and his or her spouse as joint tenants with right of survivorship or as community property.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)<u>Unused Cash Balances</u>. Subject to the following sentence, any amount remaining in the Participant's Plan Account following a purchase of Common Stock shall be carried over in the Participant's Plan Account to the next Offering Period or, if the Participant's participation is not continuing, promptly refunded to the Participant in cash, without interest. Any amount remaining in the Participant's Plan Account following a purchase of Common Stock that represents the Purchase Price for whole or fractional shares that could not be purchased by reason of Section 8(c), Section 8(d), Section 9(b) or Section 14(a) shall be promptly refunded to the Participant in cash, without interest.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)<u>Stockholder Approval</u>. The Plan shall be submitted to the stockholders of the Company for their approval within twelve (12) months after the date the Plan is adopted by the Board. Any other provision of the Plan notwithstanding, no shares of Common Stock shall be

------

purchased under the Plan unless and until the Company's stockholders have approved the adoption of the Plan.

<u>SECTION 9</u><u>Limitations on Stock Ownership.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Five Percent Limit</u>. Any other provision of the Plan notwithstanding, no Participant shall be granted a right to purchase Common Stock under the Plan if such Participant, immediately after his or her election to purchase such Common Stock, would own shares of Common Stock, together with any other equity interests, representing 5% or more of the total combined voting power or value of all classes of stock of the Company or any parent or Subsidiary of the Company. For purposes of this Section 9(a), the following rules shall apply:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Ownership of stock shall be determined after applying the attribution rules of Section 424(d) of the Code;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)Each Participant shall be deemed to own any stock that he or she has a right or option to purchase under this or any other plan; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)Each Participant shall be deemed to have the right to purchase up to the maximum number of shares of Common Stock that may be purchased by a Participant under this Plan under the individual limit specified pursuant to Section 8(c) with respect to each Offering Period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Dollar Limit</u>. Any other provision of the Plan notwithstanding, no Participant shall accrue the right to purchase Common Stock at a rate which exceeds $25,000 of Fair Market Value of such Common Stock per calendar year (under this Plan and all other employee stock purchase plans of the Company or any parent or Subsidiary of the Company), determined in accordance with the provisions of Section 423(b)(8) of the Code and applicable Treasury Regulations promulgated thereunder.

For purposes of this Section 9(b), the Fair Market Value of Common Stock shall be determined as of the beginning of the Offering Period in which such Common Stock is purchased. Employee stock purchase plans not described in Section 423 of the Code shall be disregarded, and this dollar limit shall not apply to such plans. If a Participant is precluded by this Section 9(b) from purchasing additional Common Stock under the Plan, then his or her employee contributions shall automatically be discontinued and shall resume at the beginning of the earliest Offering Period ending in the next calendar year (if he or she then is an Eligible Employee).

<u>SECTION 10</u><u>Rights Not Transferable.</u>

The rights of any Participant under the Plan, or any Participant's interest in any Common Stock or cash to which he or she may be entitled under the Plan, shall not be transferable by voluntary or involuntary assignment or by operation of law, or in any other manner other than by the laws of descent and distribution. If a Participant in any manner attempts to transfer, assign or otherwise encumber his or her rights or interest under the Plan, other than by the laws of descent

------

and distribution, then such act shall be treated as an election by the Participant to withdraw from the Plan under Section 6(a).

<u>SECTION 11</u><u>No Rights as an Employee.</u>

Nothing in the Plan or in any right granted under the Plan shall confer upon any Eligible Employee or Participant any right to become or remain an employee of a Participating Company (or any affiliate thereof) or interfere with or otherwise restrict in any way the rights of the Participating Company (or any affiliate thereof), which rights are hereby expressly reserved, to terminate the employment of such person at any time and for any reason, with or without cause, except as otherwise restricted by applicable law.

<u>SECTION 12</u><u>No Rights as a Stockholder.</u>

A Participant shall have no rights as a stockholder with respect to any shares of Common Stock that he or she may have a right to purchase under the Plan unless and until such shares have been purchased on the applicable Purchase Date.

<u>SECTION 13</u><u>Securities Law Requirements.</u>

Shares of Common Stock shall not be issued under the Plan unless the issuance and delivery of such shares comply with (or are exempt from) all applicable requirements of law, including (without limitation) the Securities Act of 1933, as amended, the rules and regulations promulgated thereunder, state securities laws and regulations, and the regulations of any stock exchange or other securities market on which the Company's securities may then be traded, to the extent applicable.

<u>SECTION 14</u><u>Stock Offered under the Plan.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Authorized Shares</u>. The maximum aggregate number of shares of Common Stock available for purchase under the Plan is 1,000,000 shares. The aggregate number of shares of Common Stock available for purchase under the Plan shall at all times be subject to adjustment pursuant to Section 14(b).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Anti-dilution Adjustments</u>. The aggregate number of shares of Common Stock offered under the Plan, the individual and aggregate Participant share limitations described in Section 8(c) and the price of shares that any Participant has elected to purchase shall be adjusted proportionately by the Committee in the event of any change in the number of issued shares of Common Stock (or issuance of shares other than Common Stock) by reason of any forward or reverse share split, subdivision or consolidation, or share dividend or bonus issue, recapitalization, reclassification, merger, amalgamation, consolidation, split-up, spin-off, reorganization, combination, exchange of shares of Common Stock, or any other change in corporate structure or in the event of any extraordinary distribution (whether in the form of cash, shares of Common Stock, other securities or other property).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Reorganizations</u>. Any other provision of the Plan notwithstanding, in the event of a Corporate Reorganization in which the Plan is not assumed by the surviving corporation or its parent corporation pursuant to the applicable plan of merger or consolidation, the Offering

------

Period then in progress shall terminate immediately prior to the effective time of such Corporate Reorganization and either shares of Common Stock shall be purchased pursuant to Section 8 or, if so determined by the Board or Committee, all amounts in all Participant Accounts shall be refunded pursuant to Section 15 without any purchase of shares of Common Stock. The Plan shall in no event be construed to restrict in any way the Company's right to undertake a dissolution, liquidation, merger, consolidation or other reorganization.

<u>SECTION 15</u><u>Amendment or Discontinuance.</u>

The Board or Committee shall have the right to amend, suspend or terminate the Plan at any time and without notice. Upon any such amendment, suspension or termination of the Plan during an Offering Period, the Board or Committee may in its discretion determine that the applicable Offering shall immediately terminate and that all amounts in the Participant Accounts shall be carried forward into a payroll deduction account for each Participant under a successor plan, if any, or promptly refunded to each Participant. Except as provided in Section 14, any increase in the aggregate number of shares of Common Stock to be issued under the Plan shall be subject to approval by a vote of the stockholders of the Company. In addition, any other amendment of the Plan shall be subject to approval by a vote of the stockholders of the Company to the extent required by applicable law or regulation. This Plan shall continue until the earlier to occur of (a) termination of this Plan pursuant to this Section 15 or (b) issuance of all of the shares of Common Stock reserved for issuance under this Plan.

<u>SECTION 16</u><u>Execution.</u>

To record the adoption of the Plan by the Board, the Company has caused its authorized officer to execute the same.

CONCENTRIX CORPORATION

By: <u>/s/ Steven L. Richie</u> 

Name: Steven L. Richie

Title: Executive Vice President, Legal

Date: December 1, 2020

------

CONCENTRIX CORPORATION

INTERNATIONAL EMPLOYEE STOCK PURCHASE PLAN

(as adopted by the Board of Directors on November 12, 2020)

(Effective on December 1, 2020)

(A Sub-Plan of the Concentrix Corporation 2020 Employee Stock Purchase Plan)

<u>SECTION 1</u><u>Purpose of the Sub-Plan.</u>

Concentrix Corporation (the "<u>Company</u>") adopts this Concentrix Corporation International Employee Stock Purchase Plan (the "<u>Sub-Plan</u>"), effective as of December 1, 2020 to provide Eligible Employees (as defined below) of Participating Companies organized in jurisdictions outside of the United States (each such Participating Company, an "<u>Employer</u>") with an opportunity to increase their proprietary interest in the success of the Company by purchasing Common Stock from the Company on favorable terms and to pay for such purchases through payroll deductions. The Sub-Plan is a component of the Concentrix Corporation Employee Stock Purchase Plan (the "<u>Plan</u>") and subject to the terms and conditions of the Plan to the extent not provided otherwise herein. However, the Sub-Plan is not intended to qualify as an "employee stock purchase plan" under Section 423 of the Code. In the event of any inconsistency between this Sub-Plan and the Plan, the terms of the Sub-Plan prevail. Any terms that are capitalized but not otherwise defined herein shall have the respective meanings assigned to them in the Plan.

<u>SECTION 2</u><u>Definitions.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)"<u>Eligible Employee</u>" means any employee of a Participating Company who has rendered services as an employee for at least six (6) months after the employee's date of hire with the Company or a Participating Company and whose customary employment is for more than five (5) months per calendar year and for more than twenty (20) hours per week that the Company, in its sole discretion, determines shall receive an Invitation. The foregoing notwithstanding, an individual shall not be considered an Eligible Employee if his or her participation in the Plan is prohibited by the law of any country which has jurisdiction over him or her.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)"<u>Invitation</u>" means the written or electronic offering document inviting an Eligible Employee to participate in the Sub-Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)"<u>Participant</u>" means an Eligible Employee who received an Invitation to participate in the Sub-Plan, who elects to participate in the Sub-Plan in accordance with the terms hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)"<u>Section</u>" means the applicable section of this Sub-Plan, unless expressly identified as a reference to the applicable section of the Plan.

------

<u>SECTION 3</u><u>Enrollment and Participation.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Offering Periods</u>. While the Sub-Plan is in effect, the Committee may from time to time, in its discretion, issue or cause to be issued an Invitation on behalf of the Company to any Eligible Employee to purchase shares of Common Stock pursuant to the Plan during a specified Offering Period. Each such Invitation shall be in such form and shall contain such terms and conditions as the Committee shall determine, subject to compliance with the terms and conditions of the Sub-Plan (which may be incorporated by reference) and the requirements of applicable law. An Invitation must be issued with an enrollment form and such explanatory or other material in respect of the Plan and Sub-Plan as the Committee or the Company in its discretion considers appropriate, or as required by applicable law. The Committee or the Company may in its absolute discretion amend an Invitation for any reason at any time prior to the enrollment deadline for the applicable Offering Period. The Committee shall specify prior to the commencement of each Offering (i) the period during which the Offering shall be effective, which may not exceed 27 months from the Offering Date and may include one or more successive Purchase Periods within the Offering, (ii) the Purchase Dates and Purchase Price for shares of Common Stock which may be purchased pursuant to the Offering, and (iii) if applicable, any limits on the number of shares purchasable by a Participant, or by all Participants in the aggregate, during any Offering Period or, if applicable, Purchase Period, in each case consistent with the limitations of the Sub-Plan. The Committee shall have the discretion to provide for the automatic termination of an Offering following any Purchase Date on which the Fair Market Value of a share of Common Stock is equal to or less than the Fair Market Value of a share of Common Stock on the Offering Date, and for the Participants in the terminated Offering to be automatically re-enrolled in a new Offering that commences immediately after such Purchase Date. The terms and conditions of each Offering need not be identical, and shall be deemed incorporated by reference and made a part of the Sub-Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Enrollment</u>. Any individual who, on the day preceding the first day of an Offering Period, qualifies as an Eligible Employee may elect to become a Participant in the Sub-Plan for such Offering Period in response to an Invitation by returning a duly completed enrollment form on or before the relevant enrollment deadline. By returning a duly completed enrollment form, an Eligible Employee: (i) authorizes his or her Employer to make the relevant payroll deductions from the Eligible Employee's Compensation on each applicable payday and to pay or apply such amounts to the purchase of Common Stock under the Sub-Plan; (ii) agrees to be bound by the terms of the Invitation, the enrollment form, the Plan and the Sub-Plan; and (iii) accepts and consents to any action taken under the Sub-Plan by the Committee, the Company or the Employer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Duration of Participation</u>. Once enrolled in the Sub-Plan, a Participant shall continue to participate in the Sub-Plan until he or she ceases to be an Eligible Employee or withdraws from the Plan. A Participant who remains an Eligible Employee through an Offering Period shall be deemed to remain a Participant in the immediately following Offering Period unless the Company, in its sole discretion, determines that the Participant is no longer an Eligible Employee. Notwithstanding the foregoing, if a Participant ceases to be an Eligible Employee due to a transfer of employment to the Company or another Subsidiary, then no further payroll deductions will be made on behalf of the Participant under the Sub-Plan, the amount credited to the Participant's Plan Account shall be applied to the purchase of whole shares of Common

------

Stock on the applicable Purchase Date, and any balance credited to the Participant's Plan Account shall be returned to the Participant in one lump sum payment as soon as practicable thereafter, without any interest thereon. After such purchase, the Participant shall cease to participate in the Sub-Plan. A Participant who withdrew from the Plan may again become a Participant, if he or she then is an Eligible Employee, by following the procedure described in Section 3(b). Termination of employment as an Eligible Employee for any reason, including death, shall be treated as an automatic withdrawal from the Plan under Section 6 of the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Dollar Limit</u>. Any other provision of the Sub-Plan notwithstanding, no Participant shall accrue the right to purchase Common Stock at a rate which exceeds $25,000 of Fair Market Value of such Common Stock per calendar year (under this Plan and all other employee stock purchase plans of the Company or any parent or Subsidiary of the Company). For purposes of this Section 3(d), the Fair Market Value of Common Stock shall be determined as of the beginning of the Offering Period in which such Common Stock is purchased. If a Participant is precluded by this Section 3(d) from purchasing additional Common Stock under the Plan, then his or her employee contributions shall automatically be discontinued and shall resume at the beginning of the earliest Offering Period ending in the next calendar year (if he or she then is an Eligible Employee).

<u>SECTION 4</u><u>Employee Contributions.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Frequency of Payroll Deductions</u>. A Participant may purchase shares of Common Stock under the Plan solely by means of payroll deductions; provided, however, that to the extent provided in the terms and conditions of an Offering, a Participant may also make contributions through payment by cash or check prior to one or more Purchase Dates during the Offering. Payroll deductions, subject to the provisions of Section 4(b) or as otherwise provided under the terms and conditions of an Offering, shall occur on each payday during participation in the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Amount of Payroll Deductions</u>. An Eligible Employee shall designate during the enrollment process the portion of his or her Compensation that he or she elects to have withheld for the purchase of Common Stock. Such portion shall be a whole percentage of the Eligible Employee's Compensation, but not less than 1% nor more than 15% (or such lower rate of Compensation specified as the limit in the terms and conditions of the applicable Offering). Unless otherwise determined by the Committee, the amount of an Eligible Employee's Compensation that may be withheld for the purchase of Common Stock shall not exceed an amount per calendar year that is equal to the product of (x) $25,000 multiplied by (y) the percentage of Fair Market Value utilized for the Purchase Price, as set forth in Section 8(b) of the Plan, as such limit is converted into the applicable local currency in accordance with Section 5(b).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Changing Withholding Rate</u>. Unless otherwise provided under the terms and conditions of an Offering, a Participant may not increase the rate of payroll withholding during the Offering Period, but may decrease the rate of payroll withholding during the Offering Period to a whole percentage of his or her Compensation in accordance with such procedures and subject to such limitations as the Company may establish for all Participants. A Participant may also increase or decrease the rate of payroll withholding effective for a new Offering Period by submitting an authorization to change the payroll deduction rate pursuant to the process

------

prescribed by the Company from time to time. The new withholding rate shall be a whole percentage of the Eligible Employee's Compensation consistent with Section 4(b).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Discontinuing Payroll Deductions</u>. If a Participant wishes to discontinue employee contributions entirely, he or she may do so by withdrawing from the Plan pursuant to Section 6 of the Plan. In addition, employee contributions may be discontinued automatically as provided in Section 3(d).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Plan Account</u>. Pending purchase of shares of Common Stock in accordance with Section 5, a Participant's accumulated contributions will be credited to a Plan Account on behalf of the Participant in the local currency in which the Participant's salary is paid. The Participant's Employer may, but is not obligated to, establish a bank or other custodial account to hold contributions pending application to the purchase of Common Stock. However, amounts credited to Plan Accounts shall not be trust funds and may be commingled with the Employer's or the Company's general assets and applied to general corporate purposes. No interest will accrue, be credited or be paid to Participants in respect of any amounts credited to the Participant's Plan Account.

<u>SECTION 5</u><u>Conversion of Plan Account into U.S. Currency.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Conversion to U.S. Dollars</u>. For the purposes of determining the number of shares of Common Stock subject to purchase by a Participant on a Purchase Date, the amount accumulated as of the relevant Purchase Date and credited to the Participant's Plan Account on such Purchase Date shall be converted from local currency into U.S. currency on the relevant Purchase Date or such other time as the Company, in its discretion, may reasonably establish, and at the exchange rate utilized on the Company's general ledger, or at such other exchange rate, as the Company, in its discretion, may reasonably utilize.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Conversion to Local Currency</u>. If an Employer returns to a Participant any amounts credited to the Participant's Plan Account, it must do so in the Participant's local currency (converted, if necessary, at such time as the Company, in its discretion, may reasonably establish and at the exchange rate utilized on the Company's general ledger or such other exchange rate as the Company, in its discretion, may reasonably utilize).

<u>SECTION 6</u><u>Miscellaneous.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Effect of Addenda</u>. From time to time, the Committee may adopt one or more country-specific addenda for the purpose of specifying additional or different terms and conditions applicable to Eligible Employees of Employers located in the relevant country. In case of any conflict between the provisions in the body of the Sub-Plan and the provision in the applicable addendum, the terms of the addendum govern.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Effect of Certain Plan Terms</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Sections 4, 5, 7(a), 8(a) and 9(b) of the Plan do not apply to the Sub-Plan.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)Any adjustments to shares of Common Stock provided under Section 14(b) of the Plan, including any changes to the Purchase Price, Purchase Date or number of shares of Common Stock, shall be subject to applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)All Sections of the Plan not identified in Section 2 or this Section 6(b) apply to the Sub-Plan as if set forth verbatim herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>No Retention Rights</u>. No provision in the Plan, Sub-Plan or any Invitation available under the Sub-Plan shall be construed to give any Eligible Employee or Participant any right to become or remain an employee of an Employer (or any affiliate thereof) or interfere with or restrict in any way the rights of an Employer (or applicable affiliate thereof), which rights are expressly reserved, to terminate the employment of such person at any time and for any reason, with or without cause, except as otherwise restricted by applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>No Guaranty of Gain</u>. None of the Company, its Subsidiaries or the Employer guaranties that the value of Common Stock will increase during or after the Offering Period. Among other factors, the value of Common Stock to a Participant varies according to its demand on the stock market and changes in the exchange rate between the applicable local currency and the U.S. dollar.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Waiver.</u> No failure, delay or indulgence by a party in exercising any power or right under the Sub-Plan will operate as a waiver of such power or right. No single exercise of any power or right under the Sub-Plan will preclude any other or future exercise of that (or any other) power or right.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)<u>Severability</u>. If any provision of the Sub-Plan is rendered void, unenforceable or otherwise ineffective, such avoidance, unenforceability or ineffectiveness will not affect the enforceability of the remaining provisions of this Sub-Plan or any provision of the Plan.

<u>SECTION 7</u><u>Execution.</u>

To record the adoption of the Sub-Plan by the Board, the Company has caused its authorized officer to execute the same.

CONCENTRIX CORPORATION

By: <u>/s/ Steven L. Richie</u> 

Name: Steven L. Richie

Title: Executive Vice President, Legal

Date: December 1, 2020

## Exhibit 21.1

**Exhibit 21.1**

**Subsidiaries of the Company**

(as of November 30, 2025)

---

| | |
|:---|:---|
| **<u>Name of Subsidiary</u><br>** | **<u>Jurisdiction of Organization</u>** |
| ABC Consulting S.A. | Argentina |
| Beijing Jumeng Technology Development Ltd. | China |
| Bin Call Services Joint Stock Company | Türkiye |
| C Automobile Services France | France |
| CCS France | France |
| CGE France | France |
| Chongqing Jumeng Technologies Development Ltd. | China |
| CNX Services Jamaica Limited | Jamaica |
| CNXC CUSTOMER EXPERIENCE SPAIN, S.L. | Spain |
| CNXC Services Curaçao B.V. | Curacao |
| Concentrix (Canada) Limited | Ontario |
| Concentrix (Suzhou) Data Services Co. Ltd. | China |
| Concentrix (Suzhou) Information Consulting Co., Ltd. | China |
| Concentrix Afrique | Morocco |
| Concentrix Agadir | Morocco |
| Concentrix Albania Shpk | Albania |
| Concentrix Angers France | France |
| Concentrix Austria GmbH | Austria |
| Concentrix Benin | Benin |
| Concentrix BH d.o.o. Sarajevo | Bosnia-Herzegovina |
| Concentrix BPO Consulting Peru S.A.C. | Peru |
| Concentrix Brasil Terceirizacao de Processos, Servicos Administrativos e Tecnologia Empresarial Ltda | Brazil |
| Concentrix Business Services UK Limited | England and Wales |
| Concentrix Caen France | France |
| Concentrix Catalyst Canada, Inc. | British Columbia |
| Concentrix Catalyst France | France |
| Concentrix Catalyst FZCO | United Arab Emirates |
| Concentrix Catalyst Holdings Pty. Ltd. | Australia |
| Concentrix Catalyst LTD | United Kingdom |
| Concentrix Catalyst MX Holdings LLC | Delaware |
| Concentrix Catalyst Pty. Ltd. | Australia |
| Concentrix Catalyst Romania S.A. | Romania |
| Concentrix Catalyst Technologies Private Limited | India |
| Concentrix Catalyst Technology Mexico, S.A. de C.V. | Mexico |
| Concentrix Catalyst USA Holdings, LLC | Nevada |
| Concentrix Compiègne France | France |
| Concentrix Conseil France | France |
| Concentrix Contact Center | Morocco |
| Concentrix Costa Rica, S.A. | Costa Rica |
| Concentrix Cote D'Ivoire | Cote D'Ivoire |
| Concentrix CRM Colombia S.A.S | Colombia |

---

------

---

| | |
|:---|:---|
| Concentrix CRM Services Germany GmbH | Germany |
| Concentrix CRM Services UK Limited | United Kingdom |
| Concentrix Customer Services Joint Stock Company | Türkiye |
| Concentrix CVG (Mauritius) Ltd | Mauritius |
| Concentrix CVG Brite Voice Systems, LLC | Kansas |
| Concentrix CVG CMG Canada ULC | Nova Scotia |
| Concentrix CVG CMG Insurance Services LLC | Ohio |
| Concentrix CVG CMG UK Limited | United Kingdom |
| Concentrix CVG Contact Tunisie S.A.R.L. | Tunisia |
| Concentrix CVG Corporation | Delaware |
| Concentrix CVG Customer Management Colombia S.A.S. | Colombia |
| Concentrix CVG Customer Management Delaware LLC | Delaware |
| Concentrix CVG Customer Management Group Inc. | Ohio |
| Concentrix CVG Customer Management Group Inc. Costa Rica Branch | Costa Rica |
| Concentrix CVG Customer Management International Inc. | Ohio |
| Concentrix CVG Delaware Inc. | Delaware |
| Concentrix CVG Delaware International Inc. | Delaware |
| Concentrix CVG Delaware International Inc. French Branch | France |
| Concentrix CVG Egypt Limited Liability Company | Egypt |
| Concentrix CVG Funding Inc. | Kentucky |
| Concentrix CVG Global Services El Salvador, S.A. de C.V. | El Salvador |
| Concentrix CVG Global Services Honduras, S.A. | Honduras |
| Concentrix CVG Global Services Hong Kong Limited | Hong Kong |
| Concentrix CVG Government Solutions LLC | Ohio |
| Concentrix CVG Group Limited | United Kingdom |
| Concentrix CVG Holding LLC | Delaware |
| Concentrix CVG Intelligent Contact Limited | United Kingdom |
| Concentrix CVG International Nordic AB | Sweden |
| Concentrix CVG International sp. z o.o. | Poland |
| Concentrix CVG Ireland Contact Services Limited | Ireland |
| Concentrix CVG Ireland Limited | Ireland |
| Concentrix CVG Italy S.R.L. | Italy |
| Concentrix CVG LLC | Texas |
| Concentrix CVG Malaysia (Philippines) SDN. BHD. | Malaysia |
| Concentrix CVG Malaysia (Philippines) SDN. BHD. Philippine Branch | Philippines |
| Concentrix CVG Malaysia SDN. BHD. | Malaysia |
| Concentrix CVG Philippines, Inc. | Philippines |
| Concentrix CVG Services Singapore Pte. Ltd. | Singapore |
| Concentrix CVG Services Singapore Pte. Ltd. ROHQ | Philippines |
| Concentrix CVG Servicios Informáticos, S.L. | Spain |
| Concentrix CVG Singapore Holdings Pte. Ltd. | Singapore |
| Concentrix CVG Singapore Holdings Pte. Ltd. ROHQ | Philippines |
| Concentrix CVG South Africa (Pty) Ltd | South Africa |
| Concentrix CVG Tunisie BPO S.A.R.L. | Tunisia |
| Concentrix CX (Thailand) Co., Ltd. | Thailand |

---

------

---

| | |
|:---|:---|
| Concentrix CX Australia Pty. Ltd. | Australia |
| Concentrix CX Colombia S.A.S. | Colombia |
| Concentrix CX France | France |
| Concentrix CX Malaysia SDN. BHD. | Malaysia |
| Concentrix CX Nicaragua S.A. | Nicaragua |
| Concentrix CX Technologies Ltd | Ghana |
| Concentrix CX UK Limited | United Kingdom |
| Concentrix CyberProtect US, Inc. | Delaware |
| Concentrix Czech Republic, s.r.o. | Czech Republic |
| Concentrix d.o.o. Beograd | Serbia |
| Concentrix Daksh Services India Private Limited | India |
| Concentrix Daksh Services Philippines Corporation | Philippines |
| Concentrix Denmark A/S | Denmark |
| Concentrix Digital Services Limited | United Kingdom |
| Concentrix DOOEL Skopje | Republic of North Macedonia |
| Concentrix Düsseldorf GmbH | Germany |
| Concentrix EMEA Financing Center B.V. | Netherlands |
| Concentrix Estonia Oü | Estonia |
| Concentrix Europe Limited | United Kingdom |
| Concentrix Experts Colombia SAS | Colombia |
| Concentrix Fes | Morocco |
| Concentrix Finland OY | Finland |
| Concentrix Fontenay Le Comte France | France |
| Concentrix Frankfurt a. M. GmbH | Germany |
| Concentrix Free Trade Zone, S.A. | Costa Rica |
| Concentrix Germany GmbH | Germany |
| Concentrix Global Services GmbH | Germany |
| Concentrix Global Services Inc. | Delaware |
| Concentrix Global Services Inc. Philippine Branch | Philippines |
| Concentrix Gray France | France |
| Concentrix GRC | Morocco |
| Concentrix Greece Single Member Limited Liability Company | Greece |
| Concentrix Guatemala S.A. | Guatemala |
| Concentrix Health Management Services, Inc. | Philippines |
| Concentrix Healthcare Services LLC | Delaware |
| Concentrix Healthcare Services LLC Philippine Branch | Philippines |
| Concentrix HK Limited | Hong Kong |
| Concentrix Holding Germany GmbH | Germany |
| Concentrix Holding Germany GmbH | Slovenia |
| Concentrix Human Resource Consultancy and Support Services Joint Stock Company | Türkiye |
| Concentrix India Private Limited | India |
| Concentrix International Colombia S.A.S | Colombia |
| Concentrix International Europe B.V. | Netherlands |

---

------

---

| | |
|:---|:---|
| Concentrix International Europe B.V. (Branch) | Dominican Republic |
| Concentrix International GmbH | Germany |
| Concentrix Investment Holdings Singapore 3 Pte.Ltd. | Singapore |
| Concentrix Investments Europe B.V. | Netherlands |
| Concentrix Israel Ltd | Israel |
| Concentrix IT Services Sweden AB | Sweden |
| Concentrix KYC Services | France |
| Concentrix Latvia SIA | Latvia |
| Concentrix Le Workshop Cote D'Ivoire | Cote D'Ivoire |
| Concentrix Legal Services Co., Ltd (Branch- Hochiminh City) | Vietnam |
| Concentrix Legal Services Co., Ltd. | Vietnam |
| Concentrix Lisboa, Unipessoal LDA | Portugal |
| Concentrix Lithuania UAB | Lithuania |
| CONCENTRIX LOGBOX USA INC. | New York |
| Concentrix Madagascar | Madagascar |
| Concentrix Malaysia Sdn. Bhd. | Malaysia |
| Concentrix Management Holding B.V. & Co. KG | Germany |
| Concentrix Management Service (UK) LTD | United Kingdom |
| Concentrix Maroc | Morocco |
| Concentrix Marrakech | Morocco |
| Concentrix Medica Customer Expérience France | France |
| Concentrix Medica France | France |
| Concentrix Medica UK LTD | United Kingdom |
| Concentrix Meknes | Morocco |
| Concentrix Mexico, S. de R.L. de C.V. | Mexico |
| Concentrix Montcau France | France |
| Concentrix Multimedia | Morocco |
| Concentrix Nederland B.V. | Netherlands |
| Concentrix Netherlands CRM Services B.V. | Netherlands |
| Concentrix Netherlands Customer Contact Performance Group B.V. | Netherlands |
| Concentrix Netherlands CX Holding B.V. | Netherlands |
| Concentrix Netherlands Holdco One B.V. | Netherlands |
| Concentrix Netherlands Holdco Three B.V. | Netherlands |
| Concentrix Netherlands Holdco Three B.V. | Netherlands |
| Concentrix Netherlands Holdco Two B.V. | Netherlands |
| Concentrix Netherlands Holding B.V. | Netherlands |
| Concentrix Nicaragua S.A. | Nicaragua |
| Concentrix Norte, Unipessoal LDA | Portugal |
| Concentrix Norway AS | Norway |
| Concentrix Norway Consulting AS | Norway |
| Concentrix O2C Holding | France |
| Concentrix Oeiras, Unipessoal Lda | Portugal |
| Concentrix Payment Services Benelux | Belgium |
| Concentrix Payment Services Deutschland GmbH | Germany |
| Concentrix Payment Services Espana S.A.U | Spain |

---

------

---

| | |
|:---|:---|
| Concentrix Payment Services Espana S.A.U. Sucrsal Em Portugal | Portugal |
| Concentrix Payment Services France SAS | France |
| Concentrix Payment Services France SAS (Italy Branch) | Italy |
| Concentrix Payment Services Italia S.R.L. | Italy |
| Concentrix Payment Services Technology France | France |
| Concentrix Payment Services UK Limited | United Kingdom |
| Concentrix Prestations France | France |
| Concentrix Receivables, Inc. | Delaware |
| Concentrix Romania S.R.L. | Romania |
| Concentrix S.A.S. France | France |
| Concentrix S.A.S/Jordan/L.L.C. | Jordan |
| Concentrix SAS - Sucursal Em Portugal | Portugal |
| Concentrix Schweiz AG (English: Concentrix Switzerland AG) | Switzerland |
| Concentrix Senegal SASU | Senegal |
| Concentrix Services | Morocco |
| Concentrix Services (Dalian) Co., Ltd. | China |
| Concentrix Services (Dalian) Co., Ltd. Dalian Branch | China |
| Concentrix Services (Dalian) Co., Ltd. Foshan Branch | China |
| Concentrix Services (Dalian) Co., Ltd. Shanghai Branch | China |
| Concentrix Services (Dalian) Co., Ltd. Shenzhen Branch | Guang Dong |
| Concentrix Services (Dalian) Co., Ltd. Suzhou Branch | Jiangsu |
| Concentrix Services (Dalian) Co., Ltd. Xi'an Branch | China |
| Concentrix Services (Dalian) Co., Ltd. Yanji Branch | Jilin |
| Concentrix Services (Georgia) LLC | Georgia |
| Concentrix Services (Germany) GmbH | Germany |
| Concentrix Services (Ireland) Limited | Ireland |
| Concentrix Services (Netherlands) B.V. | Netherlands |
| Concentrix Services (New Zealand) Limited | New Zealand |
| Concentrix Services (Saudi Arabia) Corporation LLC | Saudi Arabia |
| Concentrix Services (Thailand) Co., Ltd. | Thailand |
| Concentrix Services (Uruguay) S.A. | Uruguay |
| Concentrix Services B.V. | Netherlands |
| Concentrix Services B.V. Philippine Branch | Philippines |
| Concentrix Services Bulgaria EOOD | Bulgaria |
| Concentrix Services Hungary Kft. | Hungary |
| Concentrix Services India Private Limited | India |
| Concentrix Services Korea Limited | Korea, Republic Of |
| Concentrix Services LLC | Croatia |
| Concentrix Services Mexico, S.A. de C.V. | Mexico |
| Concentrix Services Philippines, Inc. | Philippines |
| Concentrix Services Portugal, Sociedade Unipessoal, LDA | Portugal |
| Concentrix Services Pty Ltd ROHQ | Philippines |
| Concentrix Services Pty. Ltd. | Australia |
| Concentrix Services Slovakia s.r.o. | Slovakia |
| Concentrix Services UK Limited | England and Wales |

---

------

---

| | |
|:---|:---|
| Concentrix Services US, Inc. | Delaware |
| Concentrix Servicios Colombia S.A.S | Colombia |
| Concentrix SFIA - Sucursal em Portugal | Portugal |
| Concentrix SFIA France | France |
| Concentrix Slovakia s.r.o. | Slovakia |
| Concentrix Software Technologies (HK) Limited | Hong Kong |
| Concentrix Solutions Corporation | New York |
| Concentrix Solutions Guatemala S.A. | Guatemala |
| Concentrix South Africa (Pty) Ltd | South Africa |
| Concentrix Spain Business Process Outsourcing, S.L. | Spain |
| Concentrix Spain Holding, S.L. | Spain |
| Concentrix Spain NWE Services, S.L. | Spain |
| Concentrix SREV Bulgaria EOOD | Bulgaria |
| Concentrix SREV Delaware, Inc. | Delaware |
| Concentrix SREV Europe Limited | Ireland |
| Concentrix SREV Europe UK Limited | United Kingdom |
| Concentrix SREV Malaysia SDN. BHD. | Malaysia |
| Concentrix SREV Philippines, Inc. | Philippines |
| Concentrix SREV Singapore Pte. Ltd. | Singapore |
| Concentrix SREV, Inc. | Delaware |
| Concentrix Succursale CI (Ivory Coast Branch) | Cote D'Ivoire |
| Concentrix Succursale Maroc | Morocco |
| Concentrix Succursale Senegal | Senegal |
| Concentrix Sun Portugal Lda | Portugal |
| Concentrix Suriname N.V. | Suriname |
| Concentrix Sweden AB | Sweden |
| Concentrix Technologies (India) Private Limited | India |
| Concentrix Technologies Services (Canada) ULC | Nova Scotia |
| Concentrix Technopolis | Morocco |
| Concentrix TSC UK LTD | United Kingdom |
| Concentrix UK Holdings LTD | United Kingdom |
| Concentrix UK Trading LTD | United Kingdom |
| Concentrix University France | France |
| Concentrix University Maroc | Morocco |
| Concentrix US Holdings, Inc. | Delaware |
| Concentrix Verwaltungs GmbH | Austria |
| Concentrix Vitré France | France |
| Concentrix VN Technologies Services Company Limited | Vietnam |
| Concentrix Wuppertal GmbH | Germany |
| Concentrix Xperts Guatemala S.A. | Guatemala |
| Convergys Customer Management International Inc. - Regional Operating Headquarters | Philippines |
| Convergys Holdings (GB) Limited | United Kingdom |
| Convergys Holdings (UK) Limited | United Kingdom |
| Convergys India Services Private Limited | India |

---

------

---

| | |
|:---|:---|
| Convergys International Inc. | Delaware |
| CTG France | France |
| Dalian Jumeng Information Services Ltd. | China |
| Dalian Jumeng Technologies Development Ltd. | China |
| Direct Medica Iberica S.L. | Spain |
| DMHP Direct Medica Portugal, Lda | Portugal |
| Encore Receivable Management, Inc. (Philippines Branch) | Philippines |
| Encore Receivable Management, Inc (Costa Rica Branch) | Costa Rica |
| Encore Receivable Management, Inc. | Kansas |
| Encore Receivable Management, Inc. (branch in South Africa) | South Africa |
| Encore Receivable Management, Inc. Sucursal Colombia | Colombia |
| eTelecare Philippines, Inc. | Philippines |
| EXQ Service LLC | Kosovo |
| Foshan Jumeng Information Technology Service Co., Ltd. | China |
| Getcom International SA de CV | El Salvador |
| Gobeyond Partners Asia Limited | Hong Kong |
| Grupo Services SA | Brazil |
| Guiyang Jumeng Technology Development Ltd. | China |
| Intervoice Acquisition Subsidiary, Inc. | Nevada |
| Intervoice GmbH | Germany |
| Intervoice GP, Inc. | Nevada |
| Intervoice Limited | United Kingdom |
| Intervoice Limited Partnership | Nevada |
| Intervoice LP, Inc. | Nevada |
| IQ-to-Link GmbH (Kosovo Branch) | Kosovo |
| Japan Concentrix KK | Japan |
| Kayni.com S.A.C. | Peru |
| Les Services Webhelp Inc. | Quebec |
| Marnix French ParentCo S.A.S. | France |
| Marnix Lux S.à r.l. | Luxembourg |
| Marnix S.A.S. | France |
| Netino Madagascar | Madagascar |
| Netino S.A.S. | France |
| Onelink Mexico S.A. de C.V. | Mexico |
| Onelink S.A. de C.V. | El Salvador |
| Onelink Servicios S.A. de C.V. | Mexico |
| OSYRIS LLC | Delaware |
| Patientys S.A.S. | France |
| PT Concentrix Services Indonesia | Indonesia |
| PT Convergys Customer Management Indonesia | Indonesia |
| RH-T SA de CV | El Salvador |
| Righthead GmbH | Germany |
| SAI Digital K.K. | Japan |
| SAI Digital Limited | Hong Kong |
| SAI Digital Limited | Vietnam |

---

------

---

| | |
|:---|:---|
| SAI Digital Limited Korea | Korea, Republic Of |
| SAI Digital PTE LTD | Singapore |
| SAIDIGITAL AGENCY PRIVATE LIMITED | India |
| Sellbytel Group (Branch) | South Africa |
| Sellbytel Group Tunisie S.à r.l | Tunisia |
| Sellbytel Marketing Services India Private Limited | India |
| Services Assessoria Digital Ltda | Brazil |
| Services Tech Experience Inovaçao e technologia em relacionamento Ltda | Brazil |
| SGS Holdings, Inc. | Delaware |
| Shenzhen Shunrong Telecommunication Technologies Ltd | China |
| Sichuan 86Bridge Information Technology Ltd. | China |
| Solvencia S.A.S. | France |
| SPA Concentrix Algerie | Algeria |
| Stream Florida Inc. | Delaware |
| Stream Global Services, Inc. | Delaware |
| Stream Holdings Corporation | Delaware |
| Suzhou Ke Wei Xun Information Services Co., Ltd. | China |
| Teknofix Telecomunication and Information Services Joint Stock Company | Türkiye |
| Tetel SA de CV | El Salvador |
| The Global Email Trustee Limited | United Kingdom |
| Thinkblink Inc. | Philippines |
| Transactel Honduras S.A. de C.V. | Honduras |
| Velami Holdings Corporation | Philippines |
| Vietnam Concentrix Services Company Limited | Vietnam |
| Webhelp Americas LLC | Delaware |
| Webhelp Arabia Telecommunication Company LLC | Saudi Arabia |
| Webhelp Brasil Participaçoes LTDA | Brazil |
| Webhelp Bulgaria EOOD | Bulgaria |
| Webhelp Colombia SAS | Colombia |
| Webhelp Egypt LLC | Egypt |
| Webhelp Enterprise Sales Solutions Italy S.r.l. | Italy |
| Webhelp Japan KK | Japan |
| Webhelp Kosovo L.L.C. | Kosovo |
| Webhelp Mexico, S. de R.L. de C.V. | Mexico |
| Webhelp New Generation Lisbon Unipessoal Lda | Portugal |
| Webhelp Peru S.A.C. | Peru |
| Webhelp Philippines, Inc. | Philippines |
| Webhelp Poland Sp. z o.o. | Poland |
| Webhelp Romania S.R.L. | Romania |
| Webhelp SAS, Sucursal en Espana | Spain |
| Webhelp Sun Holding GmbH | Germany |
| Webhelp USA Group Inc | Delaware |
| Webhelp USA LLC | Delaware |

---

------

Xi'an Jumeng Technologies Development Ltd China <br> Xperts Nicaragua SA Nicaragua

## Exhibit 23.1

**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation by reference in the following Registration Statements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Registration Statements on Form S-3 (Nos. 333-278190 and 333-273277)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Registration Statements on Form S-8 (Nos. 333-251003, 333-262184, 333-262187, 333-269412, 333-277592 and 333-282946)

of our reports dated January 28, 2026, with respect to the consolidated financial statements of Concentrix Corporation and the effectiveness of internal control over financial reporting of Concentrix Corporation included in this Annual Report (Form 10-K) of Concentrix Corporation for the year ended November 30, 2025.

/s/ Ernst & Young LLP

Cincinnati, Ohio

January 28, 2026

## Exhibit 23.2

**Exhibit 23.2**

**Consent of Independent Registered Public Accounting Firm**

We consent to the incorporation by reference in the registration statements (Nos. 333-278190 and 333-273277) on Form S-3 and the registration statements (Nos. 333-251003, 333-262184, 333-262187, 333-269412, 333-277592 and 333-282946) on Form S-8 of our report dated January 28, 2025, except for Note 16, as to which the date is January 28, 2026, with respect to the consolidated financial statements of Concentrix Corporation.

/s/ KPMG LLP

Cincinnati, Ohio

January 28, 2026

## Exhibit 31.1

**Exhibit 31.1**

**SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

I, Christopher Caldwell, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Annual Report on Form 10-K of Concentrix Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| January 28, 2026 | |
| | /s/ Christopher Caldwell |
| | President and Chief Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2**

**SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER**

I, Andre Valentine, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Annual Report on Form 10-K of Concentrix Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| January 28, 2026 | |
| | /s/ Andre Valentine |
| | Chief Financial Officer |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. § 1350**

We, Christopher Caldwell, the President and Chief Executive Officer of Concentrix Corporation (the "Company"), and Andre Valentine, the Chief Financial Officer of the Company, certify for the purposes of section 1350 of chapter 63 of title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of our knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Annual Report of the Company on Form 10-K for the period ended November 30, 2025 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| | /s/ Christopher Caldwell |
| Date: January 28, 2026 | Christopher Caldwell<br>President and Chief Executive Officer |

---

---

| | |
|:---|:---|
| | /s/ Andre Valentine |
| Date: January 28, 2026 | Andre Valentine<br>Chief Financial Officer |

---

The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Report. A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

<br>